TW203050B - - Google Patents
Download PDFInfo
- Publication number
- TW203050B TW203050B TW081104603A TW81104603A TW203050B TW 203050 B TW203050 B TW 203050B TW 081104603 A TW081104603 A TW 081104603A TW 81104603 A TW81104603 A TW 81104603A TW 203050 B TW203050 B TW 203050B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- methyl
- isobutylphenyl
- alkyl
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 113
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 83
- 150000003839 salts Chemical class 0.000 claims abstract description 82
- 238000002360 preparation method Methods 0.000 claims abstract description 65
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 51
- 125000001424 substituent group Chemical group 0.000 claims abstract description 22
- 239000001257 hydrogen Substances 0.000 claims abstract description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 19
- 125000006239 protecting group Chemical group 0.000 claims abstract description 18
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 15
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 13
- -1 isobutylphenyl Chemical group 0.000 claims description 281
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 120
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 103
- 239000007789 gas Substances 0.000 claims description 86
- 238000011049 filling Methods 0.000 claims description 82
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 54
- 239000002253 acid Substances 0.000 claims description 38
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 38
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 23
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 11
- 230000002079 cooperative effect Effects 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 125000003277 amino group Chemical group 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 7
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 150000003973 alkyl amines Chemical class 0.000 claims description 5
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims description 3
- XDLDASNSMGOEMX-UHFFFAOYSA-N benzene benzene Chemical compound C1=CC=CC=C1.C1=CC=CC=C1 XDLDASNSMGOEMX-UHFFFAOYSA-N 0.000 claims description 2
- 230000033228 biological regulation Effects 0.000 claims description 2
- 125000006267 biphenyl group Chemical group 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 2
- 239000004606 Fillers/Extenders Substances 0.000 claims 3
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N isobutyl amine Natural products CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 claims 2
- YQIASAUDDDCAKU-UHFFFAOYSA-N 2-hexylbenzoic acid Chemical compound CCCCCCC1=CC=CC=C1C(O)=O YQIASAUDDDCAKU-UHFFFAOYSA-N 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 229930194542 Keto Natural products 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 229910052797 bismuth Inorganic materials 0.000 claims 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims 1
- CYTQYSOLBGISKD-UHFFFAOYSA-N butan-1-amine;formaldehyde Chemical compound O=C.CCCCN CYTQYSOLBGISKD-UHFFFAOYSA-N 0.000 claims 1
- 229910017052 cobalt Inorganic materials 0.000 claims 1
- 239000010941 cobalt Substances 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- VNEBWJSWMVTSHK-UHFFFAOYSA-L disodium;3-hydroxynaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=CC2=C1 VNEBWJSWMVTSHK-UHFFFAOYSA-L 0.000 claims 1
- DYDNPESBYVVLBO-UHFFFAOYSA-N formanilide Chemical compound O=CNC1=CC=CC=C1 DYDNPESBYVVLBO-UHFFFAOYSA-N 0.000 claims 1
- 239000001307 helium Substances 0.000 claims 1
- 229910052734 helium Inorganic materials 0.000 claims 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical group [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims 1
- 125000004245 indazol-3-yl group Chemical group [H]N1N=C(*)C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- 125000000468 ketone group Chemical group 0.000 claims 1
- OXZMETJYUPZXIZ-UHFFFAOYSA-N methylazanium;phenoxide Chemical compound [NH3+]C.[O-]C1=CC=CC=C1 OXZMETJYUPZXIZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 27
- 125000003118 aryl group Chemical group 0.000 abstract description 21
- 125000002947 alkylene group Chemical group 0.000 abstract description 18
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 9
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract description 7
- 229910052736 halogen Inorganic materials 0.000 abstract description 7
- 150000002431 hydrogen Chemical class 0.000 abstract description 7
- 150000002367 halogens Chemical class 0.000 abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 3
- 125000004450 alkenylene group Chemical group 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 204
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 181
- 101150041968 CDC13 gene Proteins 0.000 description 179
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 116
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 83
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- 238000003756 stirring Methods 0.000 description 50
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 37
- 239000002585 base Substances 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 37
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 35
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 33
- 235000019341 magnesium sulphate Nutrition 0.000 description 33
- 239000002904 solvent Substances 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 32
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000012267 brine Substances 0.000 description 28
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 28
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000012044 organic layer Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 239000000203 mixture Substances 0.000 description 22
- 239000000741 silica gel Substances 0.000 description 22
- 229910002027 silica gel Inorganic materials 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 150000002148 esters Chemical class 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
- 229920002554 vinyl polymer Polymers 0.000 description 12
- 238000003379 elimination reaction Methods 0.000 description 11
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 11
- 235000011054 acetic acid Nutrition 0.000 description 10
- 125000005907 alkyl ester group Chemical group 0.000 description 10
- 238000010898 silica gel chromatography Methods 0.000 description 10
- 229960003604 testosterone Drugs 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 9
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 230000008030 elimination Effects 0.000 description 8
- 125000004494 ethyl ester group Chemical group 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- 150000004702 methyl esters Chemical class 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 125000006242 amine protecting group Chemical group 0.000 description 7
- 239000001273 butane Substances 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- RWRIWBAIICGTTQ-UHFFFAOYSA-N difluoromethane Chemical compound FCF RWRIWBAIICGTTQ-UHFFFAOYSA-N 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229940095102 methyl benzoate Drugs 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 4
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 4
- PWATWSYOIIXYMA-UHFFFAOYSA-N Pentylbenzene Chemical compound CCCCCC1=CC=CC=C1 PWATWSYOIIXYMA-UHFFFAOYSA-N 0.000 description 4
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229940022663 acetate Drugs 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 4
- 125000006309 butyl amino group Chemical group 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 229910000071 diazene Inorganic materials 0.000 description 4
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 3
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 3
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N N-butylamine Natural products CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 235000019445 benzyl alcohol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- GGARKJIWYNVMBF-UHFFFAOYSA-N n-(2-methylpropyl)aniline Chemical group CC(C)CNC1=CC=CC=C1 GGARKJIWYNVMBF-UHFFFAOYSA-N 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 3
- 125000003386 piperidinyl group Chemical group 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 3
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 3
- 229940094989 trimethylsilane Drugs 0.000 description 3
- ADIWYEUMOCNZRS-CQSZACIVSA-N (1r)-1-[4-(2-methylpropyl)phenyl]butan-1-ol Chemical compound CCC[C@@H](O)C1=CC=C(CC(C)C)C=C1 ADIWYEUMOCNZRS-CQSZACIVSA-N 0.000 description 2
- GGFQGSUQOGVNBQ-UHFFFAOYSA-N 1-(1-bromohexyl)-4-(2-methylpropyl)benzene Chemical compound CCCCCC(Br)C1=CC=C(CC(C)C)C=C1 GGFQGSUQOGVNBQ-UHFFFAOYSA-N 0.000 description 2
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 2
- ODWLKBUYETXVEX-UHFFFAOYSA-N 1-[3-fluoro-4-(2-methylprop-1-enyl)phenyl]pentan-1-ol Chemical compound CCCCC(O)C1=CC=C(C=C(C)C)C(F)=C1 ODWLKBUYETXVEX-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 2
- FHIWTZOWCILSIC-UHFFFAOYSA-N 1-phenylpyridin-1-ium Chemical compound C1=CC=CC=C1[N+]1=CC=CC=C1 FHIWTZOWCILSIC-UHFFFAOYSA-N 0.000 description 2
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IWPFQZYKVVFMBC-UHFFFAOYSA-N 4-(cyclopropylmethyl)benzaldehyde Chemical compound C1=CC(C=O)=CC=C1CC1CC1 IWPFQZYKVVFMBC-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 206010020112 Hirsutism Diseases 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 2
- 150000008046 alkali metal hydrides Chemical class 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- JPYQFYIEOUVJDU-UHFFFAOYSA-N beclamide Chemical compound ClCCC(=O)NCC1=CC=CC=C1 JPYQFYIEOUVJDU-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- VQFAIAKCILWQPZ-UHFFFAOYSA-N bromoacetone Chemical compound CC(=O)CBr VQFAIAKCILWQPZ-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical class [H]C#C* 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 150000002500 ions Chemical group 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- DYVOLUUJJDFBFC-UHFFFAOYSA-N tripotassium butan-1-olate Chemical compound [K+].[K+].[K+].CCCC[O-].CCCC[O-].CCCC[O-] DYVOLUUJJDFBFC-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229920001567 vinyl ester resin Polymers 0.000 description 2
- QPADXQOVVOPFDD-UHFFFAOYSA-N (3-nitrophenyl)methyl nitrate Chemical compound [O-][N+](=O)OCc1cccc(c1)[N+]([O-])=O QPADXQOVVOPFDD-UHFFFAOYSA-N 0.000 description 1
- FGYSDVLPRLHZDA-ORCRQEGFSA-N (e)-5-pyridin-2-ylpent-4-enoic acid Chemical compound OC(=O)CC\C=C\C1=CC=CC=N1 FGYSDVLPRLHZDA-ORCRQEGFSA-N 0.000 description 1
- USVVENVKYJZFMW-ONEGZZNKSA-N (e)-carboxyiminocarbamic acid Chemical compound OC(=O)\N=N\C(O)=O USVVENVKYJZFMW-ONEGZZNKSA-N 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- AOQRFLNYCYWPBI-UHFFFAOYSA-N 1,2-dibutyl-3-octylbenzene Chemical compound CCCCCCCCC1=CC=CC(CCCC)=C1CCCC AOQRFLNYCYWPBI-UHFFFAOYSA-N 0.000 description 1
- NMUWSGQKPAEPBA-UHFFFAOYSA-N 1,2-dibutylbenzene Chemical compound CCCCC1=CC=CC=C1CCCC NMUWSGQKPAEPBA-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- MASDFXZJIDNRTR-UHFFFAOYSA-N 1,3-bis(trimethylsilyl)urea Chemical compound C[Si](C)(C)NC(=O)N[Si](C)(C)C MASDFXZJIDNRTR-UHFFFAOYSA-N 0.000 description 1
- OVISMSJCKCDOPU-UHFFFAOYSA-N 1,6-dichlorohexane Chemical compound ClCCCCCCCl OVISMSJCKCDOPU-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- KDWFDFLJYJADJK-UHFFFAOYSA-N 1-(2-methylpropyl)-4-propylbenzene Chemical compound CCCC1=CC=C(CC(C)C)C=C1 KDWFDFLJYJADJK-UHFFFAOYSA-N 0.000 description 1
- RFDOTTUPKXBZMV-UHFFFAOYSA-N 1-(4-bromo-2-fluorophenyl)pentan-1-ol Chemical compound CCCCC(O)C1=CC=C(Br)C=C1F RFDOTTUPKXBZMV-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- LBNXAWYDQUGHGX-UHFFFAOYSA-N 1-Phenylheptane Chemical compound CCCCCCCC1=CC=CC=C1 LBNXAWYDQUGHGX-UHFFFAOYSA-N 0.000 description 1
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 1
- OHYLOLSYVWKZGA-UHFFFAOYSA-N 1-[3-fluoro-4-(2-methylpropyl)phenyl]pentan-1-ol Chemical compound CCCCC(O)C1=CC=C(CC(C)C)C(F)=C1 OHYLOLSYVWKZGA-UHFFFAOYSA-N 0.000 description 1
- XVRARUWBUUITIO-UHFFFAOYSA-N 1-[3-fluoro-4-[1-(methoxymethoxy)pentyl]phenyl]-2-methylpropan-1-ol Chemical compound CCCCC(OCOC)C1=CC=C(C(O)C(C)C)C=C1F XVRARUWBUUITIO-UHFFFAOYSA-N 0.000 description 1
- PJIAESCRZTYNKC-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]but-3-en-1-ol Chemical compound CC(C)CC1=CC=C(C(O)CC=C)C=C1 PJIAESCRZTYNKC-UHFFFAOYSA-N 0.000 description 1
- KEAGRYYGYWZVPC-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]ethanone Chemical compound CC(C)CC1=CC=C(C(C)=O)C=C1 KEAGRYYGYWZVPC-UHFFFAOYSA-N 0.000 description 1
- LILNXNJUTKZRTF-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]hexan-1-ol Chemical compound CCCCCC(O)C1=CC=C(CC(C)C)C=C1 LILNXNJUTKZRTF-UHFFFAOYSA-N 0.000 description 1
- YSIJIZJIBMUQFC-UHFFFAOYSA-N 1-[chloro-[4-(2-methylpropyl)phenyl]methyl]-4-(2-methylpropyl)benzene Chemical compound C1=CC(CC(C)C)=CC=C1C(Cl)C1=CC=C(CC(C)C)C=C1 YSIJIZJIBMUQFC-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- LEQIWQWMOHGNSM-UHFFFAOYSA-N 1-ethoxy-2-(2-methylpropyl)benzene Chemical compound CCOC1=CC=CC=C1CC(C)C LEQIWQWMOHGNSM-UHFFFAOYSA-N 0.000 description 1
- DBUJFULDVAZULB-UHFFFAOYSA-N 1-methoxypentane Chemical compound CCCCCOC DBUJFULDVAZULB-UHFFFAOYSA-N 0.000 description 1
- VCGBZXLLPCGFQM-UHFFFAOYSA-N 1-methyl-4-(2-methylpropyl)benzene Chemical compound CC(C)CC1=CC=C(C)C=C1 VCGBZXLLPCGFQM-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- NFKAWBGFIMBUMB-UHFFFAOYSA-N 1-phenylpentan-2-one Chemical compound CCCC(=O)CC1=CC=CC=C1 NFKAWBGFIMBUMB-UHFFFAOYSA-N 0.000 description 1
- XNVONTNIANKYKT-UHFFFAOYSA-N 1-propan-2-yl-2-propylbenzene Chemical compound CCCC1=CC=CC=C1C(C)C XNVONTNIANKYKT-UHFFFAOYSA-N 0.000 description 1
- XDJWZONZDVNKDU-UHFFFAOYSA-N 1314-24-5 Chemical compound O=POP=O XDJWZONZDVNKDU-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- POXWDTQUDZUOGP-UHFFFAOYSA-N 1h-1,4-diazepine Chemical compound N1C=CC=NC=C1 POXWDTQUDZUOGP-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- AMOYMEBHYUTMKJ-UHFFFAOYSA-N 2-(2-phenylethoxy)ethylbenzene Chemical compound C=1C=CC=CC=1CCOCCC1=CC=CC=C1 AMOYMEBHYUTMKJ-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical group NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- TVCXVUHHCUYLGX-UHFFFAOYSA-N 2-Methylpyrrole Chemical compound CC1=CC=CN1 TVCXVUHHCUYLGX-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- OYKJWTVFOJZDOC-UHFFFAOYSA-N 2-ethyl-1h-benzimidazol-4-ol Chemical compound C1=CC=C2NC(CC)=NC2=C1O OYKJWTVFOJZDOC-UHFFFAOYSA-N 0.000 description 1
- BWNBLGQCCSCCHF-UHFFFAOYSA-N 2-ethyl-1h-indole Chemical compound C1=CC=C2NC(CC)=CC2=C1 BWNBLGQCCSCCHF-UHFFFAOYSA-N 0.000 description 1
- QISSVLCQDNIJCS-UHFFFAOYSA-N 2-fluoro-1h-indole Chemical compound C1=CC=C2NC(F)=CC2=C1 QISSVLCQDNIJCS-UHFFFAOYSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- FGLBSLMDCBOPQK-UHFFFAOYSA-N 2-nitropropane Chemical compound CC(C)[N+]([O-])=O FGLBSLMDCBOPQK-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 1
- HSZNIKOMWDEGLU-UHFFFAOYSA-N 4,4,4-trifluoro-1-[4-(2-methylpropyl)phenyl]butan-1-ol Chemical compound CC(C)CC1=CC=C(C(O)CCC(F)(F)F)C=C1 HSZNIKOMWDEGLU-UHFFFAOYSA-N 0.000 description 1
- WTUCTMYLCMVYEX-UHFFFAOYSA-N 4,4,4-trifluorobutanoic acid Chemical compound OC(=O)CCC(F)(F)F WTUCTMYLCMVYEX-UHFFFAOYSA-N 0.000 description 1
- PEPSSOQTTNKEIJ-UHFFFAOYSA-N 4-(2-methylprop-1-enyl)benzoic acid Chemical compound CC(C)=CC1=CC=C(C(O)=O)C=C1 PEPSSOQTTNKEIJ-UHFFFAOYSA-N 0.000 description 1
- LXPWGAZYJHUWPM-UHFFFAOYSA-N 4-(2-methylpropyl)benzaldehyde Chemical compound CC(C)CC1=CC=C(C=O)C=C1 LXPWGAZYJHUWPM-UHFFFAOYSA-N 0.000 description 1
- GDBUZIKSJGRBJP-UHFFFAOYSA-N 4-acetoxy benzoic acid Chemical compound CC(=O)OC1=CC=C(C(O)=O)C=C1 GDBUZIKSJGRBJP-UHFFFAOYSA-N 0.000 description 1
- XMHNLZXYPAULDF-UHFFFAOYSA-N 4-bromo-1-(bromomethyl)-2-fluorobenzene Chemical compound FC1=CC(Br)=CC=C1CBr XMHNLZXYPAULDF-UHFFFAOYSA-N 0.000 description 1
- JMCVOEQGNFKGDP-UHFFFAOYSA-N 4-bromo-2-fluoro-1-(2-methylprop-1-enyl)benzene Chemical compound CC(C)=CC1=CC=C(Br)C=C1F JMCVOEQGNFKGDP-UHFFFAOYSA-N 0.000 description 1
- UPCARQPLANFGQJ-UHFFFAOYSA-N 4-bromo-2-fluorobenzaldehyde Chemical compound FC1=CC(Br)=CC=C1C=O UPCARQPLANFGQJ-UHFFFAOYSA-N 0.000 description 1
- NJESAXZANHETJV-UHFFFAOYSA-N 4-methylsalicylic acid Chemical compound CC1=CC=C(C(O)=O)C(O)=C1 NJESAXZANHETJV-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- YAMJAMOVZMFSGW-UHFFFAOYSA-N BCCCCCCCCC Chemical compound BCCCCCCCCC YAMJAMOVZMFSGW-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FYOHMHYPEADDCV-UHFFFAOYSA-N C(=O)(C=C)C12CCC(CC1)(CC2)C(=O)C=C Chemical compound C(=O)(C=C)C12CCC(CC1)(CC2)C(=O)C=C FYOHMHYPEADDCV-UHFFFAOYSA-N 0.000 description 1
- NGFCZLBYRRVPMW-UHFFFAOYSA-N C(C)(=O)OC.CNC Chemical compound C(C)(=O)OC.CNC NGFCZLBYRRVPMW-UHFFFAOYSA-N 0.000 description 1
- JYQVSLXGTXXOBN-UHFFFAOYSA-N C(C)C1=C(C(OC=C1)C(=O)N)CC Chemical compound C(C)C1=C(C(OC=C1)C(=O)N)CC JYQVSLXGTXXOBN-UHFFFAOYSA-N 0.000 description 1
- NHADDWWRCFUJMK-UHFFFAOYSA-N C(C)NCC.COC(C)=O Chemical compound C(C)NCC.COC(C)=O NHADDWWRCFUJMK-UHFFFAOYSA-N 0.000 description 1
- SZTAAXUNQDBYJM-UHFFFAOYSA-N C.[N].[N] Chemical compound C.[N].[N] SZTAAXUNQDBYJM-UHFFFAOYSA-N 0.000 description 1
- SAVAUFHMQCRIKW-UHFFFAOYSA-N C1=CC=CC=C1.C1=CC=CC=C1.C=C Chemical compound C1=CC=CC=C1.C1=CC=CC=C1.C=C SAVAUFHMQCRIKW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OKJCFMUGMSVJBG-ABEVXSGRSA-N Delta(1)-dihydrotestosterone Chemical compound C1C(=O)C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 OKJCFMUGMSVJBG-ABEVXSGRSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- HDFFVHSMHLDSLO-UHFFFAOYSA-N Dibenzyl phosphate Chemical compound C=1C=CC=CC=1COP(=O)(O)OCC1=CC=CC=C1 HDFFVHSMHLDSLO-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- GMEONFUTDYJSNV-UHFFFAOYSA-N Ethyl levulinate Chemical compound CCOC(=O)CCC(C)=O GMEONFUTDYJSNV-UHFFFAOYSA-N 0.000 description 1
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 1
- 240000007108 Fuchsia magellanica Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- RMOUBSOVHSONPZ-UHFFFAOYSA-N Isopropyl formate Chemical compound CC(C)OC=O RMOUBSOVHSONPZ-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- DDZOQGUFSZLNIA-UHFFFAOYSA-N P(=O)(O)(O)O.[He] Chemical compound P(=O)(O)(O)O.[He] DDZOQGUFSZLNIA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 206010036976 Prostatism Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241000656145 Thyrsites atun Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021623 Tin(IV) bromide Inorganic materials 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910001297 Zn alloy Inorganic materials 0.000 description 1
- YBQSHGZGWSUGJX-UHFFFAOYSA-N [4-(2-methylpropyl)phenyl]-phenylmethanone Chemical compound C1=CC(CC(C)C)=CC=C1C(=O)C1=CC=CC=C1 YBQSHGZGWSUGJX-UHFFFAOYSA-N 0.000 description 1
- OWEDCFLMKHNPMB-UHFFFAOYSA-M [Br-].CC(C)=CC1=CC=C([Mg+])C=C1F Chemical compound [Br-].CC(C)=CC1=CC=C([Mg+])C=C1F OWEDCFLMKHNPMB-UHFFFAOYSA-M 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- UGZICOVULPINFH-UHFFFAOYSA-N acetic acid;butanoic acid Chemical compound CC(O)=O.CCCC(O)=O UGZICOVULPINFH-UHFFFAOYSA-N 0.000 description 1
- FDTGUDJKAXJXLL-UHFFFAOYSA-N acetylene Chemical group C#C.C#C FDTGUDJKAXJXLL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 125000001243 alanino group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910000316 alkaline earth metal phosphate Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000005257 alkyl acyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229920006187 aquazol Polymers 0.000 description 1
- 239000012861 aquazol Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005264 aryl amine group Chemical group 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- LTYQFBLSWFTJQD-UHFFFAOYSA-N benzenesulfonyl iodide Chemical compound IS(=O)(=O)C1=CC=CC=C1 LTYQFBLSWFTJQD-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- SIOVKLKJSOKLIF-UHFFFAOYSA-N bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)OC(C)=N[Si](C)(C)C SIOVKLKJSOKLIF-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- XZKRXPZXQLARHH-UHFFFAOYSA-N buta-1,3-dienylbenzene Chemical compound C=CC=CC1=CC=CC=C1 XZKRXPZXQLARHH-UHFFFAOYSA-N 0.000 description 1
- LNRDXPVJYYJWLM-UHFFFAOYSA-N butan-1-amine methyl acetate Chemical compound CCCCN.CC(=O)OC LNRDXPVJYYJWLM-UHFFFAOYSA-N 0.000 description 1
- MKHUPLOSCAJXET-UHFFFAOYSA-N butan-1-amine;methanamine Chemical compound NC.CCCCN MKHUPLOSCAJXET-UHFFFAOYSA-N 0.000 description 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 description 1
- PIJXRNNCIJAUOX-UHFFFAOYSA-N butanoic acid;hydrochloride Chemical compound Cl.CCCC(O)=O PIJXRNNCIJAUOX-UHFFFAOYSA-N 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical group [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 150000001845 chromium compounds Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- GUGXBRGATQTAFP-UHFFFAOYSA-N cyclopropylmethylbenzene Chemical compound C=1C=CC=CC=1CC1CC1 GUGXBRGATQTAFP-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- CGZAMBNIGLUBRY-UHFFFAOYSA-N difluoro(methoxy)methane Chemical compound COC(F)F CGZAMBNIGLUBRY-UHFFFAOYSA-N 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- RPOFUHSBFMBNMW-UHFFFAOYSA-N ethanamine;methyl acetate Chemical compound CCN.COC(C)=O RPOFUHSBFMBNMW-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- WMYNMYVRWWCRPS-UHFFFAOYSA-N ethynoxyethane Chemical group CCOC#C WMYNMYVRWWCRPS-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- JVZRCNQLWOELDU-UHFFFAOYSA-N gamma-Phenylpyridine Natural products C1=CC=CC=C1C1=CC=NC=C1 JVZRCNQLWOELDU-UHFFFAOYSA-N 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- ZVUZTTDXWACDHD-UHFFFAOYSA-N gold(3+);trinitrate Chemical compound [Au+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O ZVUZTTDXWACDHD-UHFFFAOYSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- RCEHZMJZHHUGOL-UHFFFAOYSA-N hexan-3-yl butanoate Chemical compound CCCC(CC)OC(=O)CCC RCEHZMJZHHUGOL-UHFFFAOYSA-N 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
- 125000004126 inden-3-yl group Chemical group [H]C1=C(*)C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H] 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- RWGFKTVRMDUZSP-UHFFFAOYSA-N isopropyl-benzene Natural products CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- ZNMJRMHCZAYNCM-UHFFFAOYSA-N methanamine methyl acetate Chemical compound C(C)(=O)OC.NC ZNMJRMHCZAYNCM-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- QQCLNRPRQRDMCK-UHFFFAOYSA-N methyl 2,4-dimethylbenzoate Chemical compound COC(=O)C1=CC=C(C)C=C1C QQCLNRPRQRDMCK-UHFFFAOYSA-N 0.000 description 1
- FPCOMZPQIDCHPP-UHFFFAOYSA-N methyl 2-[2-[4-(2-methylpropyl)phenyl]ethenyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1C=CC1=CC=C(CC(C)C)C=C1 FPCOMZPQIDCHPP-UHFFFAOYSA-N 0.000 description 1
- PTSSKYUSCIALKU-UHFFFAOYSA-N methyl 3,4-dimethylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C)=C1 PTSSKYUSCIALKU-UHFFFAOYSA-N 0.000 description 1
- UXSNXOMMJXTFEG-UHFFFAOYSA-N methyl 4-(bromomethyl)-3-methoxybenzoate Chemical compound COC(=O)C1=CC=C(CBr)C(OC)=C1 UXSNXOMMJXTFEG-UHFFFAOYSA-N 0.000 description 1
- WRINWCFVADRICI-UHFFFAOYSA-N methyl 4-methyl-2-(methylamino)benzoate Chemical compound C(=O)(OC)C1=C(NC)C=C(C)C=C1 WRINWCFVADRICI-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 229950006999 methylsulfonal Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- KIQJGHREEIWLFI-UHFFFAOYSA-N n'-heptylmethanediamine Chemical compound CCCCCCCNCN KIQJGHREEIWLFI-UHFFFAOYSA-N 0.000 description 1
- SWVGZFQJXVPIKM-UHFFFAOYSA-N n,n-bis(methylamino)propan-1-amine Chemical compound CCCN(NC)NC SWVGZFQJXVPIKM-UHFFFAOYSA-N 0.000 description 1
- VMESOKCXSYNAKD-UHFFFAOYSA-N n,n-dimethylhydroxylamine Chemical compound CN(C)O VMESOKCXSYNAKD-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- CCRUHKGZAQXBKC-UHFFFAOYSA-N n-(2-methylpropyl)butan-1-amine Chemical compound CCCCNCC(C)C CCRUHKGZAQXBKC-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- FSSVIYSWRLKICW-UHFFFAOYSA-N n-ethyl-n-phenylacetamide Chemical compound CCN(C(C)=O)C1=CC=CC=C1 FSSVIYSWRLKICW-UHFFFAOYSA-N 0.000 description 1
- LWFWUJCJKPUZLV-UHFFFAOYSA-N n-trimethylsilylacetamide Chemical compound CC(=O)N[Si](C)(C)C LWFWUJCJKPUZLV-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QTYUSOHYEPOHLV-UHFFFAOYSA-N octa-1,3-diene Chemical compound CCCCC=CC=C QTYUSOHYEPOHLV-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- VATYWCRQDJIRAI-UHFFFAOYSA-N para-aminobenzaldehyde Natural products NC1=CC=C(C=O)C=C1 VATYWCRQDJIRAI-UHFFFAOYSA-N 0.000 description 1
- IWDCLRJOBJJRNH-UHFFFAOYSA-N para-hydroxytoluene Natural products CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical group CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 125000004675 pentylcarbonyl group Chemical group C(CCCC)C(=O)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- VSAISIQCTGDGPU-UHFFFAOYSA-N phosphorus trioxide Inorganic materials O1P(O2)OP3OP1OP2O3 VSAISIQCTGDGPU-UHFFFAOYSA-N 0.000 description 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N phthalic acid di-n-ethyl ester Natural products CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- NVIFVTYDZMXWGX-UHFFFAOYSA-N sodium metaborate Chemical compound [Na+].[O-]B=O NVIFVTYDZMXWGX-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAZLUNIWYYOJPC-UHFFFAOYSA-M sulfenamide Chemical compound [Cl-].COC1=C(C)C=[N+]2C3=NC4=CC=C(OC)C=C4N3SCC2=C1C QAZLUNIWYYOJPC-UHFFFAOYSA-M 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940095585 testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy Drugs 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- LTSUHJWLSNQKIP-UHFFFAOYSA-J tin(iv) bromide Chemical compound Br[Sn](Br)(Br)Br LTSUHJWLSNQKIP-UHFFFAOYSA-J 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- NNPPMTNAJDCUHE-UHFFFAOYSA-N trimethylmethane Natural products CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Description
k-03050 A6 B6 五、發明説明(1 ) 本發明為有關新穎雜環衍生物及其製藥容許鹽。詳言 之,有關具有對睪固酮5α-還原酶等有抑制活性等藥理 活性之新穎雜環衍生物及其製藥容許鹽,其製法,其製 藥組成物及其當作醫藥之用途。 故本發明之目的為提供可當作睾固-還原酶抑制 劑之新穎雜環衍生物及其製藥容許鹽。 本發明之另一目的為提供此雜環衍生物或其鹽之製法 0 本發明之另一目的為提供此雜環衍生物或其裂藥容許 鹽為有效成分之製藥組成物。 本發明之另一目的為提供此雜環衍生物或其製藥容許 鹽為如睪固酮5α-還原酶抑製劑等醫藥,用以防治人或 動物中睪固酮5α-還原酶仲介病,如禿髮,痊瘡,前列 腺症等。 本發明之雜環衍生物為新穎者,可用式(I)表示:
Q-X-Y-Z-R 、11 3 (I) (請先閲讀背面之注意事項再填寫本頁) 裝- 經濟部中央標準局員工消費合作社印製 式中R1 為羧基或被保護羧基, R 2 為氫,低烷基或鹵素, R 3 為芳基或芳低烷基而各可有適當取代基,取代 胺甲醯低烷基,或 -(co)n - nD 其中 3 本紙張尺度逍用中國《家«準(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) ,03050 A6 B6 五、發明説明(2.)
-N
為含N雜環基,n為〇或1 R 11 為氫或低烷基, Α 為可被氣取代之低伸烷基,或低伸烯基, Q 為羰基或低伸烷基,
R R 或 其中r 4為氫或低 烷基,Rs為氫,低烷基或Y-Z-R3 為鍵或低伸烷基, R 6 為低伸烷基,低伸烯基,-0 -或- N- ,其中R6 為氫,低烷基,可有適當取代基之芳低烷基或 胺基保護基。 依本發明,目的物(I)及其鹽可依如下製法製造 製法1 (請先閱讀背面之注意事項再填寫本頁)
Z 丁 經濟部中央標準局員工消費合作社印製
(II) 或其鹽 4 - 本紙張尺度逍用中國家樣準(CNS)甲4規格(210x297公釐) +
W - R: a (III) 砗其鞠 x XuZ 81. 5. 20.000(H) jg〇305〇 A 6 B6 五、發明説明(3 )
R
N
Q-X-Y-Z-R 11 a R A-R1 (I-a) 或其鹽 製法2
q-x-y^-w2 11 或其鹽 + h-z2-r3
(V) -τΛ ^ N _CS (請先閱讀背面之注意事項再填寫本頁) 裝-
Q-xW-R3 .11 (I-b) 砖其翰 —Λ 1ΠΪ
Js . 經濟部中央標準局貝工消費合作社印製
R
•N
Q-X-Y-NHR 11 A-R + * Ra (VI) >-ίΛί J44*
(Ilia) 沛其賺 •CAi y \ nTT 本紙張尺度遑用中國國家橾準(CNS) f 4規格(210X297公*) 81. 5. 20,000(H) "ϋΟ3 AU —知
66 AB 五、發明説明(4 )
Q-X-Y-N-R ,11 或其鹽
R a
R
Q-X-Y-Z-R 3
R 11 消去羧基保 護基 (請先閲讀背面之注意事項再填寫本頁)
A-RJ a (Ι-d) ·<Α* ΠΤΪ
R
ς-χ-γ-ζ-R 11 3 R A-COOH (I-e)或其鹽 經濟部中央標準局員工消費合作社印製 製法5
Q-X-Y-Z-CHR 11 I COOR -6 - 本紙張尺度遑用中困《家楳準(CNS)甲4規格(210X297公*) 8 消去羧基保 護基 81. 5. 20.000(H) ⑽0_ 五、發明説明(5 )
Q-X-Y-Z-CHR7 I COOH (i-g> ^ Μ. & /N XlJ* 製農6
Q-X-Y-Z-CHR7
COOH A 6 B6 (請先閱讀背面之注意事項再填寫本頁) 或其在羧基之反應 性衍生物或其鹽 9 + Η - R (VII) 或其在胺基之反應 性衍生物或其鹽
經濟部中央標準局貝工消費合作社印製 (I-h) 或其 -τΛ ΉΒ. -7 本紙張尺度逍用中國家樣準(CNS)甲4規格(210X297公釐) 81. 5 . 20.000(H) A6 B6 五、發明説明(6 ) 餺法7
消去胺基保護基 (I-i) 或其翰 Π3Ι
Ol A-R1 (I-j) 或其翰 —Λ y \ mi ,Ν
R Q-X-Y-NHR3 11
A-R·1· d-j) 或K ® —5Λ» J* > JQX Q-X-Y-NHR-11 +
W - R 6 c
(VIII) 61/ ^ ^ —^ x fnT (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製
R 2
N
A-R Q-X-Y-N-R11 I 6 R、 c (I-k) 或其鹽 * 8 本紙張尺度逍用中《«家«準(CNS)甲4規格(210X297公*) 3 81. 5. 20.000(H)
ο ύ 66ΑΒ 五、發明説明(7 )製..法9
引入羧基保護基 (I - e) 碑? g翰 -τΛ 7^; πτί
(I-d) 沛其竊 -Ά mi (請先閱讀背面之注意事項再填寫本頁) 象 經濟部中央標準局員工消費合作社印製
11 -9- 本紙張尺度逍用中國家標準(CNS)甲4規格(210x297公*) W1〇-Q-X-Y-Z-R3 (XXI) 砗其發 -rxu Jm 81. 5 . 20.000(H) -娜_- 五、發明説明(8 )
Q-X-Y-Z-R· 11 或其鹽 ,R 5 , R11 式中 R 1 , R 2 , R 3 各同前, β i 為被保護羧基, R I 為可有適當取代基之芳低烷基,取代胺甲醯低 烷基,或 -(CO) - 其中 -Ν
R
A, Q, X , Y及 Z
(請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 及η各同上, R I 為胺基保護基, R ® 為低烷基,可有適當取代基之芳低烷基,或胺 基保護基, R 7 為可有適當取代基之芳基, R 8 為羧基保護基, R 9 為可有適當取代基之胺基, W 1 為離基, w i 為W2, W3及各為酸殘基, Y 1 為低伸烷基, 10 各紙張尺度遑用中國家樣準(CNS) T 4規格(210 X 297公*) 81. 5. 20,000(H) i.aaoso A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(9) R1 I z 1 為-0-或-N-其中R I為氫,低烷基或胺基保護 基, R 6 Z2 為-〇-,或-N-其中Re同前。 化合物(I)之適當鹽為習用無毒製藥容許鹽,可包括 與鹼之鹽或酸加成鹽,諸如無機齡鹽,例如鹼金颶鹽( 如鈉鹽,鉀鹽,絶鹽等),鹼土金屬鹽(如鈣鹽,鎂鹽 等),銨鹽,有機鹺鹽,例如有機胺鹽(如三乙胺鹽, 吡啶鹽,甲基吡啶鹽,乙醇胺鹽,三乙醇胺鹽,二環己 胺鹽,Ν, Ν’-二苄基乙二胺鹽等)等;無機酸加成鹽( 如鹽酸鹽,氫溴酸鹽,硫酸鹽,磷酸鹽等);有機羧酸 或磺酸加成鹽(如甲酸鹽,乙酸鹽,三氟乙酸鹽,順丁 烯二酸鹽,酒石酸鹽,甲磺酸鹽,苯磺酸鹽,對甲苯磺 酸鹽等),與胺基酸之鹽(如精胺酸鹽,天冬胺酸鹽, 麩胺酸鹽等)等,而直酸加成鹽。 至於製法1〜1 0中化合物(I - a )〜(I - k ) , (H ) , ( ffl ) ,(ΠΙ a), (IV), (V), (VI), (W), (VI), (XII)及 (XX I)之鹽可參照在目的物(I )例示者β 在本文中,包括在本發明之種種定義之適例詳述如下 0 除另行規定外,低乃指Cl - 6 .宜Cl - 4。 適當之低烷基可包括Ci _10直或分枝者,如甲基, -1 1 - (請先閲讀背面之注意事項再填寫本頁) 裝· 訂· 線· 本紙張尺度遑用中諷家樣毕(CHS>甲4規格(210X297公 81. 5. 20,000(11) 經濟部中央標準局員工消費合作社印製 -03050 五、發明説明(10) 乙基,丙基,異丙基,丁基,異丁基,第三丁基,戊基 ,己基,庚基,辛基,士基,癸基等,宜Cl - e,尤 宜C i - 4者。 鹵素乃指氟,氣,溴及碘。 適當之低伸烷基乃指直或分枝二價低烷,如亞甲基, 伸乙基,三亞甲基,四亞甲基,五亞甲基,六亞甲基, 伸丙基等而可取代箸氣。 適當之離基可包括羥基,從羥基衍生之反應性基等。 適當之「從羥基衍生之反應性基」可包括酸殘基等。 適當之酸殘基可包括鹵素(如氟,氣,溴,碘),醯 氣基(如乙醯氣基,甲笨磺醯氣基,甲磺醯氣基等)等 〇 適當之低伸烯基可包括C2 - 6者,如伸乙烯基,伸 丙烯基等。 適當之可有取代基之芳基可包括習用基,如芳基(如 苯基,萘基等),取代芳基,如低烷芳基(如甲苯基, 二甲苯基,三甲苯基,異丙笨基,異丁苯基等),鹵芳 基(如氣苯基等)等。 在「可有適當取代基之芳低烷基中「芳低烷基」乃指 被芳基取代之直或分枝Ci -10烷基,而適當之「可有 適當取代基之芳低烷基」可包括習用基,如芳低烷基( 如三苯甲基,二苯甲基,苄基,苯乙基,赛甲基,1-苯 乙基,苯丙基,苯丁基,苯戊基,苯己基,苯庚基,苯 -1 2 - A 6 B6 (請先閲讀背面之注意事項再填寫本頁) 裝. 訂- 線· 本紙》尺度遑用中國國家楳毕(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) 五、發明説明(n) A6 B6 經濟部中央標準局貝工消費合作社印製 低,適氣} 丁等炔可丨,戊苯雙}<{卩基丁 丁苯丁 芳基有甲等異基低 Γ ,基 }丁 ,基羧 ,7?苯<異丁異 代烷可如基氣甲及之基丙基異基苯,基:τ丁 ,ί 異ί 一一 取低述< 丁醯基,義苄丨苯ί 甲 丁基甲^異基 ,逑前基異乙 丁>定 丁基甲 ,} 異甲}ί}甲基 ,, }前,氣羥如環等此異苯 ί 基基 基 基}醯基基 等如基烷如丨,基如,甲,己苯雙基苯’醯基甲乙甲 基,羧低ί 基基烯。基 ί 基丨甲,苯丁 W 甲苯胺}} 丙基護,基烷甲丁}苄 ,丁基 ί 基丁異 胺丁 庚基基 苯代保基烷低基,等甲基>苯雙甲異is)苯異 <苯苯 1-取被羧低氣丙基基為乙基丁 ,丁丁 E-上述化羥醯環烯炔可丨苯異基基氰基豸,丨基異異 基 丁 以前胺,烷如丙丁 J基丁 ί辛苯,羰 基基甲 1 ,醯丨低 ί ,,基苯異 ,} 丁基氣(^甲醯 }}} -_有基述等如基基基烷丁 ί 基基 <甲苄 }甲基基基 ?而羧後基,烷烯炔低異,戊笨«}<η基胺苯氣苯 2 基,,氣基低乙丙芳 <基} 丁 ,基 ,^3苯苯丁乙< ,烷基基丙烷烷如,之,丙基異基苯基¥r丁丁異< , 基低氣芳,低低ί 基基基}苯ί甲氣甲卩異異丨,基 癸芳,之基羥環基炔代乙基丁 ,丨基丁 苯如素基氣護,烯乙取}苯異基基雙基 1} >基甲氟 ,,鹵代乙保}低如當基丁 ί 庚苯,笨一,一基基醯}三 基基逑取,被等,< 適苯異 ,}丙基丁 Κ 醯甲甲基} 辛烷前當基,基}基有甲<基基<甲異=’甲}胺苯基 (請先閲讀背面之注意事項再填窝本頁) 本紙張尺度遑用中諷家標毕(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 b〇30 ⑽ 五、發明説明(12) 基)(甲氧基)苯基〕戊基,〔(輻)(異丁基)苯基 〕戊基,〔(氟)(羥異丁基)苯基〕戊基,(環丙基 甲苯基)丁烯基,(異丁苯基)丁炔基,(異丁苯基) 丁烯基,(異丁苯基)戊烯基等〕等。 適當之胺基保護基可為習用於有機化學之保護基,可 包括醯基,如低烷醯基(如甲醯基,乙酵基,丙醯基, 丁醯基,異丁醯基,戊醯基,異戊醯基,持戊醯基,己 醯基等),低烷氣羰基(如甲氣羰基,乙氣欺基,丙氣 羰基,丁氣羰基,第三丁氣羰基等)等。 適當之「被保護羧基」可包括酯化羧基。 酯化羧基之酯部分之適例可為如低烷酯(如甲酯,乙 酯,丙酯,異丙酯,丁酯,異丁酯,第三丁酯,戊酯, 己酯,1-環丙基乙酯等)而可有至少一個適當取代基, 如低烷醯氣低烷酯(如乙醯氣甲酯,丙酵氣甲酯,丁醒 氣甲酯,戊醯氣甲酯,待戊醯氧甲酯,己醯氣甲酯,1 (或2)-乙醛氣乙酯,1(或2或3)-乙醯氣丙酯,1( 或2或3或4)-乙醯氣丁酯,1(或2)丙醯氧乙酯,1( 或2或3)-丙酷氧丙酯,1(或2) -丁醯氧乙酯,1(或2 )-異丁醯氣乙酯,1(或2)-待戊醯氣乙酯,1(或2) -己醯氣乙酯,異丁醯氣甲酯,2-乙基丁醛氣甲酯,3, 3-二甲基丁醯氣甲酯,1(或2)-戊醯氣乙酯等),低 烷磺醛低烷酯(如2-甲磺醛乙酯等),一(或二或三) 鹵低烷酯(如2-碘乙酯,2, 2, 2-三氣乙酯等),低烷 -1 4 - (請先閲讀背面之注意事項再填寫本頁) 裝· 線. 本紙張尺度逍用中困家樣準(CNS)甲4規格(210 X 297公釐) 81. 5. 20.000(H) A 6 B6 ^Q3〇u〇 五、發明説明(13) (請先閲讀背面之注意事項再填寫本頁) 氣羰氣低烷酯(如甲氣羰氣甲酯,乙氣羰氣甲酯,2 -甲 氣羰氣乙酯,1-乙氣羰氣乙酯,1-異丙氣羰氣乙酯等) ,亞献低院酷,或(5-低院基-2-氣-1, 3-二吗茂- 4- 基)低烷酯(如5 -甲基-2-氣-1, 3 -二垮茂-4 -基)甲酯 ,(5 -乙基-2-氧-1, 3-二枵茂-4-基)甲酯,(5 -丙基 -2-氣-1, 3-二枵茂-4-基)乙酯等;低烯酯(如乙烯酯 ,烯丙酯等);低炔酯(如乙炔酯,丙炔酯等);可有 至少一個適當取代基之芳低烷酯(如苄酯,4 -甲氣苄酯 ,4-硝苄酯,苯乙酯,三苯甲酯,二笨甲酯,二(甲氣 苯基)甲酯,3, 4 -二甲氣苄酯,4 -羥基-3, 5 -二第三 丁苄酯等);可有至少一値適當取代基之芳酯(如苯酯 ,4 -氯苯酯,甲苯酯,第三丁苯酯,二甲苯酯,三甲苯 酯,異丙苯酯等);酞醏等。 上述酯化羧基之適例可包括低烷氣羰基(如甲氧羰基 ,乙氣羰基,丙氣羰基,異丙氣羰基,丁氣羰基,異丁 氣羰基,第三丁氣羰基,戊氧羰基,第三戊氣羰基,己 氣羰基,1-環丙基乙氧羰基等)。 經濟部中央標準局貝工消費合作社印製 適當之「羧基保護基」可為上逑「被保護羧基」之酯 部分,可包括低烷基(如甲基,乙基等),芳低烷基( 如苄基等)等。 適當之「可有適當取代基之胺基」為製藥上習用者, 可含括胺基,一或二低烷胺基(如甲胺基,二甲胺基, 乙胺基,二乙胺基,丁胺基,第三丁胺基,庚胺基等) 本紙張尺度遑用中國家樣準(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) ί〇3_ A 6 Β6 經濟部中央標準局貝工消費合作社印製 五、發明説明(14) ,芳胺基(如苯胺基等),低烷芳胺基(如異丁苯胺基 等)等。 適當之「含N雜單環基j可包括有至少一値N之飽和 或不飽和單環或多環雜環基。尤宜5或6員脂族雜單環 基(如嗎啉基,吡咯啶基,眯唑啶基,哌啶基,哌阱基 等),不飽和稠合雜環基,如二苯駢〔6或6員不飽和 ]雜單環基(如苯駢枵阱基,苯駢噃阱基,10,U -二 氫-5H -二苯駢吖庚因基等)等。 適當之「醯胺化羧基」為可有適當取代基之胺甲醯基 ,可包括胺甲醯基,一或二低烷胺甲醯基(如甲胺甲醯 基,二甲胺甲醯基,乙胺甲醯基,二乙胺甲醯基,丁胺 甲醯基,第三丁胺甲醯基,庚胺甲醯基等),低烷芳胺 甲醯基(如異丁苯胺甲醯基等)等。 適當之「取代胺甲醯基低烷基j乃指胺甲醯低烷基, 其中胺甲醯基部分有一或二锢取代基,宜包括習用基, 如前述低烷基,芳述可有適當取代基之芳基。如此定義 之「取代胺甲醯基低烷基」之適例為丁胺甲醯甲基,1-(庚胺甲醯基)乙基,異丁苯胺甲醯甲基,1-(異丁苯 胺甲醯基)乙基等。 尤其,R1,R2,R3,R11,A, Q, X,Y及 Z 之適例 如下。 R1為羧基;酯化羧基,如低烷氣羰基,尤宜Ci - 4 烷氧羰基(如甲氣羰基,乙氣羰基等);或芳低烷氧羰 -1 6 - (請先閲讀背面之注意事項再填寫本頁) 裝. 線· 本纸張尺度遑用中困國家樣準(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) ο ;tj ο 3 ο
66 AB 15) /fv 明説 明發 、五 苯 三 或二 或 1 .宜 尤, > \—/ 基等 基 羰 氣 烷 基 羰 氣 苄 如 宜 尤 基 烷 低 氫 為 基 烷 等 基 甲 如 等 0 如 /«V 素 鹵 或 被 宜 尤 基 芳 之 代 取 基 烷 低 被 可 為 取 基 烷 以基基 1 羧烷 著護低 代保羥 取被護 可,保 而基被 基羧 , 烷,基 低基烷 芳氰低 ; , 羥 } 素 , 等鹵基 基 ,氧 苯基烷 丁烷低 異低 , 如自基 {選羧 基基化 苯代胺 之取蜷 代上 , 烷基 低羧 苯 , 三基 或氰二 , 或素 一 鹵 宜 , 尤基 ,烷 基低 炔自 低選 及基 基代 烯取 低個 4 *]~ 烷有 低可 環而 ,基 ,烷 基低 醯氣 甲酷 胺烷 苯低 9 f 基基 醯烷 甲低 胺羥 烷 , 低基 二氣 或烷 一 低 ί ί 基基 羰醯 氧甲 烷胺 低苯 苯烷 ,低 基 C 素 苯鹵 三 , 自基 選羰* * * ^ ^ ^ Θ取4 低 個-及4fil 基 ~ C #们"本 低1¾, ,i * 基sffi^ 烷基 炫烷, 0 ο 0 烷 1氰 低-, 環. 最 或基 二烷 或10 1 -為 1 rJ 好 或 (請先閲讀背面之注意事項再填寫本頁) 基 醯 甲 胺 苯 基 醯 甲 胺 烷 is 甲 胺 苯 烷 基 羥 經濟部中央標準局貝工消費合作社印製 及基基氰基 基 ,30卞 基C3如 氣環ί 烷,基 4 基炔 - 烷 4 1 4 - ,基 基苯 丙丁 }異 基ί 苯雙 丁 , 異基 < 辛 羧 , ,基 基甲 甲} }基 基笨 苯 丁 丁異 異< 基 烷 4 烷 ,異 基丨 烷 , 4 基 - 苄 1 丁 :異 基 « ^ 2 0 ) 烷4基 4 笨 2 基雙 苯 , 丁基丁 異甲異 ,基 基苯 庚氱 基 甲 基 苯 基 醯 甲 胺 乙 二 苯 , 丁基 異甲苄 羰 氧 異 本紙張凡度逍用中國家樣芈(CNS)甲4規格(210 X297公*) 81. 5. 20,000(H) (〇3〇u〇 A6 B6
五、發明説明(16) 丁苯基)甲基,(第三丁胺甲 ,(苯胺甲醯基)(異丁苯基 基)(異丁笨基)甲基,(丁 甲基,(庚胺甲醯基)(異丁 (異丁苯基)乙基,(異丁苯 基)(異丁苯基)甲基,〔( 〕戊基,〔(氟)(異丁基) 羥異丁基)苯基〕戊基,〔( 基〕戊基,(環丙基甲苯基) 炔基,(異丁苯基)丁烯基, ;胺甲醯低烷基,其中胺甲醯 選自:低烷基及低烷苯基,尤 烷基或Ci — 4烷苯胺甲醯Ci 基,異丁苯胺甲醯甲基,異丁 6員脂族雜單環羰基(如呢啶 雜環基(如苯駢枵阱基,苯駢 -二笨駢[b,f]吖庚因基等), R 11為氫;或低烷基,尤宜C 醯基)(異丁苯基)甲基 )甲基,(異丁苯胺甲醯 胺甲醯基)(異丁苯基) 苯基)甲基,(乙氣基) 基)(三氟)丁基,(苯 異丁基)(甲氧基)苯基 苯基〕戊基,〔(氟)( 氟)(乙醯氣異丁基)苯 丁烯基,(異丁苯基)丁 (異丁笨基)戊烯基等) 基部分有一或二個取代基 宜C i 10烷胺甲醯c i --4烷基(如庚胺P醯乙 苯胺甲醯乙基等);5或 羰基等);或不飽和稠合 瞎阱基,10, 11-二氫-5H 1 - 4烷基(如甲基等) (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A為可被氧取代之低伸烷基,尤宜被氣取代之Ci -, 伸烷基(如伸乙基,三亞甲基,氣三亞甲基等):或低 伸烯基,尤宜C2 - 4伸烯基(如伸丙烯基等), Q為羰基;或低伸烷基,尤宜Ci - 4伸烷基(如亞 18- 本紙張尺度遑用中國家樣準(CHS)甲4規格(210 X297公*) 81. 5 . 20,000(H) i〇3㈣ it 五、發明説明(17) 甲基等) R- ¥ 為 或 'CT 其中R4為氫;或低烷基,尤宜Ci — 4烷基(如甲基等 5為氫;低烷基,尤宜Ci — 4烷基(如甲基等) ;或可有選自低烷基或低烷氣羰基之取代基之 芳低烷胺基,尤宜Ci - 4烷苄胺基或N-Ci - 4烷氣羰基-N- Ci - 4烷苄胺基(如異 丁苄胺基,N-第三丁氣羰基-N-異丁苄胺基等 Y為鍵;或低伸烷基 等), Z為低伸烷基,尤宜 低伸烯基,尤宜C 5 R 6 或-M-其中Re 尤宜 伸烷基(如亞甲基 -4伸烷基(如亞甲基等); 4伸烯基(如伸乙烯基等); (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 為氮;低院基,宜Cl - 4院基( ;低烷氧羰基,宜Ci - 4烷氣羰 基(如第三丁氧羰基等):可被低烷基取代之芳低院 基,尤宜可被低烷基取代之一或二或三苯低烷基,最 好為可被^ - 4烷基取代之一或二或三苯Ci _ e院 基(如苄基,異丁苄基等)。 如甲基,乙基等) -19- 本紙張尺度遑用中家樣毕(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) 03_ A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(IS) 下面詳述本發明目的物(I )之製法1〜10。 魁法1 目的物(I-a)或其鹽可令化合物UI )或其鹽與化合物 (ΠΙ )或其鹽反應來製造。 此反應常在如醇〔如甲醇,乙醇等〕,二氛甲烷,苯 ,N, N -二甲基甲醯胺,四氫呋喃,乙醚,甲苯或任何 其他對反應無不良影鬱之溶劑中進行。 在此反應中,若化合物(ΠΙ)中W1為酸殘基時,反應 可在無機或有機鹼之存在下進行,諸如齡金屬氫氣化物 〔如NaOH, Κ0Η等〕,鹼金羼硝酸鹽〔如磺酸鈉,碩酸 鉀等〕,齡金屬重磺酸鹽〔如重硪酸納,重碩酸鉀等〕 ,鹸金屬氫化物〔如NaH, KH等〕,三低烷胺〔如三甲 胺,三乙胺,二異丙基乙胺等〕,吡啶或其衍生物〔如 甲基吡啶,二甲吡啶,4 -二甲胺基吡啶等〕等。若所用 龄為液髏,則也可當作溶劑。 若化合物(ΙΠ)中W1為羥基時,反應宜在如下列習用 縮合劑之存在下進行,如Ν, Ν’-二環己基碩化二亞胺; Ν -環己基- Ν’ -嗎啉乙基磺化二亞胺;Ν -璟己基- Ν’ - (4-二乙胺環己基)磺化二亞胺;Ν, Ν' -二乙基磺化二亞胺 ,Ν, Ν' -二異丙基磺化二亞胺;Ν -乙基- Ν1- (3 -二甲胺 丙基)磺化二亞胺,N, fT -羰基-雙(2 -甲基咪唑); 五亞甲基烯酮-N-環己基亞胺,二苯烯酮-N-環己亞胺; 乙氣基乙炔;1-烷氣基-1-氣乙烯;亞磷酸三烷酯;聚 -2 0 - (請先閲讀背面之注意事項再填寫本頁) 本紙張疋度逍用中譎·家橾毕(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) ^03000 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(L9) 磷酸乙酯;聚磷酸異丙酯;氣氦化磷(磷醯氣);三氣 化磷;亞磺醛氯;草醯氣;鹵甲酸低烷酯〔如氣甲酸乙 酯,氣甲酸異丙酯等〕;三芳_ 〔如三苯瞵等〕或三低 烷瞵〔如三乙膦等]與偶氮基二羧酸二低烷酯〔如偶氪 基二羧酸二乙酯等〕之合雨;2 -乙基-7-羥基苯駢異鸣 唑錨鹽;氫氣化2 -乙基-5-(間磺酸笨基)異枵唑_分 子内鹽;1-(對氩苯磺醛氣基)-6 -氣-1H -苯駢三唑; 由N, N-二甲基甲醯胺與亞磺醯氣,光氣,氣甲酸三氯 甲酯,氧氯化磷等反應製得之Vilsmeier試劑等。 反應溫度無關緊要,常在冷卻,室溫或加溫〜加熱下 進行。 製法2 目的物(I-b)或其鹽可令化合物(IV )或其鹽與化.合物 (V )或其鹽反應來製造。 此反應常在如醇〔如甲醇,乙醇等],二氣甲烷,苯 ,N, N -二甲基甲醯胺,四氫呋喃,乙醚,或任何其他 對反應無不良影饗之溶劑中進行。 反應可在無機或有機驗之存在下進行,諸如鹼金屬氫 氣化物〔如NaOH, Κ0Η等〕,_金屬磺酸鹽〔如碩酸納 ,磺酸鉀等〕,齡金屬重碩酸鹽〔如重磺酸鈉,重碩酸 鉀等〕,鹸金属氫化物〔如NaH, KH等〕,三低烷胺〔 如三甲胺,三乙胺,二異丙基乙胺等〕,吡啶或其衍生 物〔如甲基Pit啶,二甲吡啶,4 -二甲胺基吡啶等〕等。 -2 1 - (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑《中家樣準(CNS)甲4規格(210X297公釐) 81. 5. 20,000(H) g〇3〇y〇 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(20) 若所用鹼為液體,則也可當作溶劑。 反應溫度無關緊要,常在冷卻,室溫或加溫〜加熱下 進行。 製法3 目的物(I-c)或其鹽可令化合物(VI )或其鹽與化合物 (ΠΙ a)或其鹽反應來製造。 此反應可仿製法2,故反應方式及條件〔如溶劑,反 慝溫度等〕可參照製法2。 本反應包括當R1為羧基時,在反應中或在本製法中 後處理步驟中被保護之情形。 製法4 目的物(I-e)或其鹽可令化合物(I-d)或其鹽消去羧基 保護基來製造。 在此消去反應中,可用如水解,還原,用劉易士酸之 消去等所有習用於消去羧基保護基之方法。若羧基保護 基為酯時,可藉水解或用劉易士酸之消去來消去。水解 宜在鹼或酸之存在下進行。 適當之鹼可包括如無機鹸,如鹼金屬氫氣化物(如 MaOH, K0H等),鹼土金屬氫氣化物(如Ca(0H)2 , Mg (OH) 2等),鹼金靨碩酸鹽(如碳酸鈉,碩酸鉀等) ,鹼土金屬碩酸鹽(如碩酸鎂,碩酸鈣等),驗金靨重 碩酸鹽(如重碩酸鈉,重磺酸鉀等),_金屬乙酸鹽( 如乙酸納,乙酸狎等),鹼土金屬磷酸鹽(如磷酸鎂, -2 2 - (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中家橾毕(CNS)甲4規格(210x297公教) 81. 5 . 20.000(H) 經濟部中央標準局員工消費合作社印製 03咖 五、發明説明(2l) 磷酸鈣等),磷酸氫鹼金屬(如磷酸氫二納,.磷酸氫二 鉀等)等,及有機鹼,如三烷胺(如三甲胺,三乙胺等 ),甲基吡啶,N -甲基吡咯啶,N -甲基嗎啉,1, 5 -二 吖雙環〔4.3.0〕壬-5-酮,1, 4 -二吖雙環〔2.2.2〕辛 烷,1, 5 -二吖雙環〔5.4.0〕十一碩烯-5-等。用鹼之 水解常在水或親水性有機溶劑或其混液中進行。 適當之酸可包括有機酸(如甲酸,乙酸,丙酸等)及 無機酸(如鹽酸,氫溴酸,硫酸等)。 本水解常在有機溶劑,水或其混液中進行。 反應溫度無嚴格限定,可依羧基保護基之種類及消去 方法適當地選擇。 用劉易士酸之消去宜消去取代或未取代芳低烷酯,乃 令化合物(Ig)或其鹽與劉易士酸,如三鹵化硼(三氣化 硼,三氟化硼等),四鹵化鈦(如四氣化鈦,四溴化欽 等),四鹵化錫(如四氣化錫,四溴化錫等),鹵化IS (如氣化鋁,溴化鋁等),三鹵乙酸(如三氣乙酸,三 氟乙酸等)等之存在下反應。此消去反應宜在陽離子吸 收劑(如甲氣苯,酚等)之存在下進行,常在如硝基院 (如硝基甲烷,硝基乙烷等),二鹵化烷(如二氣甲院 ,二氣乙烷等),水,醇〔如甲醇,乙醇等],二鸣院 ,乙醚,二硫化碩或對反應無不良影響之任何其他溶劑 中進行。這些溶劑可混合使用。 還原消去宜用以消去保護基,如鹵低烷基(如2 -碘乙 -2 3 - A 6 B6 (請先閲讀背面之注意事項再填寫本頁) 裝. 訂_ 線· 本紙張尺度逍用中《家樑竿(CNS)T4規格(210X297公;》) 81. 5. 20,000(H) 經濟部中央標準局貝工消費合作社印製 L03_0 五、發明説明(22) 基,2, 2, 2-三氣乙基等)酯,芳低烷基(如乍基等) 酯等。 用於消去反應之還原方法可包括例如用金屬(如鋅, 鋅合金等)或鉻化合物之鹽(如氣化亞鉻,乙酸亞鉻等 )與有機或無機酸(如乙酸,丙酸,鹽酸等)之合劑之 還原,及在習用金屬觸媒(如Pd-C,阮來錁等)之存在 下之習用觸媒還原。 反應溫度無簌格限定,常在冷卻,室溫或加溫下進行 〇 製法5 目的物u-g)或其鹽可令化合物(Ι-P)或其鹽消去羧基 保護基來製造。 此反應可仿製法4,故反應方式及條件〔如鹼,.酸, 還原劑,觸媒,溶劑,反應溫度等〕可參照製法4。 製法6 目的物(I-h)或其發可令化合物(I-g)或其在羧基之反 應性衍生物或其鹽與化合物(W)或其在胺基之反應性衍 生物或其鹽反應來製造。 化合物(VB)在胺基之適當反應性衍生物包括令化合物 (W)與如醛,酮等羰基化合物反應所生成之許夫氏齡型 亞胺,或其互變烯胺型異構物;由化合物(VI)與如雙( 三甲基矽烷基)乙醯胺,單(三甲基矽烷基)乙醯胺, 雙(三甲基矽烷基)脲等矽烷基化合物反應而成之矽院 -24- A 6 B6 (請先閲讀背面之注意事項再填窝本頁) -裝- 訂- 線- 本紙張尺度遑用中«家螵準(CNS)甲4規格(210x2974*) 81. 5. 20.000(H) ^030^0 經濟部中央標準局员工消費合作社印製 五、發明説明(2 3) 基衍生物;由化合物(Vi)與三氣化磔或光氣反應而成之 衍生物等。 化合物(I-g)在羧基之適當反應性衍生物可包括醯齒 ,酐,活化醯胺,活化酯等。例如醯氣;醯基β氮;與 下列酸之混合酐;如取代磷酸〔如二烷基磷酸,苯基磷 酸,二苯基磷酸,二苄基磷酸,鹵化磷酸等〕,二烷基 亞磷酸,亞硫酸,硫代硫酸,硫酸,磺酸〔如甲磺酸等 〕,脂族羧酸〔如乙酸,丙酸,丁酸,異丁酸,待戊酸 ,戊酸,異戊酸,2-乙基丁酸,三氣乙酸等〕或芳族羧 酸〔如苯甲酸等〕:對稱酐;與眯唑,4 -取代眯唑,二 甲基吡脞,三唑,四唑之活化醯胺;或活化酯〔如氱甲 酯,甲氣甲酯,二甲亞胺甲酯〔(CH3)2i = CH-]酯, 乙烯酯,丙炔酯,對硝苯酯,2, 4 -二硝苯酯,三.氣苯 酯,五氣苯酯,甲磺醯苯酯,苯偶氪苯,苯硫酯,對硝 苯硫酯,對甲酚硫酯,羧甲硫酯,吡喃酯,吡啶酯,哌 啶酯,8 - Pf啉硫酯等〕,或與N -羥基化合物〔如N, N-二甲基羥胺,卜羥基- 2- (]Η)-ίϋ啶酮,N -羥基丁二醯亞 胺,Ν-羥基酞醯亞胺,卜羥基-1Η-苯駢三唑等〕之酯等 。這些反應衍生物可依所用化合物(I-g)之種類任意選 擇。 反應常在習用溶劑,如水,醇〔如甲醇,乙酵等〕, 丙酮,二鸣烷,乙腈,氣仿,二氛甲烷,二氣乙烷,四 氫呋喃,乙酸乙酯,N,N -二甲基甲醯胺,吡啶,或對 -2 5 - (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中國家揉毕(CNS)甲4規格(210X297公*) 81. 5 . 20.000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 ίτΟ 凝 Ο- 五、發明説明(24) 反應無不良影轡之任何其他有機溶劑。這些習用溶劑也 可與水混合。 在此反應中,若化合物(I-g)以自由酸或其鹽使用, 反應宜在如下列習用縮合劑之存在下進行,如Ν, Ν’-二 環己基磺化二亞胺;Ν -環己基- Ν' - (4 -二乙胺環己基) 碩化二亞胺;Ν, Ν' -二乙基碩化二亞胺,Ν, Ν' -二異丙 基碩化二亞胺;Ν -乙基- Ν' - (3 -二甲胺丙基)磺化二亞 胺,Ν, Ν' -羰基雙(2 -甲基眯唑);五亞甲基烯酮-Ν-環己基亞胺,二苯烯酮-Ν-環己亞胺;乙氣基乙炔;1-烷氣基-1-氯乙烯;亞磷酸三烷酯;聚磷酸乙酯;聚磷 酸異丙酯;氧氣化磷(磷醯氣);三氱化璘;二苯基磷 醯叠氮;亞磺醯氣;草醯氣;鹵甲酸低烷酯〔如氣甲酸 乙酯,氯甲酸異丙酯等〕;三苯瞵;2-乙基-7-羥基苯 駢異鸣唑錨鹽;氫氣化2 -乙基-5 -(間磺酸苯基)異 唑鑛分子内鹽;1-(對氣笨磺醯氣基)-6 -氨-1H -苯駢 三脞;由N, N -二甲基甲醯胺與亞磺醯氨,光氣,氣甲 酸三氣甲酯,氧氣化磷等反應製得之Vilsmeier試劑等 〇 反應也可在如鹼金屬重硪酸鹽,三低烷胺,吡啶,N-低烷基嗎啉,N, N -二低烷苄胺等無機或有機驗之存在 下進行。 反應溫度無關緊要,常在冷卻〜加溫下進行。 製法7 -2 6 - (請先閲讀背面之注意事項再塡寫本頁) 裝· 訂- 本紙張尺度遑用中國國家標準(CNS)甲4規格(210X297公*) 81. 5. 20,000(8) L0301.0 A 6 B6 五、發明説明(25) 物 合 化 令 可 鹽 其 或 \Ι/ ο ,7造 (I製 物來 的基 目護 保 基 胺 去 消 鹽 其 或 酸 C » 4 鹼法 如製 t 照 件參 條可 及 J 式等 方度 應溫 反應 故反 , » 4 劑 法溶 製 ’ 仿媒 可觸 應 , 反劑 8 此原法 還製 物 合 化 令 可 鹽 其 或 k I I λΐ\ 物 的 百 物 合 化 與 RK 鹽 其 或 vlfl 件 條 及 式 方 應 反 〇 c故 2 造,法 製 2 製 來法照 應製參 反仿可 鹽可 j 其應等 或反度 丨此溫 應 劑 溶 如 反 (請先閲讀背面之注意事項再填寫本頁) 時 基 羧 .為 形 情 之 護 R1保 當被 括中 包驟 應步 反理 9 本處法 後製 中 法 製 本 在 或 中 應 反 在 物 合 化 令 可 鹽 其 件 條 及 式 方 應 反 c 故 2 ,法 2 製 交法照 )。製參 -d造仿可 { ‘製可 物來應等 的基反度 目護此溫 保 應 基 羧 入 引 鹽 其 或 反 劑 溶 如 裝. 訂 經濟部中央標準局員工消費合作社印製 目的物(I )或其鹽可令化合物(XII)或其鹽與化合物 (XXI)或其鹽反應來製造。 此反應可仿製法2,故反應方式及條件〔如溶劑,反 應溫度等〕可參照製法2。 本反應包括R1為被保護羧基時,在反應當中或在本 製法之後處理步驟中消去之情形。 出發化合物(II)及(IV)可依下列方法(如後製備例詳 -2 7 - 本紙張尺度遑用中祖家楳準(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) A 6 Β6
五、發明説明(26) 述)或常法製造 方法A
R
Cr
CH2-A-R 1
(XIV) Λ SK w6-ch9-c-r1;l ^ II o (XV) 砖其翔 >* n it n (請先閱讀背面之注意事項再塡寫本頁) 裝· 0 1 B 法 方 經濟部中央標準局員工消費合作社印製
2 2 R R
訂- 本紙張尺度逍用中國國家揉準(CNS)甲4規格(210X297公》) 81. 5. 20,000(H) 五、發明説明(27)
R A-RJ 方法R -⑵
或其鹽 66 ΑΒ W -A-R (XVIII) £ SB -CAi rm 11
R 11 1 „1 還原 (請先閲讀背面之注意事項再填寫本頁) 裝- 經濟部中央標準局員工消費合作社印製
(XII-b) 或其嫌 JSI -2 9- 本紙張尺度遑用中 a家樣準(CNS)甲4規格(210X297公釐) 81. 5. 20,000(H) fj 030ii A6 B6 五、發明説明(28) 方法C-(1)
R A-RJ 或其鹽 11 w8-q-x-y-no(χιχ)或其鹽 2 (請先閲讀背面之注意事項再填寫本頁) Q-X-Y-NO 11 2
(IX) 却宜趟 -¾ 7¾ BH 還原 經濟部中央標準局員工消費合作社印製 R-
A-R Q-X-Y-N〇2 11 (IX)或其鹽 3 0- 本紙張尺度逍用中困國家橾準(CNS) f 4規格(210X297公釐) 81. 5. 20.000(H) o 3o
66 AB 五、發明説明(29)
Q-X-Y-NH2 ,11 方法C-(3)
R A-R* (II-a)或其鹽 -Q-X-Y-NH2 11 + w4-Rd (X) 或其鹽 -ίΛι ^ X ϋΧΧ (請先閲讀背面之注意事項再填寫本頁)
R Q-X-Y-NHR^ A-R (II-b) 或其鹽 方法Γ:-⑷ 經濟部中央標準局員工消費合作社印製
R 11 -31 本紙張尺度逍用中國國家揉準(CNS) f 4規格(210X297公*) 81. 5. 20.000(H) 五、發明説明(30) 方法C - (5) ,Ν A6 B6 W9-Q-X-Y-R10 (XX)
或其鹽 10 (請先閲讀背面之注意事項再填寫本頁)
R Q-X-Y-R 11 10 消去羥基保護基 A-RJ (XI)或其鹽
Q-X-Y-OH 或其鹽 經濟部中央標準局员工消費合作社印製 3 2 本紙張疋度逍用中國國家樣準(CNS)甲4規格(210X297公發) 81. 5. 20,000(H) ύ 3 ο
66 AB 五、發明説明(31) 方法Γ - (6)
消去羧基保護基
(II-e)
或其额 XQI (請先閲讀背面之注意事項再填寫本頁)
方法D 經濟部中央標準局員工消費合作社印製
R 11 + 3 3- 本紙張尺度遑用中《 a家揉準(CNS) f 4規格(210X297公釐) (XIII) 砟其鞠 —cA* jm 81. 5. 20.000(H) 箱- 五、發明説明(32) A6 B6
Q-X-Y1^2 R I , R 2 , R | , R11,A, Q , X, Y 及W 2同前, 經濟部中央標準局員工消費合作社印製 式中R 1 , R 10 W 4 , A 1 A 2 方法A 目的物 層板等常 所得目 目的物 酮5« -還 腺癌,禿 (或男樣 性素過多 為說明
Y 為低烷基或胺基保護基, 為被保護羥基, W 5 , W 6 , W 7 , W8及W9各為酸殘基, 為有氣基之低伸烷基, 為低伸院基。 〜D可依常法進行。 (I)可依如萃取,沉澱,分步結晶,再結晶, 法單離及精製。 的物(I )可依常法轉變為其馥。 (I)可當作睪固酮5ct-還原酶抑制劑,對睪固 原酶仲介病,如前列腺病,前列腺肥大,前列 髮,多毛症(如女性多毛症等),雄性素禿髮 禿),痤瘡(如替通痊瘡,丘疹等),其他雄 症等。 目的物(I)之有用性,本發明化合物之藥理活 -34 本紙張尺度遑用中國國家揉準(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 L030C0 五、發明説明(33) 性列示如下。 〔1〕供試化合物 ⑴4-〔 3-〔 3-〔雙(4-異丁苯基)甲胺基]苄醯基〕B引 胼-1-基〕丁酸 ⑵4-〔1-〔4-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕B引 阱-3-基〕丁酸 ⑶4-〔 3-〔 3-〔雙(4-異丁苯基)甲氣基〕苄醯基〕Ϊ引 畊-1-基〕丁酸 ⑷4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丙氣基〕苄醯基〕J引 阱-3-基〕丁酸 ⑸4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)戊氣基〕苄醯基〕Ϊ引 阱-3-基〕丁酸 〔2〕在老鼠對睪固_5«-還原酶之抑制活性 . 試驗方法 i )材料 1, 2, 6, 7-3H-睪固酮(85-105 Ci/mmol):此為 1 ,2 , 6,7 - 3 Η -睪固酮與毎in m ο 1睪固酮含1 , 2 , 6,7- 3H -睪固酮85-105Ci之睪固酮之混合物,購自美國麻州 波士頓新英格蘭核子公司。 Aquazol (Aquazol-2 Universal LSC Cocktail):商 品名,購自美國麻州波士頓新英格蘭核子公司。 ii )前列腺睪固酮5« -還原酶之製備 用乙醚處死成熟Spraque-Dawley雄鼠(7〜8週齡)。 -3 5 - A 6 B6 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中國國家樣竿(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) A 6 B6 :030^0 五、發明説明(34) 將腹部前列腺切離其囊,其合計容量乃由冰冷培養液A (0.32M蔗糖),O.lmM二硫蘇糖醇及20bM磷酸銷,pH 6 . 5 )之置換數m 1來測定。除持定者外,所有下列程序 均在0〜4°C進行。將前列腺弄乾而切碎後,用派熱司玻 璃均化機均化在3〜4倍容量培養液A。將此均化物以 3,〇〇Gg撤分離心15分。所得粒子再懸浮於培養液A。將 此懸浮液(20〜30m g蛋白質/Bl)貯存於-80 °C。 iii)睪固酮5α -還原酶分析 反應液含有1 βΜ二硫蘇糖醇,4[)ιβΜ磷酸納pH 6.5, 50
NADPH, <,2,6, 7-3H-睪固酮 / 睪固酮(2.2X 10 — 9 Μ)及上述懸浮液(0.8m g蛋白質)共565// 1。供 試化合物投入lOyl 10%乙醇中,而對照試管也接受同 容量1 〇 %乙醇。加酵素懸浮液來開始反保溫.3 7 °C 3 0 分後,以lffll乙酸乙酯萃取。取50// 1乙酸乙酯相層析在 黙克矽石塑膠片衫膠60 F2B4 (乙酸乙酯:環己烷= 1:1)。將此塑膠片風乾而切取睪固酮及5α-二氫睪固 _區。其放射活性乃在5ml Aquazol-2以派克閃爍計 (PACKARD TRI-CARB 4530)計數,而算出抑制比。 (請先閲讀背面之注意事項再填寫本頁) 裝· 線· 經濟部中央標準局員工消費合作社印製 _ 3 6 一 81. 5 . 20,000(H) 本紙張尺度遑用中國國家锞毕(CNS)甲4規格(210x297公*) AW五
AB 5) 3 /V 明 説 明 發 結 驗 試 物 合 化
X
X
X (請先閲讀背面之注意事項再填窝本頁) ⑷
X ⑸
X 許摻 容 , 藥分 製成 其效 及有 5為 I ί 物 物合 合化 化該 的以 目 » 之用 明使 發劑 本製 ,藥 待 0 藥用 投習 療以 治乃 鹽 適末 , ,粉液 劑 ,乳 形粒, 賦顆 體 , 液錠 或如 體呈 固可 機劑 無製 或此 i 機 〇 有用 如外 , ,及型 體腸劑 載經體 許非固 容,等 藥服囊 製口膠 和合 , 漿 糖 液 浮 懸 液 容 > J1 如 或 經濟部中央標準局貝工消費合作社印製 劑 濕 潤 劑 定 安 劑 肋 輔 含 。包 型可 劑時 體要 液必 等中 液劑 洗製 ,述 水上 樣在 檸 ,花 酸膠 脂果 硬 , ,菜 酸洋 脂 , 硬膠 ! 明 酸 , 樣石 擰滑 酸粉 石澱 酒米 ,玉 糖 , 乳糖 如蔗 他 , 其土 及白 本紙張尺度遑用中《两家#毕((》5)甲4規格(210x297公*) 81. 5. 20,000(H) 經濟部中央標準局员工消費合作社印製 L030S0___ 五、發明説明(36) 生油,橄攬油,可可脂,乙二醇等。 化合物(I)之劑量可依病人之年齡,狀況,病及所用 化合物(I )之種類等而異,但一般每日0.01〜約500mg 以上。平均單一劑量約0.05, 0.1, 0.25, 0.5, 1,20 ,5 0 , 1 0 G B g ,本發明目的化合物(I )可用以治病。 下面舉製備例及實施例說明本發明。 製備例1 將3 -氛甲醯基丙酸乙酯1.65克及氣化鋁1.78克溶在二 氛甲烷20nl,而在室溫加吲阱977m g/二氛甲烷5ml。攪 拌1小時後,加放而以氣仿萃取,以飽和重碩酸鈉水及 食鹽水洗濯,以硫酸鈉乾燥,蒸除溶劑,在矽膠層析( 己烷:乙酸乙酯=3 : 2 ),得下列化合物。 4 - ( 3 -吲阱基)-4 -氣丁酸乙酯0 · 7 4克 NMR (CDC13, 6) : 1.28 (3H, t, J=7Hz), 2.79 (2H, t, J=7HZ), 3.29 (2H, t, J=7HZ), 4.18 (2H, q, J=7Hz), 6.51 (1H, d, J=5Hz), 6.84 (1H, dt, J=lHz, 6Hz), 7.12 (1H, m), 7.52 (1H, m), 7.58 {1H, d, J=5Hz), 9.83 (1H, dd, J=lHz, 6Hz) 4-(卜吲阱基)-4 -氣丁酸乙酯0.26克 NMR (CDC13, δ) : 1.28 (3Hr t, J=7Hz), 2.78 (2H, t, J=7Hz), 3.25 (2H, t, J=7Hz), 4.17 (2H, q, J=7Hz), 6.77 (1H, dt, J=lHz, 7Hz), 7.12 (1H, m), 7.22 (2H, m), 8.03 UH, dt, J=7Hz, 1Hz), 8.44 (1H, dt, J=9Hz, 1Hz) 餺備例2 一 3 8 _ (請先閲讀背面之注意事項再填窝本頁) 本紙張尺度遑用中國家揉準(CNS) f 4規格(210X297公釐) 81. 5. 20.000(H) 汕3㈣_έβ_ 五、發明説明(37) 將4- (3-Β引哄基)-4-氣丁酸乙酯556m g溶在四氳呋喃 5ml,而在0°C加硼烷/四氫呋喃(1M溶液,3.6ml)。 在室溫攪拌1G分後,以〇°C磷酸二氫鉀水溶液淬冷。次 以乙醚萃取而以水,重磺酸納水及食鹽水洗濯後,以硫 酸鈉乾燥,蒸除溶劑,在氣化鋁層析(己烷:二氣甲烷 =1 : 1 ),得4 - ( 3 - P引阱基)丁酸乙酯2 9 4 m g。 NMR (CDC13, δ) : 1.26 (3Η, t, J=7Hz), 2.08 (2H, m), 2.43 (2H, t, J=7Hz), 2.89 (2H, t, J=7Hz), 4.14 (2H, q, J=7Hz), 6.3-6.7 (4H, 7.37 (1H, dt, J=9HZ, 1Hz), 7.78 (1H, dt, J=6Hz, 1Hz} 餺備例.3 仿製備例2製得下列化合物 4 - ( 1 - B引阱基)丁酸乙酯 . NMR (CDC13, 6) : 1.23 (3H, t, J=7Hz), 1.98 (2H, m), 2·34 (2H, t, J=7Hz), 2.79 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 6.37 (1H, dt, J=lHz/ 7Hz), 6.56 (1H, m), 6·62 (1H, d, J=3Hz), 7.21 (1H, d, J=3Hz)# 7.29 (1H, d, J=9Hz), 7.84 (1H, d, J=7Hz) 魁備例4 經濟部中央標準局貝工消費合作社印製 將3 -硝苄醯氛314uig溶在二氣甲烷20ml,而在室溫加 氯化鋁3 Q 5»> g。攪拌1 Q分後,加4 — ( 3 —吲哄基)丁酸乙 酯297mg與二氣甲烷3ml之溶液。1小時後,加冰而以氣 仿萃取,以水,重磺酸納水及食鹽水洗濯,以硫酸鈉乾 燥,蒸除溶劑,在矽膠層析(己烷:乙酸乙酯=2: 3) -3 9 - 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度逍用中國國家揉準(CNS)甲4規格(210x297公釐) 經濟部中央標準局員工消費合作社印製 五、發明説明(38) ,得4-〔 1-(3 -硝苄醯基)吲阱-3-基〕丁酸乙酯353ng。 NMR (CDC13,6) : 1.23 (3H, t, J=7Hz), 2.08 (2H, m), 2.46 {2H,t, J=7Hz}, 2.93 {2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.80 (1H, s), 6.98 (1H, dt, J=lHz, 7Hz), 7.30 (1H, m), 7.69 {1H, t, J=8Hz), 8.10 (1H, d, J=7Hz), 8.16 (1H, n〇, 8.39 (1H, m), 8.53 (1H, dt, J=9Hz, 1Hz), 8.57 (1H, m) 餺備例FS 仿製備例4製得下列化合物。 v ⑴4 -〔 1 - ( 4 -硝苄醯基)吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 1.25 (3H, t, J=7Hz), 2.04 (2H, m), 2.46 (2H, t, J=7Hz), 2.90 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.76 (1H, s), 6.99 (1H, dt, J=lHz, 7Hz), 7.32 (1H, m), 7.95 (2H, d, J=9Hz), 8.10 (1H, d, J=7Hz), 8.35 (2H, d, J=9Hz), 8.54 (1H, d, J=8Hz) ⑵4 -〔 3 - ( 3 -硝苄醯基)吲阱-1 -基〕丁酸乙酯 NMR (CDC13, δ) : 1.23 (3Η, t, J=7Hz)/ 2.01 (2H, m), 2.37 (2H, t, J=7Hz}, 2.81 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz>, 7.02 (1H, dt, J=lHz, 7Hz), 7.11 (1H, s), 7.28 (1H, dt, J=lHz, 8Hz), 7.62 (1H, dt, J=8HZ, 1H2), 7.69 (1H, t, J=7Hz), 8.12 (1H, in), 8.38 (1H, m), 8.63 (1H, m), 9.98 (1H, d, J=7Hz) ⑶4 -〔 3 - ( 4 -硝苄醯基)吲阱-卜基〕丁酸乙酯 -40- 本紙張尺度遑用中國踽家榣毕(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) 裝· 訂- 線- A 6 Β6 經濟部中央標準局貝工消費合作社印製 五、發明説明(39) NMR (CDC13/ 6) : 1.23 (3H, t, J=7Hz), 2.00 (2H, m), 2.36 (2Hf t, J=7Hz), 2.79 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 7.02 (1H, dt, J=lHz, 7Hz>, 7.07 (lHf s), 7.28 (1H, m)r 7.61 (1H, dt, J=9Hz, 1Hz), 7.93 (2H, d, J=9Hz), 8.36 (2H, d, J=9Hz), 9.98 (1H, d, J=7Hz)⑷4 -〔 1 - ( 4 -甲氣苄醯基)吲哄-3 -基〕丁酸乙酯 NMR (CDC13, δ) : 1.25 (3Η, t, J=7Hz), 1.98-2.17 (2H, m), 2.45 (2H, t, J=7Hz), 2.90 (2H, t, J=7Hz), 3.89 (3H, s), 4.14 (2H, q, J=7Hz), 6.84-7.04 (4H, m), 7.12-7.22 (1H, in), 7.80-7.90 (2H, m), 8.01 (1H, d, J=7Hz), 8.48 (1H, d, J=9Hz)⑸4 -〔 1 - ( 3 -甲氣苄醯基)吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 1.26 (3H, t, J=7Hz), 1.97-2.15 (2Hf m), 2.44 (2H, t, J=7Hz), 2.89 (2H, t, J=7Hz>, 3.88 (3H, s), 4.13 (2H, q, J=7Hz), 6.87-6.97 (2H, m), 7.03-7.12 (1H, m), 7.16-7.26 (1H, m), 7.32-7.43 (3H, m), 8.03 (1H, d, J=7Hz), 8.51 (1H, d, J=9Hz)⑹4 -〔 3 - ( 4 -甲氣苄醯基)吲阱-1 -基〕丁酸乙酯 NMR (CDC13# δ) : 1.23 (3Η, t, J=7Hz), 1.92-2.10 (2Hf m), 2.35 (2H, t, J=7Hz), 2.79 (2H, t, J=7Hz), 3.90 (3H, s), 4.12 (2H, q, J=7Hz), 6.85-7.23 (5H, m), 7.54 (1H, d, J=9Hz), 7.77-7.88 (2H, m)⑺4 - [ 3 - ( 3 -甲氣苄醯基)03丨阱-1 -基〕丁酸乙酯 -41- 本紙張尺度遑用中《國家樣準(CNS)甲4規格(210 X 297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填窝本頁) 裝· 訂- 線- A 6 B6 經濟部中央標準局员工消費合作社印製 五、發明説明(40) NMR (CDC13, 6) : 1.24 (3H, t, J=7Hz), 1.90-2.08 (2H, m), 2.36 (2H, t, J=7Hz), 2.78 {2H, t, J=7Hz), 3·88 (3H, s}, 4.12 (2H, q, J=7Hz), 6.87-7.07 (3H, m), 7.13-7.40 (5H, m), 7.44 (1H, d, J=9Hz> 靱備例fi 將4-〔卜(3 -硝苄醯基)吲阱-3-基〕丁酸乙酯350mg 溶在二 Hi 烷-乙醇(1 : 1 , 1 0 m 1),而加 1 0 % P d - C 2 1 0 in g ,在氫4大氣壓下氫化4小時後,濾經C e 1 i t e ,蒸除 溶劑,得4 -〔 1 - ( 3 -胺苄醯基)吲阱-3 -基〕丁酸乙酯 3 2 5 m g 〇 NMR (CDC13, δ) : 1.23 (3H, t, J=7Hz) , 2.05 (2H, n〇, 2.43 (2H, t, J=7Hz), 2.88 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 6.90 (1H, m), 6.91 (1H, s), 7·1-7·4 (5H, ra), 8.01 (1H, d, J=7Hz), 8.48 <1H, dt, J=8Hz, 1Hz) 剪備例7 仿製備例6製得下列化合物。 ⑴4 -〔 1 - ( 4 -胺苄醯基)吲阱-3 -基〕丁酸乙酯 NMR (CDC13, δ) : 1.25 (3Η, t, J=7Hz), 2.07 (2H, m),2.44 (2H, t, J=7Hz), 2.89 (2H, t, J=7Hz), 4·14 (2H, q, J=7Hz), 6.78 (2H, d, J=9Hz), 6.86 (1H, dtr J=lHz, 7Hz), 6.92 (1H, s), 7.12 (1H, m),7.76 (2H, d, J=9Hz), 7.99 (1H, d, J=7Hz), 8.43 (1H, d, J=8Hz) ⑵4-〔3- (3 -胺苄醯基)吲阱-1-基]丁酸乙酯 -42- 本紙張尺度遑用中國困家樣毕(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 裝· -訂_ 線· k,030b〇 it 經濟部中央標準局員工消費合作社印製 五、發明説明(41) NMR (CDC13, 6} : 1.23 (3H, t, J=7Hz), 1.98 (2H, m), 2.33 (2H, t, J=7Hz), 2.78 (2H, t, J=7Hz), 6.8-7.0 (2H, m), 7.1-7.3 (6H, m), 7.54 (1H, dtr J=8Hz, 1Hz), 9.94 (1H, d, J=7Hz) ⑶4 -〔 3 - ( 4 -胺苄醯基)吲阱-1 -基〕丁酸乙酯 NMR (CDC13, δ) : 1.24 (3Η, t, J=7Hz), 2.00 (2Η, m), 2.35 (2H, t, J=7Hz), 2.80 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.73 (2H, d, J=9Hz), 6.87 (1H, dt, J=lHz, 7Hz), 7.02 (1H, m), 7.20 (1H, s), 7.51 (1H, dt, J=9Hz, 1Hz), 7.72 (2H, d, J=9Hz), 9.86 (1H, d, J=7Hz) 魁備例8 混合4-〔 1-(4 -甲氣苄醛基)B?丨阱-3-基〕丁酸乙酯 6 4 0 mg及乙硫醇2 . 5 in 1於二氦甲烷8 m 1 ,而在0 °C加.氣化鋁 7 0 0 π g ^ 0 °C攪拌1 0分後,蒸除溶劑而倒入乙酸乙酯與冰 水之混液中,分取有機層而以重磺酸鈉水及食盥水洗濯 後,以硫酸鎂乾燥,並蒸發而在矽膠柱層析(氱仿:乙 酸乙酯=4: 1),得4-〔 1-(4 -羥苄醯基)吲阱-3-基 〕丁酸乙酯3 4 4 m g ,黃色固體。 NMR (DMSO-dg, δ) : 1.14 (3Η, t, J=7Hz), 1.85-2.03(2H, m), 2.41 (2H, t, J=7Hz), 2.93 (2H, t,J=7Hz), 4.01 {2H, q, J=7Hz), 6.84-7.06 (4H, m), 7.19-7.30 (1H, m), 7.67 (2H, d, J=8Hz), 8.25-8.40 (2H, m) 勦備例9 -43- 本紙張尺度逍用中困家橾準(CNS)甲4規格(210x297公釐) 81. 5. 20,000(fl) (請先閲讀背面之注意事項再填窝本頁) 〇3ΰυ〇 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(42、 仿製備例8製得下列化合物。 ⑴4 -〔 1 - ( 3 -羥苄醯基)吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) ·· 1.25 (3H, t, J=7Hz), 1.97-2.15 (2H, m), 2·43 (2H, t, J=7Hz), 2.88 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.86-6.97 (2H, m), 6.99-7.09 (1H, m), 7.16-7.37 (3H, m), 7.48 (1H, s), 8.01 (1H, d, J=7Hz), 8.50 (2H, m, J=9Hz) ⑵4-〔3- (4 -羥苄醯基)B§|阱-3-基〕丁酸乙酯 NMR (CDC13, 6) : 1.24 (3H, t, J=7Hz), 1.92-2.10 (2H, m)r 2.38 (2H, t, J=7Hz), 2.79 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.86-6.98 (3H, m), 7.12- 7.25 (2H, in), 7.55 (1H, d, J=9Hz), 7.67-7.78 (2Hr m) ⑶4 -〔 3 - ( 3 -羥苄醯基)吲阱-]-基〕丁酸乙酯 NMR (CDC13, 6) : 1.23 (3H, t, J=7Hz) , 1.90-2.08 (·2Η, m), 2.34 (2H, t, J=7Hz), 2.76 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 6.87-7.07 (3H, m), 7.13- 7.40 (5H, ra)f 7.55 (1H, d, J=9Hz) 魁備例1 0 將氣化鋁6 . 6 7克懸浮於二氣甲烷7 0 m 1 ,而在0 °C加己 醯氨7.0ml。在〇°C攪拌15分後,加異丁苯7.9ml。在0°C 攪拌3 0分後,倒入冰水中。將有機層以水,重碳酸納水 及食鹽水洗濯後,以硫酸鎂乾燥而蒸發,得4'-異丁基 苯己酮10.52克,無色油。 -44- 本紙張尺度逍用中瞩家樣準(CNS)甲根格(210x297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填窝本頁) A 6 B6 經濟部中央標準局貝工消費合作社印製 五、發明説明(43) NMR (CDC13, 0) : 0.84-0.98 (9Η, m), 1.30-1.43 (4Η, m), 1.60-2.01 (3H, in), 2.53 (2H, d, J=8.5Hz), 2.94 (2H, t, J=7Hz), 7.22 (2H, d, J=8.5Hz), 7.88 (2H, d, J=8.5Hz) 靱備例1 1 將4’-異丁基苯己酮10. 5克溶在2 -丙酵60nl,而加硼 氫化鈉2 . 0 5克。在5 0 °C攪拌6小時後,倒入冰水中而以 6H鹽酸酸化。次以乙酸乙酯萃取而以水及食鹽水洗濯後 ,以硫酸鎂乾燥而蒸發,得1-(4 -異丁苯基)己-1-醇 9 . 3 2克,無色油。 NMR (CDC13, 6) : 0.83-0.96 (9H, m), 1.16-1.40 (6H, m), 1.60-1.96 (3H, m), 2.48 (2H, d, J=7Hz), 4.64 UH, t, J=7Hz), 7.11 (2H, d, J=8.5Hz), 7.2> (2H, d, J=8.5Hz) 靱備例1 2 例1- ( 4-異丁苯基)己-卜醇9. 15克及四溴化碩25.9 克溶在四氫呋喃25ϋιη1,而加三苯膦20. 5克。在室溫攪 拌6小時後,濾除白色固體。將濾液蒸發而加正己烷300 m 1後,濾除沉澱而蒸發。將殘留之油減壓蒸發,得1 -( 1-溴己基)-4 -異丁苯3. 52克,無色油。 NMR (CDC13, 6) : 0.82-0.97 (9H, m), 1.20-1.60 (8H, in), 1.74-1.97 (1H, m), 2.00-2.38 (2H, m), 2.46 (2H, d, J=7Hz), 4.96 (1H, t, J=7.5Hz), 7.10 (2H, d, J=8.5Hz), 7.29 (2H, d, J=8.5Hz) -4 5 - (請先閲讀背面之注意事項再填窝本頁) 裝· 訂- 線- 本紙張尺度遑用中《國家標毕(CNS)甲4規格(210X297公*) 81. 5 . 20.000(H) A6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(44) 製備例丄3_ 將NaH (3.04克,60%在礦油)攪拌懸浮於二甲亞Μ 100ml,而加熱8G°C 40分後,冷卻而在室溫分添氣化( 3-羧丙基)三苯璘15.9克。30分後,在室溫加2-»ft啶甲 醛3. 96克而攪拌2小時。次加水而以1N鹽酸酸化為pH 5 後,以乙酸乙酯萃取而合併有機層,以食鹽水洗濯,乾 燥而濃縮,在矽膠層析(乙酸乙酯:甲醇〇 , 得(4 E ) - 5 - ( 2 -吼啶基)-4 -戊烯酸1 . 6克。 NMR (CDC13, δ) : 2.5-2.8 (4Η, m), 6.6-6.9 (2Η, m), 7·19 (1H, ra), 7·37 《1H, d, J=8Hz), 7.70 (1H, dt, J=lHz, 8Hz), 8.59 (1H, d, J=5Hz) 例丄4 將(4E)-5-(2 -吡啶基)-4 -戊烯酸(1.6克溶在乙醇 5〇1111,而加(1-茨基-10-磺酸2.3克,用含3 1分子篩之回 流冷縮器加熱回流β 2小時後,蒸發而以飽和重碩酸納 水稀釋。次以乙酸乙酯萃取而以食鹽水洗禪,以硫酸鎂 乾燥後,真空蒸發,得(4 Ε ) - 5 - ( 2 -吡啶基)-4 -戊烯酸 乙酯1 . 84克。 NMR (CDC13, δ) : 1.26 (3Η, t, J=7Hz), 2.45-2.7 (4H, m), 4.16 (2H, q, J=7Hz), 6.53 (1H, d, J=16Hz), 6.75 (1H, dt, J=16Hz, 7Hz), 7.11 (1H, n〇, 7.25 (1H, d, J=8Hz), 7.63 {1H, dt, J=lHz, 8Hz), 8.55 (1H, d, J=4Hz) 4 6- 本紙張尺度逍用中國《家樣準(CNS)甲4規格(210x297公釐) 81. 5 . 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 裝- 訂' 線- 經濟部中央標準局員工消費合作社印製 〇 3 0 b U 五、發明説明(45) 將(4E)-5- (2-_ft啶基)-4 -戊烯酸乙酯1.84克溶在乙 醇15b1,而加10%Pd-C 145mg,在氳4大氣壓下攪拌3 小時後,濾經c e 1 i t e而真空蒸除溶劑,得5 - ( 2 -吡啶基 )戊酸乙酯1 · 84克。 NMR (CDC13, 6) : 1.23 (3H, t, J=7Hz), 1.6-1.9 (4H, in), 2.34 <2H, t, J=7Hz), 2.82 {2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 7.05-7.2 (2H, m), 7·62 (1H, dt, J=lHz, 8Hz), 8.52 (1H, d, J=4Hz) M備例1 ft 將5- (2-吡啶基)戊酸乙酯1.07克溶在丙酮5 ml,而 加溴丙酮0 . 5 1 m 1。回流2小時後,去除溶劑。殘渣溶在 1克重碩酸納與20ml水之溶液,而回流30分後,以乙酸 乙酯萃取。合併有機層而以食鹽水洗濯後,以硫.酸鈉乾 燥,真空乾燥,在矽膠層析(二氣甲烷),得4- (2 -甲 基吲阱-1-基)丁酸乙酯778mg。 NMR 《CDCl], δ) 1.24 (3H, t, J=7Hz), 1.91 (2H, m), 2.23 (3H, s), 2.32 (2Hr t, J=7Hz), 2.74 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.32 (1H, dt,J=lHz, 7Hz), 6.53 (1H, m), 7.08 (1H, s), 7.21 (1H, d, J=9Hz), 7.76 (1H, dt, J=7Hz, 1Hz) 餺備例1 7 仿製備例1製得下列化合物。 4- (2-甲基吲阱-3-基)-4 -氣丁酸乙酯 A 6 B6 (請先閱讀背面之注意事項再填寫本頁) 裝· 訂_ 線- -47- 本紙張尺度逍用中家樣準(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) *s.f' 經濟部中央標準局M工消費合作社印製 五、發明説明(46) NMR (CDC13, 6) : 1.28 (3H, t, J=7Hz), 2.65 (3H, s), 2.79 (2H, t, J=7Hz), 3.19 (2H, t, J=7Hz), 4.18 (2H, q, J=7Hz), 6.34 (1H, s), 6.78 (1H, dt, J=lHz, 7Hz), 7.10 (1H, m), 7.40 (1H, d, J=8Hz), 9.98 (1H, dr J=7Hz)m m m i_g 彷製備例2製得下列化合物。 4- (2 -甲基吲阱-3-基)丁酸乙酯 NMR (CDC13, 6) : 1.24 (3H, t, J=7Hz), 1.90 (2H, m), 2.28 (3H, s), 2.35 (2H, d, J=7Hz), 2.91 (2H, d, J=7Hz), 4.12 (2H, g, J=7Hz), 6.25 (1H, m), 6.47 (1H, m), 6.60 (1H, m), 7.28 (1H, d, J=8Hz), 7.79 (1H, m) 靱備例1 9 仿製備例4製得下列化合物。 ⑴4 -〔 2 -甲基-3 - ( 4 -硝苄醯基)吲阱-卜基〕丁酸乙酯 NMR (CDC13, 6) : 1.23 (3H, t, J=7Hz), 1.79 (3H, s), 1.86 <2Η, π〇, 2.34 (2H, t, J=7Hz>, 2·72 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.92 UH, dt, J=lHz, 7Hz), 7.24 (1H, m), 7.52 (1H, d, J=9Hz), 7.74 (2H, d, J=9Hz>, 8.34 (2H, d, J=9Hz), 9.87 (1H, d, J=8Hz) ⑵4 -〔 2 -甲基-3 - ( 3 -硝苄醛基)丨阱-1 -基〕丁酸乙酯 NMR (CDC13, 6) : 1.24 (3H, t, J=7Hz), 1.84 (3H, s), 1.88 (2H, m), 2.35 (2H, t, J=7Hz), 2.73 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.90 (1H, dt,J=lHz, 7Hz), 7.22 (1H, m), 7·52 (1H, d, J=9Hz), 7.68 (1H, t, J=8Hz), 7.93 (1H, in), 8.37 (1H, m), 8.46 (1H, m), 9.83 (1H, d, J=7Hz) -48- (請先閲讀背面之注意事項再填寫本頁) 訂. -線, 本紙張尺度遑用中國家樣毕(CNS)甲4規格(210x 297公*) 81. 5. 20.000(H) A 6 B6 經濟部中央標準局員工消费合作社印製 五、發明説明(47) ⑶4-〔2 -甲基_1_(4-硝节酷基)丨哄-3-基j j酸乙酷 NMR (CDC13, δ) : 1·27 (3Η, t, J=7Hz), 1.91 (2Η, m), 2.19 (3H, s), 2.41 <2H, t, J=7Hz), 2.93 (2H, t, J=7Hz), 4.15 (2H, q, J=7Hz)# 6.84 (1H, dt, J=lHz, 7Hz), 7.02 (1H, m), 7.51 (1H, dt, J=9Hz, 1Hz), 7.80 (2H, d, J=8Hz)/ 8.09 (1H, d, J=7Hz), 8.32 (2H, d, J=8Hz) ⑷4 -〔 2 -甲基-1 - ( 3 -硝苄醯基)吲阱-3 -基〕丁酸乙SI NMR (CDC13, ί) : 1.26 (3Η, t, J=7Hz>, 1.92 (2Η, m), 2.20 {3H, s), 2.42 (2H, t, J=7Hz), 2.94 (2H, t, J=7Hz), 4.17 (2H, q, J=7Hz), 6.84 (1H, dt, J=lHz, 7Hz), 7.02 (1H, m), 7.53 (1H, dt, J=8Hz, 1Hz), 7.68 (1H, t, J=8Hz), 8.0-8.15 (2H, m), 8.38 (1H, m), 8.50 (1H, m) 勒備例20 仿製備例6製得下列化合物。 ⑴4-〔3- (4 -胺苄醯基)-2 -甲基吲阱-1-基〕丁酸乙酯 NMR (CDC13, 6) : 1.24 {3H, t, J=7Hz), 1.88 {2H, m), 1.99 (3H, s), 2.34 (2H, t, J=7Hz), 2.73 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.64-6.75 UH, ro), 6.68 (2H, ά, J=8Hz), 7.00 (1H, m), 7.42 {1H, dt, J=9Hz, 1Hz), 7.53 (2H, d, J=8Hz), 9.88 (1H, d, J=7Hz) ⑵4 -〔 3 - ( 3 -胺苄醯基)-2 -甲基P引畊-1 -基〕丁酸乙酯 NMR (CDC13, 0) : 1.22 (3H, t, J=7Hz), 1.75-1.95 (2H, m), 1.89 (3H, s), 2.32 (2H, t, J=7Hz), 2.72 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz)f 6.78 (1H, dt, J=lHz, 7Hz), 6.85-7.3 (5H, m), 7.44 (1H, d, J=9Hz), 9.69 (1H, d, J=7Hz) -4 9 - (請先閲讀背面之注意事項再填寫本頁) 裝- 訂· 線· 本紙張尺度逍用中國家樣率(CNS)甲4規格(210x297公釐) 81. 5. 20.000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(48) ⑶4 -〔 1 - ( 4 -胺苄醛基)-2 -甲基吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 1.25 (3H, t, J=7Hz), 1.91 (2H, m}, 2.29 {3H, s), 2.39 (2H, t, J=7Hz), 2.93 (2H, t, J=7Hz), 4.15 (2H, q, J=7Hz), 6.69 (1H, dt, J=7Hz), 6.7-6.9 (3H, m), 7.46 (1H, d, J=9Hz), 7.64 (2H, d, J=8Hz), 7·96 (1H, d, J=7Hz) ⑷4 -〔 1 - ( 3 -胺苄醯基)-2 -甲基吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 1.27 (3H, t, J=7Hz)/ 1.92 (2H, in) r 2.28 (3H, s), 2.39 (2H, t, J=7Hz), 2.93 (2H, t, J=7Hz), 4.14 (2H, q, J=7Hz), 6.72 (1H, dt, J=lHz, 7Hz), 6.8-6.95 (2H, m), 7.0-7.1 {2H, m), 7·21 {1H, t, J=8Hz), 7.46 (1H, dt, J=8Hz, 1Hz), 7.99 (1H, d, J=7Hz) 製備例2 1 將N,N -二甲基甲醯胺0.5ml投入4 -乙醯氧苯甲.酸50克 ,草醯氣27al與二氯甲烷之溶液,而在室溫!t拌 2小時後,蒸除溶劑。殘渣溶在正己烷2 0 0 B 1而過濾後 ,蒸發而得4 -乙醯氣苄醯氯,黃色油55.1克。 NMR (CDC13 , δ): 2.35 (3Η, s), 7.27 (2H, d, J= 9 Hz) , 8.16 (2H, d, J = 9 Hz) 〇 製備例22 將4 -乙醯氣苄醯氯53.6克投入氛化鋁36. 5克與二氯甲 烷500ml之懸浮液。在室溫攪拌20分後,加4-(吲阱- 3-基)丁酸乙酸57.8克與二氯甲烷50ml之溶液。在室溫攢 拌2小時後,蒸除溶劑。殘渣溶在乙酸乙酯500ml而水 -5 0 - (請先閱讀背面之注意事項再填寫本頁) 裝. 訂· 線< 本紙張尺度遑用中國家橾毕(CNS)甲4規格(210x297公*) 81. 5. 20,000(H) k.030^0 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(4^ 洗後,加N, N -二甲胺基丙胺20ml,而以稀鹽酸,水, 重磺酸納水及水洗濯,以硫酸鎂乾燥,真空乾燥,以二 異丙醚洗淨,得4-〔 1-(4 -乙醯氣苄醯基)吲阱-3-基 〕丁酸乙酯之黃色粉末36. 5克。 NMR (CDC13, 6) : 1.25 (3H, t, J=7Hz), 2.0-2.2 (2H, m), 2.35 (3H, s), 2.43 (2H, t, J=7Hz), 2.90 (2H, t, J=7Hz)/ 4.12 (2H, q, J=7Hz), 6.85-7.0 (2H,ra), 7.15-7.3 (1H, m), 7.25 (2H, d, J=8Hz), 7.88 (2H, d, J=8Hz}, 8.03 (1H, d, J=7Hz), 8.52 (1H, d, J=9Hz) 製備例23 將NaH (60%分散於礦油)4. 38克投入4-〔 1- (4 -乙 醯氣苄醯基)吲畊-3-基]丁酸乙酯36.1克在乙醇2Q0ml 與四氫呋喃200ib1混液中之冰冷溶液中。在0°C攪.拌20分 後,蒸發而倒入稀鹽酸及冰之混合物中。次以氣仿與甲 醇10: 1之混液萃取,而以重碩酸納水及食鹽水洗濯後 ,以硫酸鎂乾燥而蒸發,以乙酸乙酯及乙醚洗濯,得4 -〔1-(4 -羥苄醯基)丨阱-3-基〕丁酸乙酸之黃色粉末 2 9 . 3克。 NMR (CDC13, 0) ·· 1.25 <3H, t, J=7Hz), 2.0-2.2 (2Η, m), 2.45 (2H, t, J=7Hz), 2.89 (2H, t, J=7Hz), 4.15 (2H, g, J=7Hz), 6.8-7.0 (4H, m), 7.18 (1H, t, J=9Hz), 7·78 (2H, d, J=8.5Hz), 8.00 (1H, d, J=5.5Hz), 8.50 (1H, d, J=9Hz) -51- 本紙張尺度遑用中家樣準(CNS)甲4規格(210X297公釐) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) Q30b0 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(5〇) 靱備例24 將4’ -異丁基苯丁酮1,2克投入( + )- B-氯二異品莰非基 (pinocanphey)硼烷2. 10克與四氫呋喃4ml之25°C溶液。 5小時後,蒸除溶劑而溶在乙醋2 0 1 ,加二乙酵胺1 . 4 ® 1而攪拌2小時後,濾除固體而以乙醚洗濯合併濾液 而濃縮後,在矽膠層析(己烷:二氯甲烷二1:2),得 (R ) - 1 - ( 4 -異丁 苯基)丁 - 1 -醇 9 3 7 in g。 NMR (CDC13, &) : 0.89 (6H, d, J=7Hz), 0.92 (3H, t, J=7Hz)/ 1.2-1.5 (4H, m), 1.6-2.0 (3H, ra), 2.47 (2H, d, J=7Hz), 4.63 (1H, tr J=7Hz), 7.11 (2Hf d, J=8Hz), 7.25 (2H, d, J=8Hz) M備例25 將4'-異丁基笨丁 _以(-)-B -氣二異品莰非基硼烷仿 製備例24處理,得如下化合物。 (S)-l- ( 4-異丁 笨基)丁 -1-酵 NMR (CDC13, δ) : 0.85-1.0 (9Η, m), 1.15 -1.95 (5H, m), 2.47 (2H, d, J=7Hz)/ 4.66 (1H, t, J=7Hz), 7.12 (2H, d, J=8Hz), 7.25 (2H, d, J=8Hz) 製備例2fi 將氣三甲基矽烷16. 3克及三乙胺30.3克溶在N, N -二 甲基甲醯胺50ml,而加4’ -異丁基苯乙酮22.0克後,立 即濾除黃色固體,將濾液回流20小時後,冷卻而以己烷 烯釋,以冷重磺酸鈉水洗濯。有機層以硫酸鎂乾燥而濃 -5 2 - (請先閲讀背面之注意事項再填寫本頁) 裝. 訂· 線· 本紙張尺度遑用中B 家樣毕(CHS) T 4規格(210x297公釐) 81. 5. 20.000(H) 五、發明説明(51) A 6 B6 經濟部中央標準局貝工消費合作社印製 縮後,減壓蒸發,得4-異丁基-α-三甲基矽烷氣基苯乙 烯9 . 0克,油狀。 醜(CDC13, δ) : 0.16 (9Η, s), 1.65-1.85 (1Η, m), 2.35 (2H, d, J=7Hz), 4.27 (1H, d, J=1.5Hz), 4.76 (1H, d, J=1.5HZ), 6.98 (2H, d, J=8.5Hz), 7.38 (2H, d, J=8.5Hz> 靱備例27 將碘磺醯苯2. 18克溶在乙醇45ml,而加三氟化硼-乙 醚2.55克。在-70 °C攪拌後,加4 -異丁基-α-三甲基矽 烷氣苯乙烯2.24克。在-70 °C攪拌30分後,徐徐昇至室 溫,蒸除乙醇而加水,以重碩酸納水中和。次以二氯甲 烷萃取而以硫酸鎂乾燥後,濃縮而在矽膠柱層析(己烷 :乙酸乙酯= 94: 6),得4、異丁基-2-乙氣基苯.乙酮 1 . 90克,油狀。 NMR (CDC13# 6) : 0.91 (6H, d, J=7Hz), 1.30 (3H, t, J=7Hz), 1.80-2.0 (1H, m), 2.53 (2H, d, J=7Hz), 3.65 <2H, q, J=7Hz), 4.74 (2H, s), 7.24 (2H, d, J=8Hz), 7.87 (2H, d, J=8Hz) 餺備例28 將4'-異丁基-2-乙氣基苯乙酮以(-)-B -氯二異品莰非 基硼烷仿製備例24處理,得如下化合物。 (R) - 1- ( 4-異丁苯)-2-乙氣乙醇 -53- 本紙張尺度逍用中家椹準(CNS)甲4規格(210x297公釐) 81. 5. 20,000⑻ (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 五、發明説明(5 2) NMR (CDC13, δ) : 0.89 (6Η, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.75-1.95 (1H, π〇, 2.47 (2H, d, J=7Hz), 3.35-3.7 (4H, m), 4.87 (1H, dd, J=5.5Hz, 6.5Hz), 7.13 (2H, d, J=8.5Hz), 7.29 (2H, d, J=8.5Hz) 餺備例2Q 將4’-異丁基-2-乙氣基苯乙酮以( + )- B-氣二異品莰非 基硼烷仿製備例24處理,得如下化合物。 (S)-l-(4-異丁苯基)-2-乙氣乙醇 NMR (CDC13, 6) : 0.89 (6H, d, J=7Hz), 1.25 (3H, t, J=7Hz>, 1.75-1.95 (1H, m), 2.47 (2H, d, J=7Hz), 2.79 (1H, s), 3.35-3.7 (4H, m), 4.87 (1H, dd, J=5.5Hz, 6.5Hz), 7.13 (2H, d, J=8.5Hz), 7.29 (2H, d, J=8.5Hz) 郵備例 仿例1製得下列化合物。 ⑴4 -〔 1 -〔 3 -节氣羰甲胺基)苄醯基〕吲阱-3 -基〕丁 酸乙酯 NMR (CDC13, 6) : 1.23 (3H, t, J=7Hz), 2.05 (2H, m), 2·42 <2H, t, J=7Hz), 2.86 (2H, t, J=7Hz), 4.07 (2H, s), 4.11 (2H, q, J=7Hz), 5.21 (2H, s), 6.8-7.0 (3H, m), 7.1-7.4 (9H, m), 8.01 (1H, d, J=8Hz), 8.48 (1H, d, J=9Hz) ⑵4-〔 1-〔 3-〔 ( 1_苄氣羰乙基)胺基〕苄醯基〕吲阱 -3 -基〕丁酸乙酯 (請先閲讀背面之注意事項再填窝本頁) 裝. 訂· 線- -54- 本紙張Λ/t通用中《家«準(CHS)甲4規格(210x297公*) 81. 5. 20,000(H) A 6 B6 經濟部中央標準局貝工消費合作社印製. 五、發明説明(5¾ NMR (CDC13, δ) : 1.24 (3Η, t, J=7Hz), 1.52 (3Η, d, J=7Hz), 2.05 (2H, m), 2·42 (2H, t, J=7Hz), 2.85 (2H, t, J=7HZ), 4.12 (2H, q, J=7Hz), 4.27 (1H, q, J=7Hz), 5.16 (2H, s), 6.7-7.0 (3H, m), 7.1- 7.4 (9H, m), 8.00 UH, d, J=7Hz), 8.48 (1H, d, J=9Hz) 靱備例 將4-〔1-〔 3-〔 (1-苄氣羰乙基)胺基〕苄醯基〕吲 阱-3-基〕丁酸乙酯0·20克溶在乙酵lOml而加10% Pd-C 0.1克。在室溫氫蒙氣下攪拌2小時後,去除觸媒,蒸除 溶劑,得4 -〔 1 -〔 3 - ( 1 -羧乙胺基)苄醯基〕吲阱-3 - 基〕丁酸乙酯0.15克,黃色粉末。 NMR (CDC13/ δ) : 1.25 (3Η, t, J=7Hz), 1.57 (3Η, d, J=7Hz), 2.0-2.3 (2H, m), 2.50 (2H, t, J=7Hz), 2.83 (2H, t, J=7Hz), 4.16 (3H, q, J=7Hz), 6.8-7.0 (3H, m), 7.1-7.4 (4H, n〇, 7.96 (1H, d, J=7Hz), 8.55 (1H, d, J=9Hz) 靱備例32 仿製備例3 1製得下列化合物 4-〔 1-(3 -羧甲胺基苄醯基)吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) ·· 1.28 (3H, t, J=7HZ), 2.15 <2H, m), 2.50 (2H, t, J=7Hz), 2.83 (2H, t, J=7Hz), 4.00 (2H, s), 4.17 (2H, q, J=7Hz), 6.8-7.1 (3H, m), 7.2- 7.4 (4H, m), 7.96 (1H, d, J=7Hz), 8·55 {1H, d, J=9Hz) -55- (請先閲讀背面之注意事項再填寫本頁) 裝· 訂- 線. 本紙張尺度遑用中《國家椹毕(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) A 6 B6 經濟部中央標準局员工消費合作社印製 五、發明説明(54) 混合(環丙基甲基)苯1.32克及二氣甲基甲醚1.25ml 於二氣甲烷20nl,而在0 °C氮蒙氣下加氱化鈦(IV)與二 氣甲烷15ml之1.0M溶液。在0 °C攪拌10分後,倒入冰水 中。分取有機層而水洗後,以硫酸鎂乾燥而濃縮,在矽 膠柱層析(己烷:乙酸乙酯=9: 1),得4-(環丙基甲 基)苄醛5 8 0 π g ,油狀。NMR (CDC13, δ) : 0.5-0.65 (2Η, m), 0.9-1.2 (1Η, m), 2·63 (2H, d, J=7Hz), 7.43 (2H, d, J=8.5Hz), 7·82 (2H, d, J=8.5Hz)/ 9.99 (1H, s) 製備例34 將漠化烯丙基鎂(1.0M至乙醚,3nl)溶在乙醚5ml, 而在0 °C滴加4-(環丙基甲基)苄醛240ng與乙醚2ml之 溶液。15分後,以氣化銨水淬冷。次以乙酸乙酯萃取而 水洗後,以硫酸鎂乾燥而濃縮,在矽膠柱層析(己烷: 乙酸乙酯= 85:15),得1-〔 4-(環丙基甲基)苯基〕 -3 -丁烯-1-醇 229mg,油狀。 NMR (CDC13, δ) : 0.45-0.6 (2Η, m), 0.85-1.2 (1H, m), 2.55 (2H, d, J=6.5Hz), 4.72 (1H, t, J=6.5Hz), 5.1-5.25 (2H, m)f 5.7-5.95 (1H, n〇, 7.15-7.35 (4H, m) 靱備例 仿製備例3 4製得下列化合物。 1-(4 -異丁苯基)-3 -丁烯-1-醇 -5 6 - (請先閱讀背面之注意事項再填寫本頁) 裝- 訂_ 線· 本紙張尺度遑用中«家樣半(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) 經濟部中央標準局貝工消費合作社印製 030b0_B6_ 五、發明説明(55) NMR (CDC13, 6) : 0.89 (6H, d, J=7Hz), 1.85 (1H, ra), 2.47 (2H, d, J=7Hz), 2.52 (2H, m), 4.72 (1H, m), 5.1-5.25 (2H, m), 5.83 (1H, m), 7.13 (2H, d, J=8Hz), 7.27 (2H, d, J=8Hz) 餺備例36 將吡啶1.98nl攪拌溶在二氱甲烷15ml,而在0 °C加氧 化鉻(VI)1.23克。30分後,加1-(4 -異丁苯基)-3 -丁 烯-1 -醇5 2 5 m g與二氯甲烷2 in 1。在室溫攪拌2 0分後,濾 經Florisil而以乙醚洗淨。將濾液真空濃縮,而在矽膠 層析(己烷:二氣甲烷=1: U ,得1-(4 -異丁苯基) -3 -丁烯- l- _ 424mg。 NMR (CDC13, δ) : 0.92 (6Η, d, J=7Hz), 1.90 (1Η, m), 2.53(2H,d,J=7Hz),3.75(2H,dt,J=7.lHz),-5.18 ’(1H, m), 5.25 (1H, ro), 6.10 (1H, m), 7.23 (2H, d, J=8Hz), 7.89 (2H, d, J=8Hz) 靱備例37 混合2 -羥基-4 -甲基苯甲酸7 · 6 1克,碘甲烷1 5 . 6 in 1及 碩酸鉀1 7 . 3克於N , N -二甲基甲醛胺1 0 0 m 1 ,而在室溫攪 拌5小時後,過濾而倒入乙酸乙酯與水之混液中。分取 有機層而以水及食鹽水洗灌,以硫酸«乾燥而濃縮,在 矽膠柱層析(正己烷:乙酸乙酯=4: 1),得2 -甲氣基 -4-甲基苯甲酸甲酯7. 99克,油狀。 (請先閲讀背面之注意事項再填窝本頁) -57- 本紙張尺度遑用中國家樣毕(CNS)肀4規格(210X297公*) 81. 5. 20.000(H)
Μ 五、發明説明(56) NMR (CDC13, δ) : 2.39 (3Η, s), 3.88 (3H, s), 3.9〇(3H, s), 6.75-6.85 (2H, n〇, 7.73 (1H, d, J=8.5Hz) 製備例38 仿製備例3 7製得下列化合物e 3-甲氣基-4-甲基苯甲酸甲酯 NMR (CDC13, <5) : 2·27 {3H, s), 3.88 (3H, s), 3.91 (3H, s), 7.18 (1H, d, J=8Hz), 7.45-7.6 (2H, m) 勒備例39 混合2 -甲氣基-4-甲基苯甲酸甲酯6.95克,N -溴丁二 醯亞胺8.24克及觸媒量過氣化苄醯基2Gmg於四氣化磺 lOOinl,而加熱回流2小時後,冷卻至室溫而過濾,濃縮 而在矽膠柱層析(正己烷:乙酸乙酯= 85: 15‘),得4-溴甲基-2-甲氣基苯甲酸甲酯2.92克,油狀。 NMR (CDC13, δ) : 3.89 (3H, s), 3·93 (3H, s), 447(2H, s), 6.95-7.05 (2H, m), 7.77 (1H, d, J=8.5Hz) 先閲 -讀 背 Φ 之 Μ意事項 再填窝 本 頁 裝 訂 線 經濟部中央標準局員工消費合作社印製 毅備例40 仿製備例39製得下列化合物。 4-溴甲基-3-甲氣基苯甲酸甲酯 臟(CDC13, δ) : 3·93 (3Η, s), 3.97 (3Η, s), 4.56 {2Η, s), 7.40 (1Η, d, J=8Hz), 7.5-7.65 (2Η, m) 製備例41 _ 5 8 - 本紙張尺度逍用中«家櫺準(CHS)甲4規格(210X297公徒) 81. 5. 20,000(H) 經濟部中央標準局貝工消費合作社印製 〇3〇bO 五、發明説明(57) 混合4 -溴甲基-3-甲氧基苯甲酸甲酯1.55克及亞磷酸 三乙酯1.54B1,而在氮蒙氣下加熱5(TC 30分後,舁至 2 0 (TC 2小時。將所得鮮黃色液冷卻而在矽膠柱層析( 乙酸乙酯),得(3 -甲氧基-4-甲氧羰苄基}隣酸二乙 酯1 . 2 8克,油狀。 NMR (CDC13/ 6) : 1.2-1.4 (6H, m), 3.18 (2H, d, J=22Hz), 3·88 (3H, s), 3.92 (3H, s), 3.95-4.2 (4H, m), 6.85-7.0 (2H, m), 7.77 (1H, d, J=8Hz) 製備例42 仿製備例4 1製得下列化合物。 (2-甲氣基-4-甲氣羰苄基)膦酸二乙酯 NMR (CDC13, 6) : 1.24 (6H, t, J=7Hz), 3.29 (2H, d, J=22Hz), 3.89 (3H, s), 3.91 (3H, s), 3.95-4:1 (4H, m), 7.38 {1H, dd, J=8Hz, 3Hz), 7.5-7.65 (2H, m) 魁備例43 混合(3-甲氣基-4-甲氣羰苄基)勝酸二乙酯1.28克 及丙酮1.5ml於N, N -二甲基甲醯胺5b1,而加60%NaH-油分散液162ng。在室溫攪拌14小時後,倒入冰冷10% 檸檬酸中。次以乙酸萃取而以水及食鹽水洗濯後,以硫 酸鎂乾燥,濃縮而在矽膠柱層析(正己烷:乙酸乙酯= 85:15),得2 -甲氣基- 4-(2 -甲基-1-丙烯基)苯甲酸 甲酯184mg,油狀。 -5 9- A 6 B6 (請先閲讀背面之注意事項再填窝本頁) 裝· -線- 本紙張尺度遑用中國《家揉竿(CNS)甲4規格(210X297公*) 81. 5 . 20.000(H) ^0301 Μ 五、發明説明(5¾ NMR (CDC13, δ) : 1.89 (3Η, d, J=1.5Hz), 1.93 (3Η, d, J=1.5Hz), 3.89 (3H, s), 3.91 {3H, s), 6.27 (1H, s), 6.8-6.9 (2H, in), 7.78 (1H, d, J=8Hz) 靱備例44 仿製備例43製得下列化合物。 3-甲氣基-4-(2-甲基-1-丙烯基)苯甲酸甲酯 NMR (CDC13, <5) : 1.83 {3H, d, J=1.5Hz), 1.97 UH, d, J=1.5Hz), 3.89 (3H, s), 3.92 (3H, s), 6.33 (1H, s), 7.25 (1H, d, J=8HZ), 7.52 (1H, d, J=1.5Hz), 7.62 (1H, dd, J=8Hz, 1.5Hz) (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 將2-甲氣基-4-(2-甲基-卜丙烯基)苯甲酸甲酯178 mg 溶在甲醇 3b1 及 1, 4-二 烷 3ml,而加 IN NaOH.2ml。 在50 °C攪拌3小時後,倒入乙酸乙酯與0.5 N鹽酸之混液 中。分取有機層而以水及食鹽水洗濯後,以硫酸鎂乾燥 而蒸除溶劑,得2 -甲氣基- 4-(2 -甲基-1-丙烯基)苯甲 酸14 2mg,固體。 職(CDC13, δ) : 1.91 (3H, d, J=1.5Hz), 195 (3H, d, J=1.5Hz), 4.08 UH, s), 6.27 (1H, s), 6.87 (1H, s), 7.01 (1H, dd, J=1.5Hz, 8Hz), 8.12 (1H, ά J=8Hz) ’ 仿製備例45製得下列化合物 3 -甲氧基-4- (2 -甲基-1-丙烯基)苯甲酸 -60- 本紙張尺度遑用中國《家樣毕(CNS)甲4規格(210x297公*) 81. 5. 20,000(fl) 經濟部中央標準局员工消費合作社印製 五、發明説明(59) NMR (CDC13/ 6) : 1.85 (3H, s), 1.97 {3H, s), 3.90 (3H, s), 6.34 (1H, s), 7.28 (1H, d, J=8Hz), 7.58 {1H, s), 7.70 UH, d, J=8Hz)m m m μ 混合1-碘丁烷185mg及鋅-銅lOlmg在苯3ml及N,N-二 甲基甲醯胺0.2ml,而在6fl°C攪拌2小時後,加肆(三苯 隣)钯3 1 in g , 2 -甲氧基-4 - ( 2 -甲基-1 -丙烯基)苄醯氱 (從138mg 2-甲氣基-4-(2-甲基-1-丙烯基)苯甲酸及 0.07ml草醯氣製造)及苯2 ml之溶液。在室溫攪拌30分 後,過濾而濃縮,溶在乙酸乙酯,以水及食鹽水洗濯, 以硫酸鎂乾燥而濃縮,在矽膠柱層析(己烷:乙酸乙酯 =9: 1),得2’-甲氮基- 4' - (2 -甲基-卜丙烯基)苯戊 _ 9_ 1 ni g,油狀。 NMR (CDC13, δ) : 0.93 UH, t, J=7.5Hz), 1.25-1.5 (2H, m), 1.55-1.75 {2H, m), 1.90 (3H, d, J=1.5Hz), 1.93 (3H, d, J=1.5Hz), 2.97 (2H, t, J=7.5Hz), 3.89 (3H, s), 6.27 (1H, s), 6.78 (1H, s)t 6.87 (1H, d, J=8Hz), 7.66 (1H, d, J=8Hz) 魁備例48 仿製備例4 7製得下列化合物。 3'-甲氧基-4'-(2-甲基_7-丙烯基)苯戊酮 NMR (CDC13, δ) : 0.97 (3Η, t, J=7.5Hz), 1.3-1.55 (2H, m), 1.6-1.8 (2H, ra), 1.84 (3H, d, J=1.5Hz), 1.97 (3H, d, J=1.5Hz), 2.97 (2H, t, J=7.5Hz), 3.90 (3H, s), 6.33 (1H, s), 7.26 (1H, d, J=8Hz), 7.45-7.6 (2H, m) -61- (請先閲讀背面之注意事項再填窝本頁) 裝- 訂_ 線< 本紙張疋度遑用中家樣毕(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) B6 經濟部中央標準局员工消費合作社印製 五、發明説明(60) 靱備例49 混合2 '-甲氧基-4 ' - ( 2 -甲基-卜丙烯基)苯戊_ 8 8 m g 及10% Pd-C 3〇Bg,而在氳蒙氣下攪拌30分後,濾除觸 媒。將濾液濃縮而溶在甲醇5 m 1後,加硼氫化納1 6 m g。 在室溫攪拌30分後,倒入冰水中而以6N鹽酸酸化。次以 乙酸乙酯萃取而以水及食鹽水洗濯後,以硫酸鎂乾燥而 濃縮,得1-(4-異丁基-2-甲氣苯基)戊醇88mg,油狀。 麵(CDC13, δ) : 0.8-0.95 (9H, m), 12_155 <4H, m), 1.65- 2.0 (3H, m), 2.46 (2H, d, J=7Hz)/ 2.54 (1Η[ d, J=6.5Hz), 3.85 (3H, s), 4.81 (1H, dd, J=6Hz, 13Hz), 6.65 (1H, s), 6·73 (1H, d, j=8Hz), 7.17 (1H, d, J=8Hz) 製備例50 仿製備例49製得下列化合物。 1-(4-異丁基-3-甲氣苯基)戊醇 麵(CDC13, δ) : 0.8-0.95 (9H, m), 12-1 5 <4H,㈨, 1.65- 2.0 (4H, m), 2·47 (2H, d, J=7H2), 3.82 (31^, s), 4.55-4.7 (1H, m), 6.75-6.9 (2H, m), 7.04 (1H, d, J=7Hz) 製備例5 1 混合溴化(4-溴-2-氟苄基)三苯辚3.82克及第三丁 醇鉀786mg,而在室溫攪拌3G分後,加丙酮l.Gml,加熱 回流40小時後,過濾而濃縮。殘渣溶在乙酸乙酯而以水 及食鹽水洗灌,以硫酸鎂乾燥,蒸除溶劑,在矽膠柱層 -6 2 一 (請先閲讀背面之注意事項再填寫本頁) 本纸張尺度遑用中國困家樣準(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(6;〇 析,得1-(4 -溴-2-氟苯基)-2 -甲基-1-丙烯0.70克, 油狀β NMR (CDC13/ δ) : 1.77 (3Η, s), 1·92 (3Η, s),6.12 {1Η, s>, 7.0-7.3 (3Η, m) 製備例52 依常法用乙醚l〇ml ,镁82ng及1- ( 2-氟-4-溴苯基)-2-甲基-1-丙烯0.70克製備3-氟-4- ( 2-甲基-1-丙烯基 )苯基溴化鎂之溶液。於此格任亞溶液滴加戊醛5 2 6 ig 與乙醚5 ml之溶液,而在室溫攙拌30分後,加氣化銨水 。分取有機層而以水及食鹽水洗濯後,以·硫酸鎂乾燥而 濃縮,在矽膠柱層析(己烷:乙酸乙酯= 85: 15),得 1 -〔 3 -氟-4 - ( 2 -甲基-1 -丙烯基)苯基]戊醇3 6 9 n g , 油狀。 NMR (CDClj, 6) : 0.88 (3H, t, J=6.5Hz)/ 1.15-1.5 (4H, ra), 1.6-1.85 (5H, m), 1.92 (3H, s) 郵備例;^ 混合1-〔 3-氟-4- ( 2-甲基-卜丙烯基)苯基〕戊醇 3 0 0 m g, 10% Pd-C 90b g及甲醇lOal而在室溫氳蒙氣下攪 拌·3 0分後,濾除觸媒,蒸除溶劑,在矽膠柱層析(己烷 :乙酸乙酯= 85: 15),得1-(3 -氟-4-異丁苯基)戊 醇1 6 7 m g ,油狀β NMR (CDCl3f 6) : 0.8-0.95 (9H, m)r 1.15-1.5 (4H, m),1.6-2.0 (4H, m)f 2.49 (2H, dd, J=lHZ/ 7.5Hz), 4.55-4.7 (1H, m), 6.95-7.2 (3H, m) ’ -63- (請先閲讀背面之注意事項再填窝本頁) 裝- 訂- 線- 本紙張尺度遑用中國家標竿(CNS)甲4規格(210X297公龙) 81. 5 . 20.000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(62) 靱備例;U 將納317mg溶在乙醇30ml而加2 -硝基丙烷1.24ml後, 加4 -溴-2-氟苄基溴3.55克與乙酵IQbI之溶液。在室溫 攪拌3小時後,濾除不溶物而濃縮,溶在乙_及水中。 分取有機層而以IN NaOH及水洗濯後,以硫酸鎂乾燥而 濃縮,在矽膠柱層析(己烷•·乙酸乙酯= 20:1),得 4-溴-2-氟苄β 2 . 28克之固體。 NMR (CDCla , δ ): 7.3 5 - 7.5 5 ( 2 Η, ηι) , 7.7-7.85 ( 1 Η , a ) 〇 製備例55 用乙醚5 ml,鎂lllnig及1-溴丁烷624mg依常法製造丁 基溴化鎂之溶液。於此格任亞溶液滴加4 -溴-2 -氟苄醛 925ng與乙醚5b1之溶液。然後在室溫攪拌30分,而以氣 化銨水淬冷。分取有機層而以水及食鹽水洗濯後,以硫 酸鎂乾燥而濃缩,在矽膠柱層析(己烷:乙酸乙酯=85 :15),得1-(4 -溴-2 -氟苯基)戊醇635mg,油狀。 NMR (CDC13# 6) : 0.90 (3H, t, J=7Hz), 1.2-1.5 (4H, m), 1.65-1.9 (3H, m), 4.9-5.05 (1H, m), 7.15-7.45 (3H, in) 靱備例 混合1 - ( 4 -溴-2 -氟苯基)戊醇6 3 0 hi g,氣甲基甲醚 196m g及三乙胺246mg,而在室溫攪拌3小時後,倒入冰 水中。次以乙酸乙酯萃取而以0.5N鹽酸,水及食鹽水洗 -6 4 - (請先閲讀背面之注意事項再填窝本頁) 裝< 訂· 線- 本紙張尺度遑用中家標毕(CNS)T4規格(210x297公*) 8L 5. 20,000(H) A 6 B6 經濟部中央標準局貝工消費合作社印製 〇3〇b〇_ 五、發明説明(63) 濯後,以硫酸鎂乾燥而滠縮,在矽謬柱層析(己烷:乙 酸乙酯=19: 1),得1-(4-溴-2-氟苯基)-卜(甲氣 甲氣基)戊烷5 5 8 in g ,油狀。 NMR (CDC13, δ) : 0.89 (3Η, t, J=7Hz), 1.2-1.5 (4Η, m), 1.6-1.9 {2H, in), 3.36 (3H, s), 4.5-4.6 {2H, m), 4.88 (1H, dd, J=5.5Hz, 8Hz}, 7.15-7.35 (3H, n〇 靱備例57 將1-(4 -溴-2-氟苯基)-1-(甲氣甲氣基)戊烷368 mg溶在乙_5ml,而加正丁基鋰1.4ml與己烷之1.6 Μ溶液 。在- 60°C攢拌1小時後,加異丁基甲醛161mg與乙謎1 之溶液。3G分後,加氣化銨。分取有機層而以水及食 鹽水洗濯後,以硫酸鎂乾燥而濃縮,在矽膠柱層折(己 烷:乙酸乙酯= 4:1),得1-〔3 -氟-4-〔1-(甲氧甲 氣基)戊基〕苯基〕-2 -甲基丙醇108Bg,油狀。 NMR (CDC13, δ) : 0.8-1.05 (9Η, m), 1.15-2.05 (8H, m), 3.37 (3H, s), 4.38 (1H, d, J=6.5Hz), 4.5-4.6 (2H, m), 4.92 (1H, dd, J=5.5Hz, 8Hz), 6.95-7.15 (2H, m), 7.3-7.4 (1H, t, J=8Hz) 製備例58 混合l-〔 3-氟-4-〔 1-(甲氣甲氣基)戊基〕苯基〕-2 -甲基丙醇104mg,乙酐66mg及N, N -二甲胺基吡啶2 mg ,而在室溫攪拌1小時後,倒入冰水中。次以乙酸乙酯 -6 5 - (請先閲讀背面之注意事項再填窝本頁) 本紙張尺度遑用中國國家樣準(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(64) 举取而以水及食鹽水洗濯後,以硫酸鎂乾燥而濃縮,在 矽膠柱層析(己烷:乙酸乙酯= 85: 15),得乙酸1-〔 3-氟-4-〔1-(甲氣甲氣基)戊基〕苯基〕-2-甲基丙酯 1 1 3 b g,_ 油狀。 NMR (CDC13/ δ) : 0.75-1.0 (9Η, m), 1.2-1.5 (4Η, ra), 1.6-1.9 (2Η, m), 1.95-2.15 (4Η, πι), 3.36 (3Η,s), 4.5-4.6 (2Η, m), 4.90 (1Η, dd, J=5.5Hz, 8Hz), 5.44 (1H, d, J=6.5Hz), 6.95 (1H, dd, J=lHz, 10.5Hz), 7.05 (1H, dd, J=lHz, 8Hz), 7.35 {1H, t, J=8Hz) 剪備例 混合乙酸l-〔3-氟- 4-[l-(甲氣甲氣基)戊基]苯 基〕-2 -甲基丙酯llOng, 1N鹽酸0.3ml在乙酸3ral,而在 室溫攪拌1小時後,減壓蒸除溶劑》殘渣溶在乙酸乙酯 而以重碩酸納水,水及食鹽水洗濯後,以硫酸鎂乾燥而 濃縮,在矽膠柱層析(己烷與乙酸乙酯之混液),得乙 酸1-〔3-氟-4-(卜羥戊基)苯基〕-2-甲基丙酯70mg, 油狀。 NMR (CDC13/ 6) : 0.75-1.0 (9H, m), 1.2-1.5 (4H, πι),1.65:1.95 (2H, m), 2.0-2.15 (4H, m), 4·97 (1H, t, J=7Hz)/ 5.43 (1H, d, J=7.5Hz), 6.96 (1H, d, J=10.5Hz), 7.06 (1H, d, J=8Hz), 7.41 (1H, t, J=8Hz) 製備例fiO '將氯化(3 -甲氣羰苄基)三苯辚6.0克溶在四氫呋喃 -6 6 - (請先閲讀背面之注意事項再填窝本頁) 裝. 訂· 線- 本紙張尺度遑用中«家標準(CNS)甲4規格(210X297公*) 81. 5 . 20,000(H) k.030^0 A 6 B6 經濟部中央標準局貝工消費合作社印製 五、發明説明(65) 120ml,而在0 °C加第三丁醇鉀2.0克與四氫呋喃50b1之 溶液。攪拌30分後,加4-異丁基苄醛2 . 2克。攪拌2小時 後,倒入冰及稀鹽水中。有機層以乙酸乙酯萃取而水洗 後,以硫酸鎂乾燥而蒸發,在30Q克矽膠柱靥析(乙酸 乙酯:正己烷=1:50),得3-反-〔2- (4 -異丁苯基) 乙烯基〕苯甲酸甲酯2.23克之白色粉末及3-顒〔2-(4-異丁苯基)乙烯基〕苯甲酸甲酯1.25克之無色油。 3-反-〔2- (4-異丁基)乙烯基〕苯甲酸甲酯 NMR (CDC13, 6) : 0.92 d, J=7Hz), 1.88 (1H, m), 2.50 (2H, d, J=7Hz), 3.95 (3H, s), 7.08 (1H, d, J=16Hz), 7.15 (2H, d, J=9Hz), 7.20 (1H, d, J=16Hz), 7.43 (1H, m), 7.45 (2H, d, J=9Hz), 7.68 (1H, d, J=7Hz), 7.92 {1H, d, J=8Hz), 8.20 (1H, s) 3- 順-〔2- (4-異丁基)乙烯基〕笨甲酸甲酯 NMR (CDC13,6) : 0.90 (6H, d, J=7Hz) , 1.85 (1H, ιη), 2.43 (2Η, d, J=7Hz), 3.87 (3Η, s}, 6.55 (1Η, d, J=llHz), 6.65 (1H, d, J=llHz), 7.00 (2H, d, J=8Hz), 7.12 (2H, d, J=8Hz), 7.28 (1H, t, J=8Hz), 7·45 (1H, d, J=8Hz}, 7.85 (1H, d, J=8Hz), 7.92 (1H, s) 製備例6 1 仿製備例6 0製得下列化合物 4- 反-〔2- (4-異丁苯基)乙烯基]苯甲酸甲酯 (請先閲讀背面之注意事項再填寫本頁) 裝· 訂. 線· 本紙張尺度逍用中國家楳準(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) 丨〇3讥,〇 A 6 B6 五、發明説明(66) (CDC13, ό) : 0.90 (6H, d, J=7Hz), 1.88 (1H, m), 2.50 (2H, d, J=7Hz), 3.93 (3H, s), 7.08 (1H, d, J=16Hz), 7.15 (2H, d, J=9Hz), 7.20 <1H, d, J=16Hz), 7.45 {2H, d, J=9Hz), 7.55 (2H, d, J=9Hz), 8.03 (2H, d, J=9Hz) 4-順 2- (4-異丁苯基)乙烯基〕苯甲酸甲酯 (CDC13, δ) : 0.90 (6Η, d, J=7Hz)/ 1.83 (1H, m), 2.43 {2H, d, J=7Hz), 3.90 (3H, s), 6.55 (1H, d, J=llHz), 6.68 (1H, d, J=llHz), 7.00 (2H,—d, J=9Hz), 7.13 (2H, d, J=9Hz)/ 7.32 (2H, d, J=9Hz), 7·89 (2H, d, J=9Hz) i (請先閲讀背面之注意事項再填窝本頁) 經濟部中央標準局員工消費合作社印製 將3 -反-[2- (4 -異丁苯基)乙烯基〕苯甲酸甲酯 2 . 2 3 克溶在二嗒烷 2 0 m 1,而加 1 H N a 0 Η 1 t) m 1。在 1 Q 0 °C 攪拌45分後,倒入冰及稀鹽酸中。有機層以乙酸.乙酯宰 取而水洗後,以硫酸鎂乾燥而蒸發,以正己烷洗淨,得 3-反-〔2- (4 -異丁苯基)乙烯基〕苯甲酸之白色粉末 1 . 74 克。 NMR (CDC13 + CD3〇D, δ) : 0.92 (6Η, d, J=7Hz), 1.89 (1H, m), 2.50 (2H, d, J=7Hz), 7.08 (1H, d, J=16Hz), 7.21 (1H, d, J=16Hz), 7.15 (2H, d, J=8Hz), 7.45 (2H# d, J=8Hz)/ 7.43 (1H, m), 7.69 (1H, d, J=8Hz), 7·95 (1H, d, J=8Hz), 8.22 (1H, s) 例63 仿製備例6 2製得下列化合物e ⑴4-反-〔2- (4 -異丁苯基)乙烯基]苯甲酸 6 8 - 本紙張尺度遑用中《国家樣準(CNS)甲4規格(210x297公 81. 5. 20,000(H) 裝- 訂· 線- 030^0 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(67) NMR (CDC13 + CD3〇D, 6) : 0.90 (6H, d, J=7Hz), 1.88 (1H, m), 2.50 (2H, d, J=7Hz), 7.08 (1H, d, J=16Hz), 7.15 (2H, d, J=9Hz), 7.22 (1H, d, J=16Hz), 7.45 (2H, d, J=9Hz), 7.56 (2H, d, J=9Hz), 8.02 (2H, d, J=9Hz) ⑵3-順-〔2- (4 -異丁苯基)乙烯基]苯甲酸 NMR (CDC13, 6) : 0.90 (6H, d, J=7Hz), 1.85 (1H, m), *2.45 (2H, d, J=7Hz), 6.58 (1H, d, J=12Hz>, 6.70 (1H, d, J=12Hz)/ 7.00 (2H, d, J=9Hz), 7.13 (2H, d, J=9Hz), 7.31 (1H, t, J=8Hz), 7.50 (1H, d, J=8Hz), 7.93 (1H, d, J=8Hz), 8.00 {1H, s) ⑶4 -順-〔2 - ( 4 -異丁苯基)乙烯基〕苯甲酸 NMR (CDC13/ 6) : 0.90 (6H, d, J=7Hz), 1.87 (1H, m), 2.45 (2H, d, J=7Hz), 6.55 (1H, d, J=llHz), 6.70 (1H, d, J=llHz), 7.02 (2H, d, J=9Hz), 7.14 (2H, d, J=9Hz), 7.36 (2H, d, J=9Hz), 7·97 (2H, d, J=9Hz) 製備例fi4 將3-反-〔2- (4-異丁苯基)乙烯基〕苯甲酸0.56克 懸浮於二氱甲烷l〇ml,而加草醯氣及N, N -二甲基 甲醯胺0.05ml。在室溫攪拌30分後,蒸發而溶在正己院 l〇Bl,過濾而蒸發,得3-反-〔2-(4-異丁苯基)乙烯 基〕苄醯氯0.54克,白色粉末。 NMR (CDC13, δ) : 0.93 (6Η, d, J=7Hz), 1.90 (1H, m), 2.50 (2H, d, J=7Hz), 7.08 (1H, d, J=16Hz), 7.18 (2H, d, J=9Hz), 7.21 (1H, df J=16Hz), 7.45 (2H, d, J=9Hz), 7.5 (1H, m), 7.81 (1H, d, J=7Hz), 8.00 (1H, d, J=9Hz), 8.22 (1H, s) -6 9 - (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中B 家樣準(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) A6 五、發明説明(6白 製備例 仿製備例6 4製得下列化合物。 ⑴4-順-〔2- (4 -異丁苯基)乙烯基]苄醯氣 NMR (CDC13/ δ) : 0·90 (6Η, d, J=7Hz), 1·83 (1Η, m), 2.45 (2H, d, J=7Hz), 6.55 (1H, d, J=llHz), 6.77 (1H, d, J=llHz), 7.02 {2H, d, J=9Hz), 7.13 (2H, d, J=9Hz), 7.38 (2H, d, J=9Hz), 7.97 (2H, d, J=9Hz) ⑵4-反-〔2- (4 -異丁苯基)乙烯基〕苄醯氯 NMR (CDC13, δ) : 0.92 (6Η, d, J=7Hz), 1.38 (1H, m), 2.50 (2H, d, J=7Hz), 7.08 (1H, d, J=16Hz), 7.18 (2H, d, J=9Hz), 7.30 (1H, d, J=16Hz), 7.48 (2H, d, J=9Hz), 7.60 (2H, d, J=9Hz), 8.10 (2H, d, J=9Hz) ⑶3-順-〔2- ( 4-異丁苯基)乙烯基]苄醯氛 NMR (CDC13, ΰ) : 0.90 (6Η, d, J=7Hz), 1.85 (1Η, m), 2.43 (2H, d, J=7Hz), 6.55 (1H, d, J=12Hz), 6.72 (1H, d, J=12Hz), 7.02 {2H, d, J=9Hz), 7.12 (2H, d, J=9Hz), 7.34 {1H, t, J=8Hz), 7.55 (1H, d, J=8Hz), 7.92 (1H, d, J=8Hz), 8.02 (1H, s) (請先閱讀背面之注意事項再填寫本頁) 裝· 例 備 0 經濟部中央標準局員工消費合作社印製 基例苯 苯備丁 丁製異 異仿4-4-烷丨 /IV _ 11 1 基 } 將非U ί坎 丁 理 處 +)物 (+合 以化 Sy β 歹 S 1Χ 一· 1Χ 一 尋 -烯彳烯 品 異 二 氣 本紙張尺度遑用中困國家標準(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) ^030^0 A6 B6 五、發明説明(69) NMR (CDC13, δ) : 0.90 (6Η, d, J=7Hz)/ 1.86 (1H, m), 2_46 {2H, d, J=7Hz), 2·52 (2H, m), 4.71 (1H, t, J=7HZ), 5.12 (1H, m), 5.18 (1H, m), 5.83 (1H, in), 7.13 (2H, d, J=8Hz), 7.27 (2H, d, J=7Hz} 經濟部中央標準局貝工消費合作社印製 仿製備例1 〇製得下互化合物。 4-異丁基二苯甲酮 NMR (CDC13, 6) : 0.94 (6H, d, J=7Hz), 1.75-2.05 (1H, m), 2.57 (2H, d, J=7Hz), 7.27 (2H, d, J=9Hz), 7.35-7.85 (7H, m) 剪備例68 將4,4, 4-三氟丁酸4.15克溶在二氯甲烷50ml而加草 醯氣2.55ial及數滴N, N -二甲基甲醯胺。在室溫攪拌1小 時後,蒸除溶劑。殘渣溶在二氣甲烷lQOml而在0.°C加氯 化鋁3.89克。在0°C攪拌30分後,加異丁苯3.92克。在 〇 °C攪拌1小時後,倒入冰水中。分取有機層而以水,重 磺酸鈉水及食鹽水洗濯後,以硫酸鎂乾燥而蒸除溶劑, 得4’-異丁基-4, 4,4-三氟苯丁酮6.8Q克,油狀。 NMR (CDC13, ¢) : 。.91 (6H, d, J=7Hz), 175_2。5 (1h, m), 2.45-2.7 (4H, m), 3.25 (2H, t, J=8Hz), 1.2% (2H, d, J=8Hz), 7.39 (2H, d, J=8Hz) 仿製備例1 1製得下列化合物 ⑴(4 -異丁苯基)苄醇 7 1 - 本紙*尺度遑用中B國家«準(CNS) T4規格(210x297公釐) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) 裝. 訂- 線. 經濟部中央標準局貝工消費合作社印製 kj 0 ¢3 〇【八) 五、發明説明(7〇 NMR (CDC13, δ) : 0.89 <6H, d, J=7Hz), 1.7-1.95 (1H, m), 2.19 (1H, d, J=4Hz), 2.45 (2H, d, J=7Hz)/ 5.33 (1H, d, J=4Hz), 7.11 (2H, d, J=8Hz), 7.15-7.45 (7H, m) ⑵4 , 4 , 4 -三氟-1 - ( 4 -異丁苯基)丁醇 NMR (CDC13, δ) : 0·90 <6Η, d, J=7Hz), 1.75-2.4 (6Η, m), 2.48 (2Η, d, J=7Hz), 4.72 (1H, t, J=6.5Hz), 7.15 (2H, d, J=8Hz), 7.25 (2H, d, J=8Hz) 剪備例70 仿製備例1 2製得下列化合物 (4 -異丁苯基)苄基溴 NMR (CDCl^, δ) : 0.90 (6Η, d, J=7Hz), 1.7-2.0 (1H, τη), 2.47 {2H, d, J=7Hz), 6.29 (1H, s), 7.10.(2H, d, J=8Hz), 7.2-7.55 (7H, m) 例1 將4-〔l-(3 -胺苄醯基)B引畊-3-基]丁酸乙酯320mg 攪拌溶在二氯甲烷10ml,而在室溫加二異丙基乙胺0.22 ml,雙(4-異丁苯基)氣甲烷340m g與二氣甲烷5ml之溶 液。攪拌18小時後,蒸發而以乙醚萃取,以水及食鹽水 洗濯,以硫酸納乾燥,蒸除溶劑,在矽膠層析(二氣甲 烷:乙酸乙酯=2 0 : 1),得4 -〔 1 -〔 3 -〔雙(4 -異丁 苯基)甲胺基]苄醯基〕吲阱-3 -基〕丁酸乙酯279mg。 r6 (請先閲讀背面之注意事項再填寫本頁) -72- 本紙張尺度逍用中國國家«準(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) k,03050 A 6 B6 五、發明説明(71) NMR (CDC13, δ) : 0.92 (12H, d, J=7Hz), 1.28 (3H, t, J=7Hz)/ 1.87 (2H, m), 2.08 (2H, m), 2.4-2.55 (6H, m), 2·88 (2H, t, J=7Hz), 4.25 (2H, q, J=7Hz), 5.56 (1H, s), 6.70 (1H, ro), 6·86 (1H, s), 6.90 (1H, dt, J=lHz, 7Hz), 7.0-7.4 (12H, m), 8.02 (1H, d, J=7Hz>, 8.50 (1H, d, J=9Hz) 經濟部中央標準局員工消費合作社印製 仿例1製得下列化合物。 ⑴4 -〔 1 -〔 4 -雙(4 -異丁苯基)甲胺基]苄醯基〕吲阱 -3-基]丁酸乙酯 NMR (CDC13, δ) : 0.89 (12Η, d, J=7Hz), 1.24 (3Η, t, J=7Hz), 1.85 (2H, rn), 2.05 (2H, m) , 2.35-2.5 (6H, m), 2.88 (2H, t, J=7Hz), 4.12 {2H, q,J=7Hz>, 5·56 (1H, s), 6.59 (2H, d, J=9Hz), 6.82 (1H, dt, J=lHz, 7Hz), 6.92 (1H, s), 7.09 (1H, m), 7.12 (4H, dr J=8Hz), 7.25 (4H, d, J=8Hz), 7.72 (2Hf d, J=9Hz), 7.96 (1H, d, J=7Hz), 8.42 (1H, d, J=8Hz) ⑵4 -〔 3 -〔 3 -雙(4 -異丁苯基)甲胺基〕苄醯基〕吲阱 -1-基〕丁酸乙酯 NMR (CDC13, 6) : 0.87 (12H,d, J=7Hz), 1.22 (3H, t, J=7Hz), 1.7-2.05 (4H, m), 2.32 (2H, t, J=7Hz)f 2.43 (4H, d, J=7Hz), 2.73 (2H, t, J=7Hz), 4.10 {2H, g, J=7Hz), 5·52 (1H, s), 6.68 (1H, m), 6.88 (1H, dt, J=lHz, 7Hz), 7.0-7.3 (13H, m), 7.52 (1H, dt, J=8Hz, 1Hz), 9.92 (1H, d, J=7Hz) -7 3- 本紙張尺度遑用中《«家樣华(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) 裝· 線一 A 6 B6 五、發明説明(72) ⑶4 -〔 3 -〔 4 -〔雙(4 -異丁苯基)甲胺基〕苄醯基]吲 • 阱-卜基〕丁酸乙_ NMR (CDC13/ 6) : 0.89 <12H, d, J=7Hz), 1.22 (3H, t, J=7Hz), 1.7-2.1 (4H, m), 2.32 (2H, t, J=7Hz), 2.45 (4H, d, J=7Hz), 2.76 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 5.57 (1H, s), 6.59 (2H, d, J=9Hz), 6.83 (1H, dt, J=lHz, 7Hz), 7.0-7.35 (10H, m), 7.49 (1H, d, J=9Hz), 7.68 (2H, d, J=9Hz), 9·93 (1H, d, J=7Hz) 例3 混合4 -〔 1 - ( 4 -羥苄醯基)吲阱-3 -基〕丁酸乙酯3 3 4 mg,雙(4-異丁苯基)氣甲烷599m g及碩酸鉀394ng於N ,H -二甲基甲醯胺5 ml,而在室溫攪拌20小時後,過濾 而濾液倒入乙酸乙酯與0.5N鹽酸之混液中。分取有機層 而以水及食鹽水洗灌後,以硫酸鎂乾燥而蒸發,在矽膠 層析(正己烷:乙酸乙酯= 3:1),得4-〔1-〔4-〔雙 (4 -異丁苯基)甲氣基〕苄醯基〕吲哄-3-基〕丁酸乙 酯9 5 m g,油狀。 NMR (CDC113, 6) : 0.89 (12H, d, J=7Hz), 1.26 (3H, t, J=7Hz), 1.74-2.15 (4H, m), 2.38-2.50 (6H, m), 經濟部中央標準局貝工消費合作社印製 2.88 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.28 (1H, s), 6.80-6.92 (2H, m), 6.98-7.20 (7H, m), 7·32 (4H, d, J=8Hz), 7.77 (2H, d, J=9Hz), 7.98 (1H, d, J=8Hz), 8.44 (1H, d, J=9Hz) 例4 -74- 81. 5. 20.000(E) (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度遑用中家樣毕(CNS)甲4規格(210X297公釐) A 6 B6 五、發明説明(73) 混合4-〔 1-(4 -羥苄醛基)吲阱-3-基〕丁酸乙酯61 Bg,卜溴-卜(4-異丁苯基)丙烷53mg及磺酸鉀72fflg於 N, N -二甲基甲醯胺2ml,而在室溫攪拌18小時後,過濾 而濾液倒入乙酸乙酯與0.5Ν鹽酸之混液中。分取有機層 而以水及食鹽水洗濯後,以硫酸鎂乾燥而蒸發,在矽膠 層析(正己烷:乙酸乙酯=2: 1),得4-〔1-〔4-〔1-(4 -異丁苯基)丙氣基〕苄醒基〕吲阱-3-基〕丁酸乙 酯8 0 m g ,油狀。 TLC Rf: 0.48(正己烷:乙酸乙酯=2: 1) m F, 仿例3製得下列化合物。 4-〔 1-〔 3-〔雙(4-異丁苯基)甲氧基〕苄醯基〕吲 阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 0.88 (12H, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.74-2.11 (4H, m), 2.33-2.49 (6H, m), 2.87 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.28 (1H, s), 6.76-7.47 (15H, n〇, 8.02 (1H, d, J=9Hz), 8.47 (1H, d, J=9Hz) 例6 仿例4製得下列化合物。 經濟部中央標準局負工消費合作社印製 4-〔1-〔 3-〔 1-(4 -異丁苯基)丙氣基〕苄醯基〕吲 阱-3-基〕丁酸乙酯 -75- 81. 5 . 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中家楳準(CNS)肀4規格(210x297公*) Αβ 經濟部中央標準局具工消費合作社印製 五、發明説明(74) NMR (CDC13, δ) : 0·88 (6Η, d, J=7Hz), 0·99 (3Η, t, J=7Hz)f 1.25 (3H, t, J=7Hz), 1.72-2.12 (5H, m)( 2.42 (2H, t, J=7Hz}, 2.87 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 5.08 (1H, t, J=7Hz), 6.73-7.37 (1H, n〇, 8.01 (1H, d, J=7Hz), 8.46 (1H, d, J=9HZ) 例7 混合4-〔3- (4 -羥苄醯基〕吲阱-1-基〕丁酸乙酯400 m g ,雙(4 -異丁苯基)氯甲烷4 3 0 m g及二異丙基乙胺7 3 6 mg於二氣甲烷20ml,而回流14小時後,蒸發而溶在乙酸 乙酯,以水及食鹽水洗濯,以硫酸鎂乾燥而蒸發,在矽 膠層析(正己烷:乙酸乙酯= 4:1),得4-〔3-〔4-〔 雙(4 -異丁苯基)甲氣基]苄醯基〕11?丨畊-1-基〕丁酸 乙酯158mg,油狀。 . NMR (CDC13, 6) : 0.89 (12Η, d, J=7Hz), 1.22 (3H, t, J=7Hz), 1.74-2.07 (4H, m), 2.33 (2H, t, J=7Hz), 2·46 (4H, d, J=7Hz), 2·77 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.27 (1H, s), 6.82-7.20 (9H, m), 7.33 (1H, d, J=9Hz), 7.52 (1H, d, J=9Hz), 7.72 (1H, d, J=9Hz) 例8 仿例7製得下列化合物 4-〔3-〔3-〔雙(4 -異丁苯基)甲氣基〕苄醯基]B3丨 阱-1-基〕丁酸乙酯 -76- 本紙張尺度通用中國《家«毕(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 裝· 線- k,030b0 A6 B6 經濟部中央標準局员工消費合作社印製 五、發明説明(75) NMR (CDC13, 6) : 0.88 (12H, d, J=7Hz), 1.23 (3H, t, J=7Hz), 1.73-2.06 (4H, m), 2.33 (2H, t, J=7Hz), 2.45 {4H, d, J=7Hz), 2.76 (2H, t, J=7Hz), 4.11 (2H, q, J=7Hz), 6.28 {1H, s), 6.86-6.96 (1H, ro), 7.05-7.43 (14H, m), 7.55 (1H, d, J=9Hz), 9.93 (1H, d, J=7Hz) 例9 將4-〔l-〔3-〔雙(4-異丁苯基)甲胺基〕苄醯基〕 吲阱-1-基〕丁酸乙酯279ing溶在乙醇10ml而加4N NaOH 0.44mU於4G°C攪拌1小時後,真空蒸發而加磷酸二氫 鉀300mg水溶液及1N鹽酸26®1,以乙酸乙酯萃取。合併 有機層而以硫酸鈉乾燥後,蒸除溶劑,在矽膠層析(乙 酸乙酯),得4-〔1-〔 3-[雙(4 -異丁苯基)甲胺基] 苄醯基]吲阱-3-基〕丁酸229mg。 . 醜(CDC13, 6) : 0.87 (12H, d, J=7Hz), 183 (2H, m), 2.22 (2H, m), 2.4-2.5 (6H, m), 2.85 (2H, t,J=7Hz), 5.51 (1H, s), 6.69 (1H, m), 6.82 (1H, S), 6.84 (1H, dt, J=lHz, 7Hz), 7.0-7.3 (12H, m), 7.94 (1H, d, J=7Hz), 8.46 (1H, d, J=9Hz) 例10 仿例9製得下列化合物。 (1) 4 -〔 1 -〔 4 -〔雙(4 -異丁苯基)甲胺基)苄醯基〕B引 阱-3-基]丁酸 -77- (請先閲讀背面之注意事項再填窝本頁) 裝· 訂- 線· 本紙張尺度遑用中《家樣毕(CNS)甲4規格(210X297公«) 81. 5. 20,000(H) 經濟部中央標準局員工消費合作社印製 五、發明説明(76) NMR (CDC13, δ) : 0.88 (12Η, d, J=7Hz), 1.84 (1H, m), 2.06 (2H, m), 2.4-2.55 (6H, m), 2·88 (2H, t, J=7Hz), 5.56 (1H, s), 6.57 (2H, d, J=9Hz), 6.80 (1H, dt, J=lHz, 7Hz), 6.92 (1H, s), 7.08 (1H, m), 7.11 (4H, d, J=8Hz), 7.23 (4H, d, J=8Hz), 7.72 (2H, d, J=9Hz), 7.92 (1H, d, J=7Hz), 8.41 (1H, d, J=8Hz) ⑵4 -〔 3 -〔 3 -〔雙(4 -異丁苯基)甲胺基〕苄醯基〕B引 畊-1 -基〕丁酸 NMR (CDC13, 6) : 0.86 (12H, d, J=7Hz), 1.7-2.05 (4H, m), 2.38 (2H, t, J=7Hz), 2.43 (4H, d, J=7Hz), 2·76 (2H, t, J=7Hz), 5·52 (1H, s), 6.71 (1H, m), 6·88 (1H, dt, J=lHz, 7Hz), 7.0-7.3 (13H, m),7·49 (1H, dt, J=8Hz, 1Hz), 9.91 (1H, d, J=7Hz) ⑶4 -〔 3 -〔 4 -〔雙(4 -異丁苯基)甲胺基〕苄醛基]吲 阱-1-基〕丁酸 臟(CDC13, 6) : 0·88 (12H, d, J=7Hz), 1.7-2.1 (4H, m), 2.39 (2H, t, J=7Hz), 2.45 (4H, d, J=7Hz),2.79 (2H, t, J=7Hz), 5.57 (1H, S>, 6.58 (2H/d, J=9Hz), 6.82 (1H, dt, J=1Hz, 7Hz), 7.0-7.3 (10H, n>)/ 7.49 (1H, d, J=9Hz), 7.68 (2H, d, J=7Hz), 9.93 (1H, d, J=7Hz) ' 例1 1 將4-〔l-[雙(4 -異丁苯基)甲氣基〕苄醯基]吲阱 -7 8 - A 6 B6 (請先閲讀背面之注意事項再填寫本頁) 裝· 訂- 線- 本紙張尺度逍用中B B家樣準(CHS)甲4規格(210 x297公*) 81. 5. 20,000(H) A 6 B6 經濟部中央標準局貝工消費合作社印製 五、發明説明(77) -3-基〕丁酸乙酯(90mg)溶在乙醇lml及1, 4-二枵烷lml ,而加1 N N a Ο Η 0 . 5 ia 在室溫攪拌2小時後,倒入乙酸 乙酯舆Q.5N鹽酸之混液。分取有機層而以水及食鹽水洗 濯後,以硫酸鎂乾燥而蒸發,得4-〔 1-〔 4-〔雙(4-異 丁苯基)甲氣基〕苄醯基〕吲阱-3-基〕丁酸79mg之粉 末。 NMR (CDC13/ δ) : 〇·89 (12Η, d, J=7Hz), 1.73-1.97 (2H# m), 1.99-2.16 (2H, m), 2.40-2.55 (6H, in), 2.89 (2H, m), 6.27 (1H, s), 6.79-6.90 (2H, in), 6.98-7.18 (7H, m), 7.28-7.38 (4H, m), 7.75 (2H, df J=9Hz), 7.96 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) m 12 仿例11製得下列化合物 . ⑴4 - [ 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丙氧基〕苄醯基〕吲 阱-3-基〕丁酸 NMR (CDC13, 6) : 0.88 (6H, d, J=7Hz), 1.01 (3H, t, J=7Hz)/ 1.72-2.17 (5H, m), 2.40-2.55 (4H, m)f 2·88 (2H, t, J=7Hz), 5.08 (1H, t, J=7Hz), 6.79-6.98 (4H, m), 7.07-7.32 (5H, m), 7.73 (2H, d, J=9Hz), 7.94 (1H, d, J=7Hz), 8.42 (1H, d, J=9Hz) ⑵4-〔l-〔3-〔雙(4 -異丁苯基)甲氣基〕苄醯基]吲 阱-3-基〕丁酸 -79- 本紙張又度遑用中國*家樣半(CHS)肀4規格(210x297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 訂· 線· A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(78) NMR (CDC13, δ) : 0.88 (12H, d, J=7Hz)f 1.76-1.92 (2H, m), 1.99-2.13 (2H, m), 2.40-2.55 (6H, m), 2.88 (2H, t, J=7Hz), 6.27 (1H, s), 6.76-7.46 (15H, m), 7.98 (1H, d, J=7Hz}, 8.46 {1H, d, J=9Hz) ⑶4 -〔 1 -〔 3 -〔 1 - ( 4 -異丁苯基)丙氣基]苄醯基〕ϋ引 阱-3 -基〕丁酸 ^ 1 NMR (CDC13/ 6) : 0.88 (6H, d, J=7Hz), 0.99 (3H, t, J=7Hz), 1.70-2.14 (5H, m), 2.37-2.56 (4H, m), 2.88 {2H, t, J=7Hz>, 5.08 {1H, t, J=7Hz), 6.76-7.38 (11H# m), 7.97 (1H, d, J=7Hz), 8.47 (1H, d, J=9Hz) ⑷4 -〔 3 -〔 4 -雙(4 -異丁苯基)甲氧基]苄醯基〕吲哄 -1-基〕丁酸 NMR {CDC13, 0) : 0.88 (12H, d, J=7Hz), 1.73-2.08 (4H, m), 2.35-2.50 (6H, m), 2.80 (2H, t, J=7Hz), 6.27 {1H, s), 6.81-7.22 (9H, ra), 7.32 (4H, d, J=8Hz), 7.51 (1H, d, J=9Hz), 7.71 (2H, d, J=9Hz) ⑸4 -〔 3 -〔 3 -〔雙(4 -異丁苯基)甲氣基〕苄醯基〕B引 阱-1-基〕丁酸 NMR (CDC13, 6) : 0.88 {12H, d, J=7Hz), 1.72-2.05 (4H, m), 2.33-2.48 (6H, m), 2.78 {2H, t, J=7Hz), -8 0 - 本紙張尺度逍用中國國家樣準(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) 裝· 訂- 線- 經濟部中央標準局員工消費合作社印製 五、發明説明(79) 6.27 (1Η, s), 6.84-6.96 (1Η, in), 7.04-7.42 (14Η,m) 例1 3 將4N HC1溶在乙酸乙酯0.5ml,而加4-〔 1-〔 3-〔雙 (4 -異丁苯基)甲胺基〕苄醯基]吲阱-3-基〕丁酸 0.60克與乙酸乙酯5ml之溶液。在冰箱放置16小時後, 濾集結晶,得4-〔1-〔 3-〔雙(4 -異丁苯基)甲胺基〕 苄醯基〕吲阱-3-基〕丁酸鹽酸鹽之黃色粉末0.62克。 熔點:136-138 °C (分解) NMR (DMSO-dgf 6) : 8.40 (1h, d, J=7Hz), 8.30 (1H, d, J=9Hz), 7.35 (2H, d, J=9Hz), 7.10 (2H, drJ=9Hz), 6.9-7.4 (6H, m), 6.72 (1H, s), 5.67 (1H, s), 2.88 (2H, t, J=7Hz), 2.40 (4H, d, J=7Hz), 2.33 (2H, t, J=7Hz), 1.7-2.0 (4H, m), 0.82 (12H, d, J=7Hz) 將4-〔l-〔 3-〔雙(4-異丁苯基)甲胺基]苄醯基〕 B引阱-3-基]丁酸2 4 4 mg溶在乙醇而加IN NaOH。蒸除溶 劑後,溶在苯而濾經棉花濾器,真空蒸發,得4 -〔 1 -〔 3-〔雙.(4-異丁苯基)甲胺基〕苄醯基〕P引畊-3-基〕 丁酸鈉 24Gmg。 腿(CD3〇D, 6) : 0.88 (12H, d, J=7Hz), 1.82 (2H, m), 1·97 (2H, m), 2.31 (2H, t, J=7Hz), 2.44 (4H, d, J=7Hz), 2.88 (2H, t, J=7Hz), 5.56 (1H, s), 6.74 {1H, s), 6.81 (1H, m), 6.9-7.3 (5H, m), 7.08 <4H, d, J=8Hz), 7.28 (1H, d, J=7Hz), 8.25-8.35 (2H, m) -81- 本紙張尺度遑用中B國家橾準(CNS)甲4規格(210x297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) A 6 B6 經濟部中央標準局貝工消費合作社印製 QJ㈣_ 五、發明説明(ec) 例1 5 仿例1製得下列化合物。 (1)4-〔 3-〔4-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕-2 -甲基吲阱-1-基〕丁酸乙酯 NMR (CDC13, δ) : 0.88 (12Η, d, J=7Hz), 1.23 (3Η, t, J=7Hz), 1.75-2.0 (4H, m), 2.00 (3H, s), 2.32 (2H, t, J=7Hz), 2·46 (4H, d, J=7Hz), 2·72 (2H, t, J=7Hz}, 4·11 (2H, q, J=7Hz), 5.57 (1H, s), 6.55 {2H, d, J=8Hz), 6.65 (1H, dt, J=lHzf 7Hz), 6.98 (1H, m), 7.11 (4H, d, J=8Hz), 7.24 (1H, d, J=8H2), 7.38 (1H, d, J=8Hz), 7.49 (2H, d, J=8Hz), 9.30 (1H, d, J=7HZ) ⑵4-〔3-〔3-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕-2 -甲基B引阱-1 -基〕丁酸乙酯 ’ NMR (CDC13, δ) : 0.88 (12Η, d, J=7Hz), 1.23 (3Η, t, J=7Hz), 1.76 (3H, s), 1.83 (2H, m), 2.31 (2H, t, J=7Hz), 2·42 (4H, d, J=7Hz), 2.68 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 5.51 (1H, s)f 6.65-6.95 (4H, m), 7.08 (4H, d, J=8Hz), 7.0-7.3 (2H, m), 7.23 (4H, d, J=8Hz), 7.42 (1H, d, J=9Hz), 9.66 (1H, d, J=7Hz) (3M-〔l-〔4-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕-2 -甲基吲阱-3 -基]丁酸乙酯 (請先閲讀背面之注意事項再填寫本頁) 裝· 訂 -線- -8 2 - 本紙張尺度遑用中國《家樣毕(CNS)甲4規格(210 x 297公*) 81. 5. 20,000(H) A 6 B6 五、發明説明(81) NMR (CDC13, δ) : 0.88 (12Η, d, J=7Hz), 1.25 (3Η, t, J=7Hz), 1·87 (4H, m), 2.27 (3H, s), 2.38 (2H, t, J=7Hz), 2.45 (4H, d, J=7Hz), 2.92 (2H, t, J=7Hz), 4.14 (2H, q, J=7Hz), 5.56 (1H, s), 6.52 (2H, d, J=9Hz), 6.66 (1H, dt, J=lHz, 7Hz), 6.80 (1H, in), 7.10 (4H, d, J=8Hz), 7.22 (4H, d, J=8Hz), 7.46 (1H, d, J=9Hz), 7.59 (2H, d, J=8Hz), 7.93 (1H, d, J=7Hz) ⑷4-〔l-〔 3-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕_2 -甲基H引阱-3 -基〕丁酸乙酯 NMR (CDC13/ 6) : 0.88 (12H, d, J=7Hz), 1.27 (3H, t, J=7Hz), 1.7-2.0 (4H, m), 2.20 (3H, s), 2·38 (2H, t, J=7Hz), 2.43 (4H, d, J=7Hz), 2.90 (2H, t, J=7Hz), 4.14 {2H, g, J=7Hz), 5.51 (1H, s), 6.63-6.78 (2Hf in), 6.8-7.0 (2H, m) , 7.05-7.3 UOH, m), 7·44 (1H, d, J=8Hz), 7.97 (1H, d, J=7Hz) (請先閲讀背面之注意事項再填寫本頁) 裝· 訂- 線. 經濟部中央標準局員工消費合作社印製 仿例4製得下列化合物。 ⑴4-〔 1- [ 4-〔 1- ( 4-異丁苯基)己氣基〕苄_基〕蚓 阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.80-0.95 (9Η, m)t 1.26-1.65 (9H, m), 1.70-2.15 (4H, m), 2.35-2.50 (4H, m), 2.87 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 5.15 (1H, dd, J=2Hz, 7Hz), 6.80-6.97 (4H, m), 7.07-7.31(5H, ro), 7.72 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) -8 3 - 本紙張尺度遑用中家標準(CNS)甲4規格(210x297公釐) 81· 5, 20,000(H) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(82) ⑵4-〔3-〔4-〔 1-(4 -異丁苯基)己氧基〕苄醯基〕吲 阱-1 -基〕丁酸乙酯 NMR (CDC13,δ) : 0.80-0.95 (9Η, in), 1.17-1.63 (9H, m), 1.72-2.12 (5H, m), 2.32 (2H, t, J=7Hz), 2.46 (2H, d, J=7Hz), 2·76 (2H, t, J=7Hz), 4.10 (2H, q, J=7Hz), 5.14 (1H, dd, J=1.5Hz, 7Hz), 6.81-6.98 (3H, m), 7.06-7.19 (4Hf m), 7.27 (2H, d, J=9Hz), 7.51 (1H, d, J=9Hz), 7·68 (2H, d, J=9Hz), 9.87 (1H, d, J=7Hz) ⑶4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)辛氣基〕苄醯基〕II引 阱-3 -基〕丁酸乙酯 NMR (CDC13# 6) : 0.8-0.95 (9H, in) # 1.15-1.65 (13H, m), 1.7-2.15 (5H, m), 2.35-2.5 (4H, m)f 2.88 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.15 (1H, dd, J=2Hz, 7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.73 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) ⑷4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)庚氣基]苄醯基〕B引 胼-3-基〕丁酸乙酯 NMR (CDC13, 6) : 0.8-1.0 (9H, m), 1.2-1.65 (11H, m), 1.7-2.15 (5H, in), 2.35-2.5 (4H, m), 2.88 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.15 (1H, dd, J=2Hz, 7Hz), 6.8-6.95 (4H, n〇, 7.05-7.3 (5H, in), 7.74 (2H, d, J=9Hz)r 7.98 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) ⑸4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)戊氣基〕苄醯基〕B引 -8 4 一 本紙張尺度逍用中1國家樣準(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填窝本頁) 裝· 訂 線·
A 6 B6 五、發明説明(83) 阱-3-基〕丁酸乙酯 (請先閲讀背面之注意事項再填寫本頁) NMR (CDC13, 6) : 0.8-1.Ο (9H, m), 1.2-1.65 (7H, m), 1.7- 2.15 (5H, m), 2.35-2.5 (4H, m), 2.88 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5·15 (1H, dd, J=2Hz, 7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.73 (2H, d, J=9Hz), 7.99 (1H, d, J=7Hz), 8.44 (2Ά, d, J=9Hz) ⑹4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丁氧基〕苄醯基〕吲 阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.8-1.05 (9Η, m), 1.24 (3Η, t, J=7Hz), 1.3-1.65 (2H, m), 1.7-2.15 (5H, m), 2.35-2.5 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.17 (1H, dd, J=2Hz, 7Hz), 6.8- 6.95 (4H, m) f 7.05-7.3 (5H, in), 7.72 (2H, d, J=9HZ), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) 例1 7 經濟部中央標準局貝工消費合作社印製 混合4 -〔 1 - ( 3 -胺苄醯基〕吲阱-3 -基〕丁酸乙酯1 7 5 mg, 1-溴己基-4-異丁苯177iag及二異丙基乙胺194mg於 二氯甲烷3ml,而回流20小時後,倒入乙酸乙酯及水之 混液中。分取有機層而以水及食鹽水洗濯後,以硫酸鎂 乾燥而蒸發,在矽膠柱層析(正己烷:乙酸乙酯=3: 1 ),得4-〔1-〔3-〔1-(4-異丁苯基)己胺基〕苄醯基 ]B3I阱-3 -基]丁酸乙酯1 7 0 m g ,油狀。 -85- 81. 5. 20.000(H) 本紙張尺度逍用中家«準(CNS)甲4規格(210x297公藿) A 6 B6 經濟部中央標準局貝工消費合作社印製 五、發明説明(84 NMR (CDC13,δ) : 0.80-0.95 (9Η, in), 1.27-1.50 (9H, m), 1.68-2.12 (5H, m), 2.34-2.48 (4H, m), 2.85 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 4.33 (1H, t, J=7Hz), 6·63 (1H, d, J=7.5Hz), 6.80-6.91 {2H, m), 6.94-7.28 (9H, m), 7.98 (1H, d, J=7Hz), 8.46 (1H, d, J=9Hz) m 18 仿例1 7製得下列化合物。 ⑴4 -〔 3 -〔 3 -〔 1 - ( 4 -異丁苯基)己胺基]苄醯基〕吲 阱-1-基〕丁酸乙酯 NMR (CDC13, δ) : 0.78-0.96 (9Η, m), 1.20-1.50 (9Η, m), 1.64-2.07 (5H, m), 2.25-2.48 (4H, m), 2.75 (2H, t, J=7.5Hz), 4.11 (2H, q, J=7Hz), 4.33 (1H, t, J=7Hz), 6.64 (1H, d, J=7.5Hz), 6.83-7.30 (11H, m), 7.52 (1H, d, J=9Hz) ⑵4 -〔 1 -〔 3 -〔 1 - ( 4 -異丁苯基)丁胺基〕苄醯基〕吲 阱-3 -基]丁酸乙酯 NMR (CDC13, δ) : 0.8-1.0 (9Η, m), 1.2-1.55 (5Η, m), 1.7-2.15 (5H, m), 2.35-2.55 (4H, m), 2.87 {2H, t, J=7.5Hz), 4.13 (2H, q, J=7Hz}, 4.36 (1H, t, J=7Hz), 6.64 (1H, d, J=8Hz), 6.8-6.95 (2H, in), 7.0-7.35 {9H, m), 7.98 (1H, d, J=7Hz), 8.45 (1H, d, J=9Hz) 例1 9 仿例1 1製得下列化合物。 ⑴4 -〔 3 -〔 4 -〔 1 - ( 4 -異丁苯基)己氧基]苄醯基〕吲 -8 6 - (請先閲讀背面之注意事項再填寫本頁) 装. 訂 -線, 本紙張尺度逍用中國國家樣準(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) '· A 6 Β6 經濟部中央標準局員工消費合作社印製 五、發明説明(85) 阱-1-基〕丁酸 NMR (CDCl3, δ) : 0.81-0.96 (9Η, m), 1.20-1.62 (6H, m), 1.72-2.15 (5H, m), 2.34-2.49 (4H, ra), 2.79 (2H, t, J=7Hz), 5.14 {1H, dd, J=1.5Hz, 7Hz), 6.80-6.97 (3Hr m), 7.06-7.18 (4H, m), 7.26 (2H, d, J=9Hz), 7.50 (1H, d, J=9Hz), 7.68 (2H, d, J=9Hz), 9.87 (1H, d, J=7Hz) ⑵4-〔l-〔 4-〔 1-(4 -異丁苯基)己氣基〕苄醯基〕吲 阱-3-基]丁酸 NMR (CDCl3f 6) : 0.82-0.95 (9H, m), 1.23-1.65 (6H, m), 1.70-2.15 (5H, m), 2.38-2.55 (4H, m), 2.88 (2H, t, J=7Hz), 5.14 (1H, dd, J=2Hz, 7Hz), 6.78-6.97 (4H, m), 7.05-7.30 (5H, m), 7.72 (2H, d, J=9Hz), 7.94 (1H, d, J=7Hz), 8·43 (1H, d, J=9Hz) ⑶4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)辛氧基〕苄醯基〕吲 阱-3-基〕丁酸 NMR (CDC13, 6) : 0.8-0.95 (9H, m), 1.15-1.65 (10H, m), 1.7-2.2 (5H, m), 2.4-2.55 (4H, m), 2.89 (2H, t, J=7.5Hz), 5.15 (1H, dd, J=2Hz, 7Hz}, 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7·96 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) ⑷4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)庚氣基〕苄醯基〕吲 阱-3-基〕丁酸 -87- 本紙張尺度逍用中家標準(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) ο ο
66 AB 經濟部中央標準局員工消費合作社印製 五、發明説明(86) NMR (CDC13,δ) : 0.8-1.0 (9Η, m), 1.2-1.65 (8Η, π>), 1.7- 2.15 (5Η, π〇, 2.4-2.55 (4Η, m), 2.89 (2Η, t, J=7.5Hz)r 5.15 (1H, dd, J=2Hz, 7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.73 (2H, d, J=9Hz}, 7.95 (1H, d, J=7Hz), 8.43 <1H, d, J=9Hz) ⑸4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)戊氣基〕苄醯基]吲 阱-3-基〕丁酸 NMR (CDC13, δ) : 0.8-1.0 (9Η, m), 1.25-1.6 (4Η, m), 1.7- 2.15 (5H, m), 2.4-2.55 (4H, m), 2.88 {2H, t, J=7.5Hz), 5.14 (1H, ddf J=2Hz, 7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.73 (2H, d, J=9Hz), 7·96 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) ⑹4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丁氧基〕苄醯基]吲 阱-3-基〕丁酸 . NMR (CDC13/ δ) : 0.8-1.05 (9Η, in), 1.3-1.65 (2H, in), 1.7- 2.15 (5H, π〇, 2.4-2.55 (4H, m), 2.88 (2H, t, J=7.5Hz), 5·16 (1H, dd, J=7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7.96 (1H, dr J=7Hz), 8.42 (1H, d, J=9Hz) 例20 、 4-〔 3-〔 3-〔 1- ( 4-異丁苯基)己胺基〕苄醯基〕B3丨 阱-1-基〕丁酸乙酯117mg溶在乙醇2b1及1, 4-二呜烷2 ml,而加IN NaOH lml。在室溫攪拌3小時後,倒入乙酸 乙酯與0.5N鹽酸之混液中。分取有機層而以水及食鹽水 洗濯後,以硫酸鎂乾燥而蒸發,得4 -〔 3 -〔 3 -〔 1 - ( 4 - 一 8 8 一 (請先閲讀背面之注意事項再填寫本頁) 裝. •訂- 線. 本紙張尺度遑用中困家橾準(CNS)甲4規格(210X297公釐) 81. 5. 20,000(H) 〇3ϋ; Α6 Β6 五、發明説明(87) 異丁苯基)己胺基]苄醯基〕吲阱-1-基〕丁酸98mg之 粉末。 NMR (CDC13, 6) : 0.78-0.96 (9H, m), 1.15-1.50 (6H, m), 1.68-2.07 (5H, π〇, 2.32-2.48 (4H, m), 2.77 (2H, t, J=7.5Hz), 4·32 (1H, t, J=7Hz), 6.64 (1H, d, J=7.5Hz), 6.82-7.28 (11H, m), 7.50 (1H, d, J=9Hz) 經濟部中央標準局貝工消費合作社印製 仿例2 Q製得下列化合物。 ⑴4 -〔 1 -〔 3 -〔 1 - ( 4 -異丁苯基)己胺基〕苄醯基〕β引 阱-3-基〕丁酸 NMR (CDC13, 6) : 0.78-0.93 (9H, m), 1.15-1.50 (6H, m), 1.63-2.13 (5H, m), 2.37-2.53 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.32 (1H, t, J=7Hz), 6.62 (1H, d, J=7.5Hz), 6.79-6.90 (2H, m), 6.94-7.27 (9H, m), 7.95 (2H, d, J=7Hz), 8.45 (1H, d, J=9Hz) ⑵4-〔l-〔 3-〔 1-(4 -異丁苯基)丁胺基〕苄醯基〕项 阱-3-基〕丁酸 NMR (CDC13, δ) : 0.8-1.0 (9H, m), 1.2-1.5 (2H, m), 1.65-2.15 (5H, m), 2.35-2.5 {4H, m), 2.86 (2H, t, J=7.5Hz), 4.34 (1H, t, J=7Hz), 6·64 (1H, d, J=8Hz), 6.8-6.95 (2H, m), 7.0-7.3 (9H, m), 7.95 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) 例22 仿例9製得下列化合物。 ⑴4 -〔 3 -〔 4 -〔雙(4 -異丁苯基)甲胺基]苄醯基〕-2 -89- 本紙張尺度通用中《明家標毕(CKS)甲4規格(210X297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 裝· 訂· 線- A 6 B6 經濟部中央標準局貝工消費合作社印製 五、發明説明(88) -甲基吲阱-1 -基〕丁酸 NMR (CDC13, δ) : 0.88 (12Η, d, J=7Hz), 1.7-2.0 (4H, ro), 2·01 (3H, s}, 2.39 (2H, t, J=7Hz), 2.46 (4H, d, J=7Hz), 2.74 (2H, t, J=7Hz), 5.57 (1H, s), 6.53 (2H, d, J=8Hz), 6.64 (1H, dt, J=lHz, 7Hz), 6.95 (1H, m), 7.11 (4H, d, J=8Hz), 7.22 (4H, d, J=8Hz), 7.37 UH, d, J=9Hz), 7.50 (2H, d, J=8Hz), 9.30 (1H, d, J=7Hz) ⑵4-〔3-〔3-〔雙(4 -異丁苯基)甲胺基]苄酸.基〕-2 -甲基吲阱-1 -基〕丁酸 NMR (CDC13, 6) : 0.88 (12H, d, J=7Hz), 1.74 (3H, s), 1.75-1.95 (2H, m), 2.37 {2H, t, J=7Hz), 2.42 (4H, d, J=7Hz), 2.69 (2H, t, J=7Hz), 5.51 (1H, s), 6.6-6.8 (3H, in), 6.88 (1H, d, J=7Hz), 7.07 (4H, d, J=7Hz)r 7.0-7.3 (2H, m), 7.23 (4H, d, J=7Hz), 7.40 (1H, d, J=8Hz), 9.67 (1H, d, J=7Hz) ⑶4-〔l-〔 4-〔雙(4 -異丁苯基)甲胺基〕苄醯基〕-2 -甲基吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.88 (12Η, t, J=7Hz), 1.7-2.0 (4H, π»), 2.38 (3H, s), 2.42 {2H, t, J=7Hz), 2.44 (4H, d, J=7Hz>, 2.93 (2H, t, J=7Hz), 5.56 (1H, s), 6.52 (2H, d, J=9Hz), 6.64 (1H, dt, J=7Hz), 6.81 (1H, m), 7.09 (4H, d, J=8Hz), 7.25 (4H, d, J=7Hz), 7.45 (1H, d, J=8HZ), 7.58 (2H, d, J=9Hz), 7.90 (1H, d, J=7Hz) ⑷4-〔l-〔 3-〔雙(4 -異丁苯基)甲胺基〕苄醯基]-2 -90- 本紙張尺度遑用中B B家樣卒(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) (請先閲讀背面之注東事項再填寫本頁) 裝· 訂- 線. A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(89) -甲基吲阱-3 -基〕丁酸 NMR (CDC13, 6) : 0.88 (12H, d, J=7Hz), 1.7-2.0 (4H, m), 2.18 (3H, s), 2.42 (4Hr d, J=7Hz), 2.45 (2H, t, J=7Hz), 2.91 (2H, t, J=7Hz), 5.50 (1H, s), 6.6-7.3 (6H, m}, 7.06 (4H, d, J=8Hz), 7.22 (4H, d, J=8Hz), 7.45 (1H, d, J=8Hz), 7.92 (1H, d, J=7Hz) 例23 混合4-〔 1-(4 -羥苄醯基)B3丨阱-3-基〕丁酸乙酯392 mg, (R)-l-(4 -異丁 苯基)丁 -1-醇 230mg 及三苯膦 292 mg於四氫呋喃3rol及甲苯15ml,而在- 20°C氮蒙氣下加偶 氮二羧酸二乙酯0.178ml。在- 20°C氮氣下攪拌2.5小時 後,加乙酸0 . 〇 5 m 1而昇至室溫後,減壓蒸除溶劑,倒入 乙酸乙酯與水之混液中。分取有機相而以水及食鹽水洗 濯,以硫酸鎂乾燥,在矽膠柱層析(正己烷:乙酸乙酯 =4:1),得4-〔1-〔4-〔(3)-1-(4-異丁苯基)丁氣 基〕苄醯基〕吲阱-3 -基〕丁酸乙酯295fflg,油狀。 NMR (CDC13, 6) : 0.8-1.05 (9H, m), 1.24 (3H, t, J=7Hz), 1.3-1.65 (2H, m), 1.7-2.15 (5H, m), 2.35-2.5 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.17 (1H, dd, J=2Hz, 7Hz), 6.8-6.95 (4H, m), 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) 例24 4-〔1-〔 4-〔(S)-卜(4-異丁苯基)丁氧基〕苄醯基 -91- 本紙張尺度逍用中國家揉準(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 裝< •町. A 6B6 經濟部中央標準局員工消費合作社印製 五、發明説明(90) 〕吲阱-3-基〕丁酸乙酯2 8 2 m g溶在乙醇3m 1及1,4-二嗒 烷3 m 1,而加1 N N a 0 H 2 n 1。在室溫攪拌2小時後,倒入 乙酸乙酯與Q.5N鹽酸之混液中。分取有機層而以水及食 鹽水洗濯後,以硫酸鎂乾燥而蒸發,得4 - [ 1 -〔 4 -〔( S ) -1-(4 -異丁苯基)丁氣基〕苄醯基〕吲阱-3-基〕丁酸 2 3 2 m g之粉末。 NMR (CDC13, 6) : 0.8-1.05 (9H, m), 1.3-1.65 (2H, m), 1.7- 2.15 (5H, m), 2.4-2.55 (4H, m), 2.88 (2H, t, J=7.5Hz), 5.16 (1H, dd, J=7Hz), 6.8-6.95 (4H, m>, 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7.96 (1H, d, J=7Hz>, 8.42 (1H, d, J=9Hz) [<x]g = -78.3。(C=0.5, CHC13) 例25 仿例2 3製得下列化合物。 4-〔 1-〔4-〔(R)-l- (4-異丁苯基)丁氣基〕苄醯基 〕吲阱-3 -基]丁酸乙酯 NMR (CDC13/ <S) : 0.8-1.05 (9H, m), 1.24 (3H, t, J=7Hz), 1.3-1.65 (2H, m), 1.7-2.15 (5H, m), 2.35-2.5 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.12 (2H, g, J=7Hz), 5·17 (1H, dd, J=2Hz, 7Hz), 6.8- 6.95 (4H, m), 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) (請先閲讀背面之注意事項再填寫本頁) 仿例2 4製得下列化合物。 -92- 本紙張尺度逍用中B 家標毕(CNS)甲4規格(210X297公釐) 81. 5. 20.000(H) 經濟部中央標準局貝工消費合作社印製 五、發明説明(91) 4-〔 1-〔4-〔(R)-l- (4-異丁苯基)丁氣基〕苄醯基 〕吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.8-1.05 (9Η, m), 1.3-1.65 (2Η, m), 1.7-2.15 (5H, m), 2.4-2.55 (4H, m), 2.88 (2H, t, J=7.5Hz), 5.16 (1H, dd, J=7Hz), 6.8-6.95 (4H, m) , 7.05-7.3 (5Hf m)f 7.72 (2H, d, J=9Hz), 7.96 (1H, d, J=7Hz)r 8.42 (1H, d, J=9Hz) [a]g5 = +79.8。 (C=0.5, CHC13) m ?.7 將4-〔l-〔3-〔 (1-羧乙基)胺基〕苄醯基〕吲阱- 3 -基〕丁酸乙酯60mg,庚胺基16mg及1-羥基苯駢三唑20 fflg溶在二氣甲烷3ml,而加1-(3-二甲胺丙基)-3-乙基 碩化二亞胺鹽酸鹽3 Q m g。在室溫攪拌3小時後,蒸發而 溶在乙酸乙酯lGffll,以稀鹽酸及水洗濯,以硫酸«乾燥 ,減壓蒸除溶劑,得4 -〔 1 -〔 3 -〔〔 1 -(庚胺甲醯基) 乙基〕胺基〕苄醯基〕吲畊-3-基〕丁酸乙酯7〇mg,黃 色油。 NMR (CDC13, 6) ί 〇·84 (3H, m), 1.1-1.4 (11H, m), 1.45 (2H, m), 1.54 (3H, d, J=7Hz)/ 2.05 (2H, m), 2.43 (2H, t, J=7Hz), 2.88 UH, t, J=7Hz), 3.23 (2H, q, J=7Hz), 3.90 (1H, q, J=7Hz), 4.12 (2H, q, J=7Hz), 6.75 (1H, m), 6.88 (1H, s), 6.93 (1H, m)r 7.1-7.3 (3H, in), 7.45 (1H, ra), 7.7-7.9 (1H, m), 8.03 (lHf d, J=7Hz), 8.49 (1H, d, J=9Hz) -9 3 - (請先閲讀背面之注意事項再填寫本頁) 裝- 訂- 線- 本紙張疋度逍用中《諷家樣準(CNS)甲4規格(210X297公*) 81. 5. 20.000(H) B6 五、發明説明(92) 例28 仿例2 7製得下列化合物。 (1)4-〔1-〔3-〔 ( 丁胺甲醯基)(4 -異丁苯基)甲基〕 胺基〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13,6) : 0.8-1.0 (9H, π〇 , 1.1-1.3 (5H, m), 1·43 (2H, m), 1.82 (1H, m), 2.05 (2H, m), 2.3- 2.6 (4H, m), 2.87 (2H, t, J=7Hz), 3.25 (2H, m), 4.11 (2H, q, J=7Hz), 4.88 (1H, s), 6.7-7.0 (3H, m), 7.1-7.4 (8H, m), 8.01 (1H, d, J=7Hz), 8.48 (1H, d, J=9Hz) 0 4-〔1-〔3-〔(庚胺甲醯基)(4 -異丁苯基)甲基〕 胺基〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.8-1.0 (9H, m)f 1.1-1.3 (11H, m), 1.45 (2H, n〇, 1.85(1H, m), 2.0-2.2 (2H, m), 2.4- 2.6 (4H, m), 2.88 (2H, t, J=7Hz), 3*26 (2H, m), 4.12 (2H, q, J=7Hz), 4.70 (1H, s), 6.6-7.0 (3H, m), 7.1-7.3 (6H, m), 7.35 (2H, d, J=9Hz), 8.00 (1H, d, J=7Hz), 8.47 (1H, d, J=9Hz) ⑶4-〔l-〔 3-〔 〔N- (4 -異丁苯基)胺甲醯基〕甲胺基 ]苄醯基]吲阱-3-基〕丁酸乙酯 經濟部中央標準局貝工消費合作社印製 NMR (CDC13, 6) : 0.87 (6H, d, J=7Hz)/ 1.25 (3H, t, J=7Hz), 1.7-2.1 (3H, m), 2.3-2.5 (4H, m), 2.82 (2H, t, J=7Hz), 3·95 (2H, s), 4.11 (2H, q, J=7Hz), 6.7-7.0 (3H, m), 7.09 (2H, d, J=9Hz), 7.1-7.4 (4H, in), 7.45 (2H, d, J=9Hz), 8.02 (1H, d, J=7Hz), 8.50 (1H, d, J=9Hz), 8.58 (1H, s) -9 4 - 81. 5 . 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 本轶張尺度遑用中國家樣毕(CNS)甲4規格(210X297公激) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(93) 阁4-〔1-〔3-〔〔1-〔[^-(4-異丁苯基)胺甲醯基〕乙 基]胺基]芣醯基]B引阱-3-基]丁酸乙酯 NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.23 (3H, t, J=7Hz), 1.62 (3H, d, J=7Hz), 1.70 (1H, m), 1.9-2.1 (2H, m), 2.3-2.5 (4H, m), 2.80 (2H, t, J=7HZ), 3.96 (1H, q, J=7Hz), 4.12 (2H, q, J=7Hz)f 6.7-7.0 (3H, ra), 7.0-7.3 (4H, m), 7.4-7.5 (3H, m), 7.76 (1H, m), 8.03 (1H, d, J=7Hz), 8.50 (1H, d, J=9Hz), 8.83 (1H, s) 例29 仿例1製得下列化合物。 4- [ 1- [ 3-[(苄氧羰基)(4-異丁苯基)甲基〕胺 基〕苄醯基〕吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 0.88 (6H, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1·83 (1H, m), 1.9-2.1 (2H, m), 2.3-2.5 (4H, m), 2·85 (2H, t, J=7Hz}, 4.12 (2H, q, J=7Hz), 5.14 (2H, s), 5.19 (1H, s), 6.7-7.0 (3H, m), 7.0-7.3 (11H, m), 7.38 (2H, d, J=9Hz), 8.00 (1H, d, J=7Hz), 8.46 (1H, d, J=9Hz) 例30 仿例9製得下列化合物。 (1) 4 - [ 1 - [ 3 -[〔庚胺甲醯基)(4 -異丁苯基)甲基〕 胺基〕苄醯基〕吲阱-3-基〕丁酸 -95- 本紙張尺度遑用中困國家樣毕(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 裝- * 财 Αβ 五、發明説明(94) 經濟部中央標準局員工消費合作社印製 NMR (CDC13, 6) : 0.8-1.0 (9H, m), 1.1-1.3 (11H, m), 1.40 (2H, m), 1.85 (1H, τη), 2.0-2.3 (2H, m), 2.4-2.6 (4H, m), 2.95 (2H, t, J=7Hz), 3.22 (2H, m), 4·93 (1H, s), 6.8-7.5 (11H, m), 7.96 (1H, d, J=7Hz), 8.54 (1H, d, J=9Hz) ⑵4-〔l-〔3-[ [1-(庚胺甲醛基)乙基〕胺基〕苄醒 基]吲阱-3 -基]丁酸 NMR (CDC13, δ) : 0.8-1.0 (5H, m), 1.1-1.5 (6H, m), 1·56 (3Η, d, J=7Hz), 2.0-2.4 (4H, m), 2.47 (2H, t, J=7Hz), 2.95 (2H, t, J=7Hz), 3.17 (2H, m), 3.95 (1H, q, J=7Hz)/ 6.8-7.1 (3H, m), 7.2-7.4 (4H, m), 7.96 (1H, d, J=7Hz), 8.55 (1H, d, J=9Hz) ⑶4-〔l-〔3-〔 〔l-〔N-(4 -異丁苯基)胺甲酸基〕乙 基〕胺基〕苄醯基〕吲阱-3-基〕丁酸 NMR (CDC13, δ) : 0.85 (6Η, d, J=7Hz), 1.62 (3H, d, J=7Hz), 1.78 (1H, m), 1.9-2.2 (2H, m), 2.3-2.5 (4H, in), 2·83 (2H, t, J=7Hz), 4.05 (1H, m), 6.83 (1H, s), 6.9-7.0 (2H, m), 7.05 {2H, d, J=9Hz), 7.1-7.5 (6H, m), 7.95 (1H, d, J=7Hz), 8.50 (1H, d, J=9Hz), 8.95 (1H, s) ⑷4-〔l-〔3-〔 〔 (丁胺甲醯基)(4 -異丁苯基)甲基 〕胺基〕苄醯基〕吲阱-3-基〕丁酸 -96- 本紙張尺度通用中《«家«準(CNS)甲4規格(210x297公*) 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 裝- 訂_ A 6 B6 L030b0 五、發明説明(95) (請先閲讀背面之注意事項再填寫本頁) NMR (CDC13, 6) : 0.80 (3H, t, J=7Hz), 0.88 (6H, d, J=7Hz), 1.1-1.5 (4H, m), 1.34 (1H, m), 2.12 (2H, m), 2.4-2.6 (4H, m), 2.96 <2H, t, J=7Hz), 3.24 (2H, m), 4.99 (1H, s), 6.8-7.0 (3H, m), 7.0-7.4 (8H, m), 7·96 (1H, d, J=7Hz), 8·53 (1H, d, J=9Hz) ⑸4-〔l-〔 3-〔 〔N- (4 -異丁苯基)胺甲醯甲基〕胺基 ]苄醯基〕吲阱-3 -基〕丁酸 NMR (CDC13, 6) : 0.88 (6Hf d, J=7Hz)f 1.80 (1H, m), 2.02 (2H, m), 2.3-2.5 (4H, m), 2.84 (2H, t, J=7Hz), 3.94 (2H, s), 6.8-7.0 (3H, m), 7.08 {2H, t, J=7Hz)f 7.1-7.4 (4H, m), 7.40 (2H, d, J=9Hz), 7.95 (1H, d, J=7Hz), 8.50 (1H, d, J=9Hz), 8.57 (1H, s) MAI. 仿例2 4製得下列化合物。 (1)4-〔 1-〔4-〔(S)-l- (4 -異 丁苯基)-2 -乙氣乙氣基 〕苄醯基〕吲阱-3 -基〕丁酸 NMR (CDClj, 6) : 0.88 (6H, d, J=7Hz), 1.22 (3H, t, 經濟部中央標準局貝工消費合作社印製 J=7Hz), 1.7-2.15 (3H, m), 2.4-2.55 (4Hf m), 2.88 (2H, t, J=7.5Hz), 3.5-3.75 (3H, in), 3.8-3.95 (1H, m), 5.41 (1H, dd, J=4.5Hz, 6Hz), 6.8-6.9 (2H, m), 6.97 (2H, d, J=9Hz), 7.05-7.2 (3H, m), 7.25-7.35 (2H, m), 7.72 (2H, d, J=9Hz), 7.94 (1H, d, J=7Hz), 7.42 (1H, d, J=9Hz) 0 4-〔1-〔4-〔(1〇-1-(4-異丁苯基)-2-乙氧乙氣基 -97- 81. 5. 20.000(H) 本紙張尺度遑用中國國家樣準(CNS)甲4規格(210x297公*) A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(96) ]苄醯基]吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.22 (3Η, t, J=7Hz), 1.7-2.15 (3H, m), 2.4-2.55 (4H, m), 2.88 (2H, t, J=7.5Hz), 3.5-3.75 (3H, m), 3.8-3.95 (1H, m), 5.41 (1H, dd, J=4.5Hz, 6Hz), 6.8-6.9 (2H, m)f 6.97 (2H, d, J=9Hz)/ 7.05-7.2 (3H, rn), 7.25-7.35 (2H, m), 7.73 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) m 3 2 仿例2 3製得下列化合物。 ⑴4-〔 1-〔4-〔(S) -卜(4 -異丁苯基)-2 -乙氧乙氧基 〕苄醯基〕吲哄-3-基〕丁酸乙酯 NMR (CDC13, 6) : 0.89 (6H, d, J=7Hz), 1.15-1.3 (6H, m), 1.7-2.15 (3H, m), 2.35-2.5 (4H, m}, 2.88· (2H, t, J=7.5Hz), 3.5-3.75 (3H, m), 3.8-3.95 (1H, in), 4.13 (2H, q, J=7Hz), 5.41 (1H, dd, J=4.5Hz, 6Hz), 6.8-6.9 (2Hf in), 6.97 (2H, d, J=9Hz), 7.05-7.2 (3H, m), 7.25-7.35 {2H, m), 7.73 (2H, d, J=9Hz), 7.98 {1H, d, J=7Hz}, 7.43 (1H, d, J=9Hz) ⑵4-〔 1-〔4-〔(R)-l- (4 -異丁苯基)-2 -乙氣乙氣基 〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, &) : 0.89 (6H, d, J=7Hz), 1.15-1.3 (6H, m), 1.7-2.15 {3H, m), 2.35-2.5 (4H, m), 2.88 (2H, t, J=7.5Hz), 3.5-3.75 (3H, m), 3.8-3.95 (1H, m), 4.13 (2H, q, J=7Hz), 5.41 (1H, dd, -98 - (請先閲讀背面之注意事項再填寫本頁) 裝- 訂_ 線. 本紙張尺度逍用中《«家橾準(CHS)甲4規格(2WX297公*) 81. 5 . 20.000(H) A6 B6 五、發明説明(97) J=4.5Hz, 6Hz), 6.8-6.9 (2H, m), 6.97 (2H, d, J=9Hz), 7.05-7.2 (3H, m), 7.25-7.35 (2H, in), 7.73 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) 仿製備例3 1製得下列化合物 4- [ 1- [ 3-[〔(羧基)(4 -異丁苯基)甲基〕胺基 〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.89 (6Η, d, J=7Hz), 1.23 (3Η, t, J=7Hz), 1.83 (1H, in), 1.9-2.2 (2H, m), 2.3-2.6 (4H, m), 2.82 (2H, t, J=7Hz), 4.13 (2H, g, J=7Hz), 5.08 (1H, s), 6.7-7.0 (3H, m), 7.0-7.4 (6H, m), 7.42 (2H, d, J=9Hz), 7.96 (1H, d, J=7Hz), 8.52 {1H, d, J=9Hz)
例:U 仿例23製得下列化合物e ⑴4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)-2 - 丁炔氣基〕苄醯 基〕吲阱-3 -基〕丁酸乙酯 NMR (CDC13, ό) : 0.92 (6Η, d, J=7Hz), 1.25 (3H, t, 經濟部中央標準局員工消費合作社印製 J=7Hz), 1.75-2.2 (3H, m), 1.92 (3H, d, J=3Hz), 2.4-2.55 (4H, m), 2.91 (2H, t, J=7Hz), 4.14 (2H, q, J=7Hz), 5.86 (1H, m), 6·88 (1H, dt, J=2Hz, 7Hz), 6.93 (1H, s), 7.1-7.3 (5H, m), 7.52 (2H, d, J=9Hz), 7.85 (2H, d, J=10Hz), 8.01 (1H, d, J=7Hz), 8.48 (1H, d, J=8Hz) 9 9- 81. 5. 20.000(H) (請先閲讀背面之注意事項再填寫本頁) 本紙》尺度遑用中國国家揉毕(CNS)甲4規格(210X297公*) L〇3獅 A 6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(98) ⑵4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)-3 - 丁炔氣基〕苄醛 基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.88 (6H, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.84 (1H, m), 2·03 (2H, m), 2.35-2.5 (4H, m), 2.5-2.9 (2H, m), 2·87 (2H, t, J=7Hz), 4.12 (2H, q, J=7Hz), 5.05-5.3 (3H, m), 5.87 (1H, m), 6.8-6.97 (4H, m), 7.12 (2H, d, J=8Hz)/ 7.14 (1H, m), 7.28 (2H, d, J=8Hz), 7.74 (2H, d, J=9Hz), 7.98 UH, d, J=8Hz), 8.43 (1H, d, J=10Hz) ⑶4-〔 1-〔4-〔 1- (4 -異丁苯基)-4 -戊烯氣基〕苄醇 基〕吲阱-3 -基〕丁酸乙酯 NMR (CDCl3f δ) : 0.88 (6Η, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.7-2.35 (7H, ro), 2.42 (2H, t, J=7Hz), 2.46 (2H, d, J=7Hz), 2.88 (2H, t, J=7Hz), 4.13 {2H, q, J=7Hz), 4.95-5.25 (3H, m), 5.87 (1H, m), 6.85 (lH, m), 6.87 (1H, s), 6.93 (2H, d, J=9Hz), 7.12 (1H, d, J=8Hz), 7.04 (1H, m), 7.28 (2H, d, J=8Hz), 7.73 (2H, d, J=9Hz), 7·98 (1H, d, J=8Hz), 8.43 (1H, d, J=9Hz) ⑷ 4-〔 1-〔 4-〔(S)-;l- (4 -異 丁苯基)-3 -丁炔氣基〕 苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.25 (3Η, t, J=7Hz), 1.7-2.15 (3H, m), 2.43 (2H, t, J=7Hz), 2.46 (2H, d, J=7Hz), 2.5-2.9 (2H, m), 2.87 (2H, -10 0- 本紙張尺度通用中國家揉準(CNS)甲4規格(210x297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填窝本頁) 裝. 訂- 轉- A 6 Β6 五、發明説明(") t, J=7Hz), 4.12 (2H, q, J=7Hz), 5.05-5.3 (3H, m), 5.87 (1H, m), 6.8-6.97 {4H, m), 7·12 (2H, d, J=8Hz), 7.14 {1H, n〇, 7.28 (2H, d, J=8Hz), 7.74 (2H, d, J=9Hz), 7.98 (1H, d, J=8Hz), 8.43 (1H, d, J=10Hz) ⑸ 4-〔l-〔 4-〔4, 4, 4 -三氟-1-(4 -異丁 苯基)丁氣 基]苄醯基]吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.89 (6Η, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.7-2.5 U1H, m), 2.88 (2H, t, J=7.5Hz), 4.12 {2H, g, J=7Hz), 5.24 (1H, t, J=5.5Hz), 6.8-6.95 (4H, τη), 7.1-7.2 (3H, n〇, 7.27 (2H, d, J=8Hz), 7.73 (2H, d, J=9Hz), 7.99 (1H, d, J=7Hz), 8.44 {1H, d, J=9Hz) ⑹4-〔 1-〔4-〔 1- (4 -異丁苯基-2-甲氣苯基)戊氣基 〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13/ δ) : 0.8-1.0 (9H, m), 1.15-1.6 (7H, m), 1.7-2.2 (5H, m), 2.35-2.5 (4H, π〇, 2.87 (2H, t, J=7.5Hz), 3.91 (3H, s), 4.13 (2H, q, J=7Hz), 5.60 (1H, dd, J=5Hz, 8Hz), 6.6-7.0 (6H, m), 7.05-7.35 (2H, m), 7.72 (2H, d, J=9Hz), 7.97 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 ⑺ 基 氣 戊 \t/ 基 苯 氧 甲 I 3- 基 丁 異 酯 乙 酸 丁 基 1 3 I 阱 B3' t—\ 基 0 苄 本紙張尺度逍用中《國家樣準(CNS)甲4規格(210x297公釐) 81. 5. 20.000(H) A 6 B6 經濟部中央標準局员工消費合作社印製 五、發明説明(l〇i> NMR (CDC13, 6) : 0.8-1.0 (9H, m), 1.2-1.7 (7H, m), 1.75- 2.15 (5H, m), 2.35-2.5 (4H, m), 2.88 (2H, t, J=7.5Hz), 3.79 {3H, s), 4.13 (2H, q, J=7Hz), 5.12 (1H, dd, J=5Hz, 8Hz), 6.8-7.2 (8H, m), 7.74 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) ⑻4-〔l-〔 4-〔 1-(3 -氟-4-異丁苯基)戊氧基〕苄醯 基〕吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 0.85-1.0 (9H, m), 1.2-1.6 (7H, m), 1.75- 2.15 (5H, m), 2.35-2.5 (4H, m), 2.88 (2H, t, J=7.5Hz), 4.13 (2H, q, J=7Hz), 5.14 (1H, dd, J=5Hz, 8Hz>, 6.8-7.2 (8H, m), 7.74 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) ⑼4 -〔卜〔4 -〔卜〔4 - ( 1 -乙醯氣基-2 -甲基丙基)-2 -氟苯基〕戊氣基〕苄醯基〕吲阱-3-基〕丁酸乙酯 NMR (CDC13, δ) : 0.75-1.0 (9Η, m), 1.25 (3Η, t, J=7Hz), 1.3-1.6 (4H, m), 1.75-2.15 (8H, m), 2.42 (2H, t, J=7Hz), 2.88 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5·44 (1H, q, J=7Hz), 5.52 (1H, dd, J=5Hz, 8Hz>, 6.8-7.2 (7H, m), 7.3-7.4 (1H, m), 7.75 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) ⑽4-〔l-〔 4-〔l-〔 4-(環丙基甲基)苯基〕-3 -丁烯 氧基〕苄醯基〕吲阱-3-基〕丁酸乙酯 -10 2- •本紙張尺度逍用中國·家樣準(CNS)甲4規格(210X297公釐) 81. 5 . 20,000(H) (請先閲讀背面之注意事項再填寫本頁) A 6 B6 五、發明説明(10》 NMR (CDC13, δ) : 0.45-0.6 (2H, m), 0.85-1.1 (1H, m), 1.25 (3H, t, J=7Hz), 1.95-2.15 (2H, m), 2.35-2.95 (8H, in), 4.12 (2H, q, J=7Hz), 5.05-5.3 (3H, m), 5.75-6.0 (1H, m), 6.8-7.0 (4H, m), 7.05-7.35 (5H, m), 7.73 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) 例:^ 仿例1製得下列化合物 4-〔1-〔3-〔 (4-異丁苯基)(苯基)甲胺基〕苄醯 基〕吲啉-3 -基〕丁酸乙酯 NMR (CDC13/ δ) : 0.88 (6Η, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.7-2.1 (3H, m), 2.3-2.5 (4Hf m), 2.82 (2H, t, J=7.5Hz), 4.12 (2H, g, J=7Hz), 4.40 (1H, br s), 5.55 (1H, s), 6.6-6.95 (3H, m), 7.0-7.45 (13H, m), 7.99 (1H, d, J=7Hz), 8.48 (1H, d, J=9Hz) (請先閲讀背面之注意事項再填寫本頁) 裝. 訂- 線- - ,稀 4 1 . c ® 及 1 6 冰 z烷入 _ 乙倒 反氣 , 3 二後 及在時 克溶小 2 克 8 040流 酯ο回 乙氣 ❶ 酸醯克 丁苄23 /—*\ ϋ 基基胺 阱烯乙 吲乙基 3 丨丙 {基異 4-苯二 將丁加 異而 經濟部中央標準局具工消費合作社印製 乾 Λ$ 酸 硫3: 以 -I i , 酸 後乙 洗酸 水乙 而 : 取烷 萃己 ml正 ο ( 3 酯析 乙層 酸膠 乙矽 以在 次 , 。發 中蒸 酸而 鹽燥 1Χ 得 反 基 基 醯 苄 J 基 烯 。 乙油 }色 基黃 苯 - 丁克 . 9 異 2 - . 4 ο ^酯 2-乙 t 酸 本紙ft尺度遑用中《«家播準(CNS)甲4規格(210x297公釐) 81. 5. 20.000(H) Λβ 五、發明説明 NMR (CDC13, δ) : 0.91 (6Η, d, J=7Hz), 1.24 (3H, t, J=7Hz), 1·88 (1H, m), 2.05 (2H, m), 2.45 (2H, t, J=7Hz), 2.50 (2H, d, J=7Hz), 2.90 (2H, t, J=7Hz), 4.13 (2H, g, J=7Hz), 6.90 (1H, s), 7.14 (2H, d, J=8Hz), 7.16 (2H, s), 7.23 (1H, m), 7.45 (2H, d, J=8Hz), 7.5 (1H, m), 7.65 (2H, m), 7.95 (1H, s), 8.04 (1H, d, J=7Hz), 8·52 (1H, d, J=9Hz) 例37 彷例3 6製得下列化合物 ⑴4-〔1-〔 4-反-〔2- (4 -異丁苯基)乙烯基]苄醯基
〕吲畊-3 -基〕丁酸乙酯 mp : 94 - 95 °C NMR (CDC13, δ) : 0.92 {6H, d, J=7Hz), 1.36 (3H, t, J=7Hz), 1.88 (1H, m), 2.0-2.2 (2H, m), 2.4-2.6 (4H, m), 2.90 (2H, t, J=7HZ), 4.13 (2H, q, J=7Hz), 6.8-7.0 (2H, m), 7.1-7.3 (5H, m), 7.47 (2H, d, J=9Hz), 7.62 (2H, d, J=9Hz), 7.85 (2H, d, J=9Hz), 8.02 (1H, d, J=7Hz), 8.51 <1H, d, J=9Hz) 經濟部中央標準扃貝工消費合作社印製 ⑵4-〔l-〔 4-順-〔2- (4 -異丁苯基)乙烯基〕苄醯基 ]吲哄-3 -基〕丁酸乙酯 NMR (CDC13, δ) : 0.90 (6Η, d, J=7Hz), 1.25 (3H, t, J=7Hz), 1.85 (1H, m), 2.0-2.2 {2H, m), 2.4-2.5 (4H, m), 2.89 (2H, t, J=7Hz), 4.13 (2H, q, -10 4- 81. 5. 20,000(H) (請先閱讀背面之注意事項再壤寫本頁) 本紙張尺度逍用中國國家標準(CNS) T4規格(210x297公*) A6 B6 經濟部中央標準局员工消費合作社印製 五、發明説明(10方 . J=7Hz), 6.60 (1H, d, J=llHz), 6.68 (1H, d, J=llHz), 6.85-7.0 (2H, m), 7.02 (2H, d, J=9Hz), 7.15-7.3 (3H, m), 7.39 (2H, d, J=9Hz), 7.71 (2H, d, J=9Hz), 8.02 (1H, d, J=7Hz), 8.50 (1H, d, J=9Hz) ⑶4 -〔 1 -〔 3 -順-[2 - ( 4 -異丁苯基)乙烯基〕苄醯基 〕吲阱-3 -基〕丁酸乙酯 NMR (CDC13/ δ) : 0.85 (6Η, d, J=7Hz), 1.28 (3H, t, J=7Hz), 1.80 (1H, m), 2.05 (2H, m), 2.40 (2H, d, J=7Hz), 2.42 (2H, t, J=7Hz), 2.85 (2H, t, J=7Hz), 4.13 (2H, q, J=7Hz), 6.62 (2H, s), 6.79 (1H, s), 6.89 (1H, t, J=7Hz), 7.00 (2H, d, J=8Hz)# 7.18 (2H, d, J=8Hz), 7.1-7.2 (1H, in), 7.3-7.5 (2H, m), 7.65 (1H, d, J=8Hz), 7.71 {1H, s), 8.02 (1H, d, J=7Hz), 8.48 (1H, d, J=9Hz) 例38 仿例9製得下列化合物。 ⑴4-〔 1-〔 4-〔 1- ( 4-異丁苯基)-2-丁炔氧基〕苄醯 基〕11?丨阱-3 -基〕丁酸 臟(CDC13, δ) : 0.92 (6H, d, J=7Hz), 187 (1H, m),1·90 (3H, d, J=3Hz), 2.08 (2H, m), 2.49 (2H, d, J=7Hz), 2.50 (2H, t, J=7Hz), 2.91 (2H, t,J-7HZ), 5.86 (1H, m), 6.87 (1H, dt, J=2Hz, 7Hz), 6.92 (1H, s), 7.1-7.25 (5H, n〇, 7.52 (2H, d, J=9Hz), 7.84 (2H, d, J=10Hz), 7.97 (1H, d, J=7Hz), 8.46 (1H, d, J=8Hz) 10 5 本紙張尺度遑用中困國家椹毕(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 裝. 線. A 6 B6 經濟部中央標準局員工消费合作社印製 五、發明説明(10; ⑵4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)-3 - 丁烯氣基〕苄醒 基〕吲阱-3 -基〕丁酸 NMR (CDC13, 6) : 0.88 (6H, d, J=7Hz), 1.84 (1H, m), 2.05 (2H, m), 2.44 (2H, d, J=7Hz), 2.48 (2H, t, J=7Hz), 2.5-2.9 (2H, m), 2.88 (2H, t, J=7Hz), 5.03- 5.27 (3H, m), 5.87 (1H, m), 6.84 (1H, m), 6.87 (1H, s), 6.92 (2Hr d, J=10Hz), 7·11 (2H, d, J=8Hz>, 7.13 {1H, m), 7.27 (2H, d, J=8Hz), 7.72 (2H, d, J=10Hz), 7.94 (1H, d, J=7Hz), 8.42 <1H, d, J=9Hz) ⑶4-〔 1-〔4-〔 1- (4-異丁苯基)-4 -戊烯氣基〕苄醋 基〕吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.7-2.35 (7H, m), 2.43 (2H, d, J=7Hz), 2.49 (2H, t, J=7Hz), 2.89 (2H, t, J=7HZ), 4.95-5.1 (2H, m), 5.18 (1H, m), 5.86 (1H, m), 6.84 (1H, m), 6.88 (1H, s), 6.92 (2H, d, J=9Hz), 7.11 (2H, d, J=8Hz), 7.13 UH, m), 7.27 (2H, d, J=8Hz), 7.73 (2H, d, J=9Hz), 7.94 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) ⑷ 4 -〔 1 -〔 4 -〔( S ) - 1 - ( 4 -異 丁苯基)-3 - 丁烯氧基〕 苄醯基]吲哄-3-基〕丁酸 NMR (CDC13, δ) : 0.88 {6H, d, J=7Hz), 1.84 (1H, m), 2.05 (2H, m), 2.44 (2H, d, J=7Hz), 2.48 (2H, t, J=7Hz), 2.5-2.9 (2H, ro), 2·88 (2H, t, J=7Hz), 5.03- 5.27 (3H, m), 5.87 (1H, m), 6·84 (1H, m), -10 6- 衣紙張尺度逍用中β 家榫毕(CNS)甲4規格(210x297公*) 81. 5. 20,000(H) (請先閱讀背面之注意事項再填寫本頁) 裝- 經濟部中央標準局员工消費合作社印製 ^〇3〇b〇 ----五、發明説明(l〇5 6.87 (1H, s), 6.92 (2H, d, J=10Hz), 7·11 (2H, d, J=8Hz), 7.13 (1H, m), 7.27 (2H, d, J=8Hz), 7.72 (2H, d, J=10Hz), 7.94 (1H, d, J=7Hz), 8.42 (1H, d, J=9Hz) m 3 9 仿例1 1製得下列化合物 (1) 4 - [ 1 - [ 4 - [ 4 , 4 , 4 -三氟-1 - ( 4 -異丁 苯基)丁氣 基〕苄醇基〕吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.7-2.55 (11H, m), 2.39 (2H, t, J=7.5Hz), 5.25 (1H, t, J=5.5Hz), 6.8-7.0 (4H, m), 7.1-7.2 (3H, in), 7.27 (2H, d, J=8Hz), 7·75 (2H, d, J=9Hz), 8.97 (1H, d, J=7Hz), 8.46 (1H, d, J=9Hz) ⑵4 -〔 1 -〔 3 - [ ( 4 -異丁苯基)(苯基)甲胺基〕.苄醯 基〕吲畊-3 -基〕丁酸NMR (CDC13, δ) : 0.88 (6Η, d, J=7Hz), 1.7-2.1 (3Η,ra), 2.35-2.55 (4H, m), 2.85 (2H, t, J=7.5Hz),5.55 {1H, s), 6.6-6.9 (3H, m), 6.95-7.45 (13H, ro), 7.95 (1H, d, J=7Hz), 8.47 (1H, d, J=9Hz) ⑶4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁基-2 -甲氧苯基)戊氣基〕 苄醯基]吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.8-1.0 (9H, m), 1.2-1.65 (4H, m), 1.7-2.2 (5H, m), 2.4-2.55 (4H, in), 2.89 (2H, t,J=7·5Ηζ), 3.90 (3H, s}, 5.59 (1H, dd, J=5Hz, ' A 6 B6 (請先閱讀背面之注意事項再填寫本頁) 裝· -1 0 7 - 本紙張尺度逍用中國家樣準(CNS)甲4規格(210x297公釐) 81. 5. 20,000(H) 經濟部中央標準局頁工消費合作社印製 五、發明説明(10)6 8Hz), 6.78 (2H, d, J=7Hz), 6.8-6.95 (4H, m), 7.05-7.3 {2H, m), 7.72 (2H, d, J=9Hz), 7.94 (1H, d, J=7Hz), 8.42 (1H, d, J=9Hz) ⑷4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁基-3 -甲氣苯基)戊氣基〕 苄醯基〕吲阱-3 -基〕丁酸 NMR (CDC13, δ) : 0.8-1.0 (9H, ra), 1.25-1.6 (4H, ra), 1.75- 2.15 (5H, m), 2.4-2.55 (4H, m), 2.89 (2H, t, J=7.5Hz), 3.78 (3H, s), 5.12 (1H, dd, J=5Hz, 8Hz), 6.75-7.2 (8H, m), 7.73 (2H, d, J=9Hz), 7.95 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) (5) 4 -〔 1 -〔 4 -〔 1 - ( 3 -氟-4 -異丁苯基)戊氧基〕苄醯 基〕吲阱-3 -基〕丁酸 NMR (CDC13/ 6) : 0.8-1.0 (9H, m), 1.2-1.6 (4H, m), 1.75- 2.15 (5H, m), 2.4-2.55 (4H, m), 2.88 (2H, t, J=7.5Hz), 5.13 (1H, dd, J=5Hzr 8Hz), 6.8-7.2 (8H, ro), 7.74 {2H, d, J=9Hz>, 7.95 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) (6) 4 -〔 1 -〔 4 -〔 1 -〔 4 -(環丙基甲基)苯基〕-3 - 丁烯 氧基〕苄醯基〕吲阱-3 -基〕丁酸 NMR (CDC13,δ) : 0.45-0.6 (2Η, m) , 0.85-1.1 (1H, in), 1.95-2.15 (2H, m), 2.4-3.0 (8H, m), 5.0-5.3 (3H, m), 5.75-6.0 (1H, m) , 6.8-7.0 (4H, in), 7.05-7.4 (5H, m), 7.72 (2H, d, J=9Hz), 7.95 (1H, d, J=7Hz), 8.43 (1H, d, J=9Hz) 例40 將4 -〔 1 -〔 3 -反-〔2 - < 4 -異丁苯基)乙烯基〕苄固産 -1 0 8 - 本紙張尺度遑用中國家搮準(CNS)甲4規格(210X297公*) 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) B6 五、發明説明(i〇y 基〕時丨阱-3 -基〕丁酸乙酯Ο 2 4克溶在二吗烷5 m 1 ,而加 1 H N a Ο Η 1 m 1 在4 0°C攪拌4小時後,倒入冰與稀邇酸中 。有機層以乙酸乙酯15ml萃取而水洗後,以硫酸鎂乾燥 而蒸發,在20克矽膠層析(氣仿:甲醇= 50: 1),得 4-〔1-〔 3-反-〔2- (4-異丁苯基)乙烯基〕苄醯基〕 吲阱-3-基〕丁酸0.20克,黃色粉末。 NMR (CDC13/ 6) : 0.90 (6H, d, J=7Hz), 1.85 (1H, m), 2.0-2.2 (2H, m), 2.4-2.6 (4H, m), 2.90 (2H, t, J=7Hz), 6.8-7.0 (2H, m), 7.1-7.3 (5H, m), 7.4-7.5 (3H, m), 7.6-7.7 (2H, m), 7.93 (1H, s), 7.99 (1H, d, J=7Hz), 8.51 (1H, d, J=9Hz) 例41 仿例4 0製得下列化合物。 ⑴4-〔1-〔 4-反-〔2- (4-異丁苯基)乙烯基〕苄醒基 〕吲阱-3 -基〕丁酸
mp : 175-176°C NMR (CDC13,δ) : 0.92 (6Η, d, J=7Hz), 1.90 (1Η, in), 2.0-2.2 (2H, m), 2.4-2.6 (4H, m), 2.90 (2H, t, J=7Hz), 6.8-7.0 (2H, m), 7.0-7.2 (5H, m), 7.47 (2H, d, J=9Hz), 7.60 (2H, d, J=9Hz), 7.82 (2H, d, J=9Hz), 7.97 (1H, d, J=7Hz), 8.51 (1H, d, 經濟部中央標準局員工消費合作社印製 J=9Hz) ⑵4 - [ 1 -〔 4 -順-〔2 - ( 4 -異丁苯基)乙烯基〕苄醯基 〕吲阱-3 -基〕丁酸 -10 9- 81. 5. 20,000(H) (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度遑用中國國家樣準(CNS)甲4規格(210x297公釐) B6 五、發明説明(10史 NMR (CDC13, 0) : 0.88 (6H, d, J=7Hz), 1.83 (1H, m), 2.0- 2.2 (2H, m), 2.4-2.6 {4H, m), 2.92 (2H, t, J=7Hz), 6·58 (1H, d, J=llHz>, 6·68 (1H, d, J=llHz), 6.85-6.95 (2H, m), 7.00 (2H, d, J=9Hz), 7.1- 7.2 (1H, ro), 7.20 (2H, d, J=9Hz), 7.38 (2H, d, J=9Hz), 7.70 (2H, d, J=9Hz), 7.98 (1H, d, J=7Hz), 8.49 (1H, d, J=9Hz) _ ⑶4-〔l-〔 3-順-〔2- (4 -異丁苯基)乙烯基〕苄醯基 ]B3丨畊-3 -基〕丁酸 NMR (CDC13, δ) : 0.83 (6Η, d, J=7Hz)/ 1.80 (1H, m), 1.9-2.15 (2H, m), 2.40 (2H, d, J=7Hz>, 2.46 (2H, t, J=7Hz), 2.87 (2H, t, J=7Hz), 6.62 (2H, s), 6.79 (1H, s), 6·88 (1H, t, J=7Hz), 7.00 (2H, d, J=9Hz), 7.1-7.3 (3H, m), 7.3-7.5 (2H, m), 7.65 (1H, d, J=7Hz), 7.70 (1H, s), 7.96 (1H, d, J=7Hz), 8.48 (1H, d, J=9Hz) 例42 將4-〔 1-〔 4-〔 1-〔 4- ( 1-乙酷氧基-2-甲基丙基)-2 -氟苯基〕戊氣基〕苄醯基〕吲畊-3-基〕丁酸乙酯300 mg溶在乙醇3ml及1, 4-二鸣烷3ml,而加IN NaOH 1·5ιπ1 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 混燥 之乾 酸鎂 鹽酸 5Ν硫 ο 以 及 , 酯濯 乙洗 酸水 乙鹽 入食 倒及 ,水 後以 時而 小層 1 機 拌有 攪取 溫分 室 〇 在中 。液 膠 矽 在 縮 濃 而 基 氣 戊
析-阱 層氟吲 柱 2 <—V 仿 氣 基 羥 基 ’ }末 1)基粉 :丙之 5 6 g 2 基 B 1 < 甲 5 I*- _ 醇 甲 酸 得 基 苯 本紙張尺度逍用中困困家楳毕(CNS)肀4規格(210X297公*) 81. 5. 20.000(H) 經濟部中央標準局貝工消費合作社印製 、,,广、 A 6 _]36_ 五、發明説明(ι〇5> NMR (CDC13/ δ) : 0.75-1.05 (9H, m), 1.2-1.65 (4H, m), 1.75-2.15 (5H, m), 2.45 (2H, t, J=7Hz), 2.84 (2H, t, J=7Hz), 4.35 (1H, d, J=6.5Hz), 5.53 (1H, dd, J=5Hz, 7.5Hz), 6.75-7.2 (7H, m), 7.25-7.4 (1H, m), 7.70 (2H, d, J=9Hz), 7.91 (1H, d,J=7Hz), 8.42 (1H, d, J=9Hz) 例43 仿例3 6製得下列化合物。 (1) 4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丁氣基〕苄醯基〕吲 阱-3-基]丁酸乙酯 NMR (CDC13, δ) : 0.8-1.05 (9Η, m), 1.24 (3H, t, J=7Hz), 1.3-1.65 (2H, m), 1.7-2.15 (5H, m), 2.35- 2.5 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.17 (1H, dd, J=2Hz, 7Hz), 6.8- 6.95 (4H, m), 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz)# 7.98 (1H, d, J=7Hz), 8.44 (1H, d, J=9Hz) ⑵4-〔 1-〔4-〔(S)-l- (4 -異丁苯基)丁氧基〕苄醯基 〕吲阱-3 -基〕丁酸乙酯 NMR (CDC13, 6) : 0.8-1.05 (9H, m), 1.24 (3H, t, J=7Hz), 1.3-1.65 (2H, m), 1.7-2.15 (5H, π〇, 2.35- 2.5 (4H, m), 2.87 (2H, t, J=7.5Hz), 4.12 (2H, q, J=7Hz), 5.17 (1H, dd, J=2HZ, 7Hz), 6.8- 6.95 (4H, n〇, 7.05-7.3 (5H, m), 7.72 (2H, d, J=9Hz), 7.98 {1H, d, J=7Hz), 8·44 (1H, d, J=9Hz) (請先閱讀背面之注意事項再填寫本頁) 裝· 訂- -111- 本紙張尺度遑用中》a家標毕(CNS)甲4規格(210X297公*) 81. 5. 20.000(H)
Claims (2)
- C7 D7 六、申請專利範圍 第81104603號「雜琿衍生物.1專利案 (8 2年1月修正) 1. 一種如下式化合物及其製藥容許鹽A-R1 (請先閲讀背面之注意事項再塡寫本頁) 經濟部中央螵準局β工消费合作社印f 式中R1 為羧基或被保護羧基, R2 為氦或h 烷基,R3 為苯基取代箸Ci - β烷基,一或二苯Ci - 6 烷基,此可取代著選自Ci - β烷基,豳素,银基,羧 基,苯Ci - 6烷氣羰基,一或二“ -3烷胺甲醯基,苯胺甲醛基,Ci - e烷笨胺甲醯基,Ci - 6烷氣 基,羥Ct - 3烷基,Ci - 3烷醯氣Ci - β烷基, 環Cs - 6院Cl - 6院基.Cz - 6燦基及C2 - 6快 基之1〜4個取代基,Ci - 6烷胺甲醯Ci - 6烷基, Ci - 6烷苯胺甲醯h - β烷基, Α 為Ci-6伸院基, Z 為C! - 6伸烷基,C£ - 6伸烯基’ -0 -或 Η Η 〇 2 .如申諳專利範圍第1項之化合物,可由下式表示: •11. -線. 本紙張尺度適用中國國家標準(CNS)甲4规格(210 X 297公釐) R7 C7 D7 六、申請專利範圍A-COOH (請先閲讀背面之注意事項再塡寫本頁) 式中R2 、R3 、A及Z各同申謫專利範圍第1項所定義。 3.如申請專利範圍第2項之化合物,其中 為異丁苯基,異丁苯丙基,異丁苯丁基,異丁 苯戊基,異丁苯己基,異丁笨庚基,異丁苯辛基,雙 (異丁苯基)甲基,(羧基)(異丁苯基)甲基.( .苄氣羰基)(異丁苯基)甲基,(丁胺甲醛基)(異 丁苯基)甲基,(庚胺甲醯基)(異丁苯基)甲基, (乙氣基)(異丁苯基)乙基,(異丁苯基)(三氟 )丁基,(苯基)(異丁苯基)甲基,〔(異丁基) 經濟部中央棣準局貝工消费合作社印* (甲氣基)苯基〕戊基,〔氣(異丁基)苯基〕戊基 ,〔氟(羥異丁基)笨基]戍基,〔氣(乙醅氛異丁 基)苯基〕戊基,(環丙基甲苯基)丁烯基,(異丁 笨基)丁炔基,(異丁笨基)丁烯基,(異丁笨基) 戊烯基,庚胺甲醅乙基,異丁笨胺甲醏甲基或異丁笨 胺甲酷乙基, R2為氫或甲基, A為三亞甲基, Z為伸乙烯基,-0-或- NH-。 本紙張尺度適用中國國家標準(CNS>甲4规格(210 X 297公釐) kj 〇3〇b: Λ7 B7 C7 D7 六、申請專利範圓 4. 如申請專利範圃第3項之化合物,乃選自: 4 - Γ 1 - C 4 - ( « (4 -異丁苯基)甲胺基〕¥醯基〕吲 畊-3 -基]丁醃. 4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)丙氣基〕午醯基〕吲 哜-3-基〕丁酸, 4-〔1-〔 4-〔 1-(4 -異丁苯基1 丁氣基]芊醯基〕吲 哄-3-基]丁酸,及 4-〔1-〔 4-〔 1-(4-異丁苯基)戊氣基]苄醅基〕吲 畊-3-基〕丁酸。 5. 如申請專利範困第4項之化合物,乃選自R或S組態 下列化合物: 4-〔1-〔 4-〔 1-(4 -異丁苯基)丙氧基〕午醯基〕吲 畊-3-基〕丁酸, 4-〔 1-〔 4-〔 1-(4 -異丁苯基} 丁氣基〕午醛基〕岡 畊-3-基〕丁酸,及 4 -〔 1 -〔 4 -〔 1 - ( 4 -異丁苯基)戊氣基〕苄醯基〕岡 畊-3-基〕丁酸。 6. 如申請專利範圍第1項之化合物,可由下式表示 (楮先閲讀背面之注龙事項再塡寫本頁) 丨裝. 訂. «濟部中央標準局員工消费合作社印製-3 _ 本纸張尺度適用中國國家標準(CNS)甲4规格(210 X 297 乂'釐>Λ7 B7 C7 D7 六、申請專利範圍 3 R Λ 2 R 中 式 義 定 所 項 1J 第 圍 範 利 專 謓 * 同 各 Z 及 中 其 物 合 化 之 項 6 首 圃 範 利 專 誚 如 基 甲 基 笨 丁 異 /|\ 雙 或 基 , 己基 苯 甲 丁或 異氫 為為 3 2 R R 基 甲 亞三 為 Z 為 或 哄 吲 J 基 :0 自苄 0 J 乃基 , 胺 物甲 合 丨 化基 之笨 項 丁 7異 第4-圍 ί 範雙 利3-專 t 謫3-φ C 如4-8 及 酸 丁 基 雙 異 畊 吲 U 基 酸 苄 基 氣 甲 基 苯 (犄先閲讀背面之注意事項再堉寫本頁) 丄 酸 丁 基 下 如 1 一 9法 製 之R *11. 中 式 2 R 基0 護 保3 被-或 C 基或 羧氫 為為 基 烷 經濟部中夹標準局R工消费合作社印製 1 t c C 著自 代遘 取著 基代 苯取 為可 此 3 R , 基 烷 羧 - C 基 苯氣 二 , 或素一 0 基 基 烷烷 苯 基 基0 甲 胺羥 苯 , , 基 ♦ J -基C 二甲® 烷 或胺 1 苯* ,烷-基 C 辨 - . m 1基 烷e烷 基氣 醢烷 甲 胺 -烷:» 基 烷 本紙張尺度適用中國國家樣準(CNS)甲4規_格(210 X 297公》) Λ7 ..c- Γ·; Η 7 〇 C7 _____D7_ 六、申請專利範園 琢Csi - 6院Cl - 6院基,Ci· - 6嫌基及C2 - 6快 基之1〜4個取代基,C, - β烷胺甲β烷基, C, - β烷苯胺甲醯Ca - 6烷基, A 為Ci - (5伸院基, T- 為Ci - β伸院基,C2 - β伸嫌基,_0_或 ΝΗ » 此製法包括: (1)令如下式化合物或其鹽 (請先閲讀背面之注意事項再填寫本頁)式中R1 , R2及Α各同上, --裝- 訂. 經濟部中央棣準局貝工消费合作社印製 Z1為-0 -或- NH-,與如下式化合物或其鹽反應 W 1 - R3a R8a為一或二苯- β烷基,此可取代著選自 Ci - 6烷基,IS素,氯基,羧基,苯Ci - 6烷氣羰 基,一或二匕-β烷胺甲醯基.苯胺甲醯基, Ci - 6烷苯胺甲醯基.- β烷氣基,羥h e烷 基,Cl - 3院酿氣Ci - 6院基,環C 3 β院Cl ~ 6 烷基,C2 - β烯基及〔:£ - 6炔基之]〜4個取代基, Ct - β烷胺甲醯- β烷基,- 5烷苯胺甲醯 C 1 - β院基, 本紙張尺度適用中Β國家襟準(CNS)甲4规格(210 X 297公» ) Λ7 B7 C7 D7六、申請專利範圍 W1為離基, 而得如下式化合物或其齧 式中R1 , R2 , R】,A及Z1各同上,或 0令如下式化合物或其鹽 (請先閲讀背面之注意事項再塡寫本頁)-COZ-R3 .裝. .ΤΓ. 式中R2 , R3 ,A及Z各同上, Rk為被保護羧基, 消去羧基保護基而得如下式化合物或其馥 線. 經濟部中央樣準局Λ工消費合作社印製Z- R: 式中R2 , R3 , A及Z各同上,或 -6 - 本紙張又度適用中國國家標準(CNS)甲4規格(210 X 297公* ) 申請專利範圍 (3)令如下式化合物或其SI -C〇- -N A-R」 A7 B7 C7 D7
- 2-Cx4Rf I COOR 式中R1 , R2 , A及Z各同前, R7為可有h - 6烷基之苯基, R8為羧基保護基, 消去雜基保謹基而得如下式化合物或其鹽(請先閲讀背面之注意事項再塡寫本頁) —裝. 訂. 式中R1 , R2 , R7 , A及Z各同上,或 ⑻令如下式化合物或其在羧基之反應性衍生物或其鹽A-R 經濟部中央螵準局ικ工消费合作社印製 式中R 1 , R 2 . R 7 ,A及Z各同上, 與如下式化合物或其在胺基之反應性衍生物或其隳反 應 H-R9 -7 - 本紙張尺度適用中國國家標準(CNS>甲4规格(210 X 297公釐) Λ7 R7 C7 D7 六、申請專利範圍 式中R3為可有Ci - 6烷基之胺基, 而得如下式化合物或其鹽 1 ―CO~k\ A-R R2 , R7 ,Rs ,A及 Z-CHR 7 COR 9 (請先閲讀背面之注意事項再堉寫本頁) ®令如下式化合物或其鹽 R Z-R3 —裝. A-COOH 式中R2,R3,A 及Z各同上, 引入羧基保護基而得如下式化合物或鹽 R A-R 式中RaA , R2 , Rs ,A及Z各同上,或 ©令如下式化合物或其鹽 本紙張又度適用中國國家樣準(CNS)甲4规格(210 X 297公«) 訂. -c〇Z-R: 經濟部中央襟準局典工消费合作社印製 iJ Λ7 B7 C7 D7 六、申請專利範圍2 R , 應 上反 同镛 各其 A 或 及物 合 化 ,式 R1下 中如 式與 W(請先閲讀背面之注意事項再堉寫本頁) I 上 同 各 Z 及 基 殘 酸 為0 其 或 物 合 化 式 下 R3如 中得 式而 R丨裝. 訂. 2 R 鹽 許 容 藥 製 其 或 物 上 Μ 合_ ί π «--#之 Ζ 酶項 及原 1 Α還第 ,-圍 3 α R35 範 , 酮利 固專 睪諳 •治申 R1防如 中種含 式一内 10 物 成 組00 之 病 介 仲 經濟部中央標準局貝工消费合作社印製 鹽 許 容 0 製 0 其 0 劑或用 形物之 賦合劑 或化制 體之抑 載項酶 毒 1 原 無第 1 許圍_ 容範 藥利酮 製專固 合諳睪 配申作 1 如當 α 本紙張尺度適用中國a家樣準(CNS)甲4规格(210 X 297公釐)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919113027A GB9113027D0 (en) | 1991-06-17 | 1991-06-17 | Indolizine derivatives |
| GB919120764A GB9120764D0 (en) | 1991-09-30 | 1991-09-30 | Heterocyclic derivatives |
| GB919124345A GB9124345D0 (en) | 1991-11-15 | 1991-11-15 | Heterocyclic derivatives |
| GB929203809A GB9203809D0 (en) | 1992-02-21 | 1992-02-21 | Heterocyclic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW203050B true TW203050B (zh) | 1993-04-01 |
Family
ID=27450702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081104603A TW203050B (zh) | 1991-06-17 | 1992-06-12 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5334716A (zh) |
| EP (1) | EP0519353B1 (zh) |
| JP (1) | JP2663794B2 (zh) |
| KR (1) | KR100244879B1 (zh) |
| CN (1) | CN1042226C (zh) |
| AT (1) | ATE195521T1 (zh) |
| AU (1) | AU656197B2 (zh) |
| CA (1) | CA2071375C (zh) |
| DE (1) | DE69231350T2 (zh) |
| DK (1) | DK0519353T3 (zh) |
| ES (1) | ES2149160T3 (zh) |
| GR (1) | GR3034429T3 (zh) |
| HU (2) | HUT61544A (zh) |
| IE (1) | IE921805A1 (zh) |
| MX (1) | MX9202901A (zh) |
| PT (1) | PT519353E (zh) |
| TW (1) | TW203050B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318790D0 (en) * | 1993-09-10 | 1993-10-27 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
| US6214876B1 (en) | 1994-07-21 | 2001-04-10 | Eli Lilly And Company | Indene-1-acetamide sPLA2 inhibitors |
| US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
| WO2003020311A1 (fr) * | 2001-08-28 | 2003-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Remedes contre les maladies de la peau |
| EP1531817B1 (en) * | 2002-08-27 | 2008-07-30 | MERCK PATENT GmbH | Glycinamide derivatives as raf-kinase inhibitors |
| EP1543875A1 (en) * | 2003-12-04 | 2005-06-22 | Boehringer Ingelheim Pharma GmbH & Co. KG | Novel metathesis ruthenium catalyst |
| FR2893616B1 (fr) * | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
| CN101486710B (zh) * | 2009-02-11 | 2011-04-06 | 中国科学院上海有机化学研究所 | 一种合成3-卤代中氮茚类化合物的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3806513A (en) * | 1969-10-04 | 1974-04-23 | Beecham Group Ltd | Alpha-substituted indolizine propionic acid and its salts |
| GB1268424A (en) * | 1969-10-04 | 1972-03-29 | Beecham Group Ltd | Indolizine derivatives |
| US4205074A (en) * | 1977-05-16 | 1980-05-27 | Hokuriku Pharmaceutical Co., Ltd. | Anti-spasmodic substituted quinolizidine and indolizidine compounds |
| ATE110712T1 (de) * | 1987-06-04 | 1994-09-15 | Ono Pharmaceutical Co | Benzoylaminophenoxybuttersäure-derivate. |
| GB9011335D0 (en) * | 1990-05-21 | 1990-07-11 | Fujisawa Pharmaceutical Co | Indolebutyric acid derivatives and process for preparation thereof |
-
1992
- 1992-06-02 US US07/892,453 patent/US5334716A/en not_active Expired - Fee Related
- 1992-06-12 TW TW081104603A patent/TW203050B/zh active
- 1992-06-13 DK DK92109968T patent/DK0519353T3/da active
- 1992-06-13 EP EP92109968A patent/EP0519353B1/en not_active Expired - Lifetime
- 1992-06-13 ES ES92109968T patent/ES2149160T3/es not_active Expired - Lifetime
- 1992-06-13 AT AT92109968T patent/ATE195521T1/de not_active IP Right Cessation
- 1992-06-13 DE DE69231350T patent/DE69231350T2/de not_active Expired - Fee Related
- 1992-06-13 PT PT92109968T patent/PT519353E/pt unknown
- 1992-06-15 KR KR1019920010367A patent/KR100244879B1/ko not_active Expired - Fee Related
- 1992-06-15 HU HU929201993A patent/HUT61544A/hu unknown
- 1992-06-16 CN CN92104790A patent/CN1042226C/zh not_active Expired - Fee Related
- 1992-06-16 MX MX9202901A patent/MX9202901A/es not_active IP Right Cessation
- 1992-06-16 JP JP4157074A patent/JP2663794B2/ja not_active Expired - Fee Related
- 1992-06-16 AU AU18270/92A patent/AU656197B2/en not_active Ceased
- 1992-06-16 CA CA002071375A patent/CA2071375C/en not_active Expired - Fee Related
- 1992-07-01 IE IE180592A patent/IE921805A1/en not_active Application Discontinuation
-
1995
- 1995-06-22 HU HU95P/P00394P patent/HU211621A9/hu unknown
-
2000
- 2000-09-18 GR GR20000402118T patent/GR3034429T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT61544A (en) | 1993-01-28 |
| US5334716A (en) | 1994-08-02 |
| HU9201993D0 (en) | 1992-09-28 |
| ES2149160T3 (es) | 2000-11-01 |
| CN1042226C (zh) | 1999-02-24 |
| CA2071375C (en) | 2003-02-11 |
| AU656197B2 (en) | 1995-01-27 |
| KR930000513A (ko) | 1993-01-15 |
| DK0519353T3 (da) | 2000-09-18 |
| AU1827092A (en) | 1992-12-24 |
| GR3034429T3 (en) | 2000-12-29 |
| DE69231350T2 (de) | 2001-01-04 |
| CA2071375A1 (en) | 1992-12-18 |
| EP0519353B1 (en) | 2000-08-16 |
| JP2663794B2 (ja) | 1997-10-15 |
| ATE195521T1 (de) | 2000-09-15 |
| HU211621A9 (en) | 1995-12-28 |
| EP0519353A2 (en) | 1992-12-23 |
| CN1067893A (zh) | 1993-01-13 |
| DE69231350D1 (de) | 2000-09-21 |
| MX9202901A (es) | 1993-05-01 |
| IE921805A1 (en) | 1992-12-30 |
| KR100244879B1 (ko) | 2000-03-02 |
| PT519353E (pt) | 2000-12-29 |
| JPH05178856A (ja) | 1993-07-20 |
| EP0519353A3 (en) | 1993-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU691561B2 (en) | Biphenyl derivatives | |
| TW200456B (zh) | ||
| TW202204323A (zh) | 經取代之嗒𠯤化合物 | |
| TW201733B (zh) | ||
| TW316904B (zh) | ||
| JPH05503720A (ja) | ペプチジル誘導体 | |
| JP2013537535A (ja) | Statタンパク質の阻害剤としての、置換2−ヒドロキシ−4−(2−(フェニルスルホンアミド)アセトアミド)安息香酸類似体 | |
| AU2022317677B2 (en) | Benzo [b] selenophene sting regulating agent, preparation method therefor and application thereof | |
| JPS58164557A (ja) | 新規ピリジル化合物 | |
| WO2005044780A1 (ja) | アミノカルボン酸誘導体とその付加塩及びs1p受容体調節剤 | |
| CA3185111A1 (en) | Amido cyclohexane acid derivatives as lpa receptor inhibitors | |
| JPWO2003061658A1 (ja) | インダノン誘導体を含有するシグマ受容体結合剤 | |
| TW203050B (zh) | ||
| WO2016073889A1 (en) | Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders | |
| JPS63270678A (ja) | 新規含窒素化合物 | |
| JP2012067111A (ja) | ベンジルピペリジン化合物 | |
| TWI296268B (en) | Process for producing 1,1-difluorovinyl cycloaliphatic compounds | |
| TW200303745A (en) | Novel compounds | |
| EP1196403B1 (fr) | N-aralkyl amines cycliques antipsychotiques | |
| JP5677855B2 (ja) | 新規抗感染誘導体、それらの製造方法、それらを含有する医薬組成物、及び治療におけるその誘導体の使用 | |
| JPH10316617A (ja) | 新規なフタル酸誘導体 | |
| JPS61227568A (ja) | 新規3‐ピリジルメチルナフチル誘導体およびそれらの製法 | |
| JPS6056130B2 (ja) | 新規なサリチル酸誘導体 | |
| JP2021523207A (ja) | 去勢抵抗性前立腺がんの処置のためのアンドロゲン受容体の核移行の低分子阻害剤 | |
| RU2854366C2 (ru) | БЕНЗО[b]СЕЛЕНОФЕНОВЫЙ STING РЕГУЛИРУЮЩИЙ АГЕНТ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ |